Guanidinium-Rich ROMP Polymers Drive Phase, Charge, and Curvature-Specific Interactions with Phospholipid Membranes by Lis, Michael T W
University of Massachusetts Amherst 
ScholarWorks@UMass Amherst 
Doctoral Dissertations Dissertations and Theses 
Summer November 2014 
Guanidinium-Rich ROMP Polymers Drive Phase, Charge, and 
Curvature-Specific Interactions with Phospholipid Membranes 
Michael T W Lis 
University of Massachusetts - Amherst 
Follow this and additional works at: https://scholarworks.umass.edu/dissertations_2 
 Part of the Biophysics Commons, and the Polymer Chemistry Commons 
Recommended Citation 
Lis, Michael T W, "Guanidinium-Rich ROMP Polymers Drive Phase, Charge, and Curvature-Specific 
Interactions with Phospholipid Membranes" (2014). Doctoral Dissertations. 231. 
https://doi.org/10.7275/v9r6-cp77 https://scholarworks.umass.edu/dissertations_2/231 
This Open Access Dissertation is brought to you for free and open access by the Dissertations and Theses at 
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Doctoral Dissertations by an authorized 
administrator of ScholarWorks@UMass Amherst. For more information, please contact 
scholarworks@library.umass.edu. 
  
GUANIDINIUM-RICH ROMP POLYMERS DRIVE PHASE, CHARGE, AND CURVATURE-SPECIFIC 
INTERACTIONS WITH PHOSPHOLIPID MEMBRANES 
 
 
 
 
 
 
 
 
A Dissertation Presented 
 
 
By 
 
 
MICHAEL THOMAS WOODS LIS 
 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate School of the 
University of Massachusetts Amherst in partial fulfillment 
of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
September 2014 
 
Department of Polymer Science and Engineering 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Michael T. W. Lis 2014 
 
All Rights Reserved 
 GUANIDINIUM-RICH ROMP POLYMERS DRIVE PHASE, CHARGE, AND CURVATURE-SPECIFIC 
INTERACTIONS WITH PHOSPHOLIPID MEMBRANES 
 
 
 
 
 
 
 
 
A Dissertation Presented 
 
by 
 
MICHAEL THOMAS WOODS LIS 
 
 
 
 
 
Approved as to style and content by: 
 
 
 _________________________________________  
Gregory N. Tew, Chair 
 
 
 _________________________________________  
Maria Santore, Member 
 
 
 _________________________________________  
Anthony Dinsmore, Member 
 
 
 ______________________________________  
David Hoagland, Head 
Department of Polymer Science and 
Engineering 
 
 
 
iv 
DEDICATION 
Dedicated to my wonderful wife Vera, without whose care and tolerance none of this would 
have been possible, and to our newborn son Jonathan, who already means everything to me. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
v 
ACKNOWLEDGMENTS 
 I would like to thank Professor Gregory N. Tew for his support, guidance, and direction 
in the work of this thesis.  I would like to thank my committee members, Professors Anthony 
Dinsmore and Maria Santore for their always engaged and incisive commentary and helpful 
suggestions on my research.  Meetings with them presented a real turning point in the progress 
of this research. I have been very fortunate to have exceptionally productive and helpful 
collaborators in Professor Gerard Wong, Dr. Karen Lienkamp, Dr. Frederica Sgolastra and Dr. 
Nathan Schmidt.  Dr. Lienkamp, Professor William T. Verts, Dr. Semra Colak and Dr. Ahmad 
Madkour have also been exceptional mentors during my graduate career, keeping me firmly 
grounded in reality at all times.  Professor Lara A. Estroff, Dr. Farhad Riahi, and Dr. Rebecca 
Jackman provided inspiration and a drive for research in my formative years.  Much of how I 
approach science is a credit to them.  Lastly, I would like to thank my wife, my parents and my 
sister for their endless love and support, and for creating an environment where any question 
can be asked at any time. 
 
 
 
 
 
 
 
 
  
vi 
ABSTRACT 
GUANIDINIUM-RICH ROMP POLYMERS DRIVE PHASE, CHARGE, AND CURVATURE-SPECIFIC 
INTERACTIONS WITH PHOSPHOLIPID MEMBRANES 
 
SEPTEMBER 2014 
 
MICHAEL T. W. LIS, B.S.E., CORNELL UNIVERSITY 
 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Gregory N. Tew 
 
 
Protein transduction domains (PTDs) and their and their synthetic mimics (PTDMs) are 
short sequences capable of unusually high uptake in cells.  Several varieties of these molecules, 
including the arginine-rich Tat peptide from HIV, have been extensively used as vectors for 
protein, DNA, and siRNA delivery into cells.  Despite the wide-ranging utility of PTDs and their 
mimics, their uptake mechanism is still under considerable debate.  How the molecules are able 
to cross phospholipid membranes, and what structural components are necessary for optimal 
activity are poorly understood.  This thesis explores how PTDMs interact with phospholipid 
membrane phase, anionic lipid content and negative Gaussian curvature generation along the 
structural variables of polymer length, charge density, hydrophobicity, aromaticity, and 
architecture. 
Chapter 1 of the thesis provides a thorough introduction and history both of 
antimicrobial polymer-membrane interactions and PTDs and PTDMs.  While much of the thesis 
is focused on the latter category, the rich history of cationic antimicrobial polymers provides an 
extensive framework with which to study PTDMs. 
Chapter 2 examines the link between membrane phase and PTDMs activity.  It is shown 
that cooling phospholipid membranes reduces PTDM activity, but that this barrier can be 
vii 
overcome by increased polymer hydrophobicity.  Cooling cells to 4°C is a common practice to 
distinguish between energy-dependent and energy-independent uptake.  If cooling cells alters 
energy-independent activity, such an experiments may claim a higher fraction of the uptake is 
endocytotic than actually occurs at room temperature. 
Chapter 3 shows that for ROMP-based PTDMs, anionic lipid content in the phospholipid 
membrane is also a barrier to activity. This is counter to the commonly-cited “adaptive 
translocation” model of PTDM activity, where anionic content is seen as a vital component.  
Furthermore, it is demonstrated through the use of zeta potential and surface plasmon 
resonance experiments that hydrophobicity, not cation-anion interactions.  Anionic lipids, 
instead, serve to “pin” the PTDM onto the lipid surface, limiting membrane activity. As with the 
studys regarding membrane phase in chapter 2, this barrier is overcome by added polymer 
hydrophobicity.  These results suggest that cationic content may not strictly speaking be 
necessary to PTDM activity, as is generally assumed, and that a sufficient balance of 
hydrophobicity and water solubility are more critical.  It may then be possible to introduce 
charge-neutral PTDM variants. 
Chapters 4 and 5 explore the relationship between PTDM functionality and architecture 
and negative Gaussian curvature formation in high-phophatidylethanolamine (PE) lipid systems.  
These studies measure negative Gaussian curvature across polymer length, hydrophobicity, 
charge density, and copolymer arrangement.  While all of these factors are found to alter 
curvature formation in high-PE bulk systems, it is still unclear how well these results correlate to 
PTDM activity in cellular systems. 
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CHAPTER 1  
INTRODUCTION 
Note:  Portions of this work appear in: 
Lis M. and G. Tew (2012) Polymer–Membrane Interactions. In: Matyjaszewski K and 
Möller M (eds.) Polymer Science: A Comprehensive Reference, Vol 9, pp. 289–315.  
Amsterdam: Elsevier BV. 
 Protein transduction domains (PTDs) and their and their synthetic mimics (PTDMs) are 
short sequences capable of unusually high uptake in cells.[1-3]  Several varieties of these 
molecules, including the arginine-rich Tat peptide from HIV, have been extensively used as 
vectors for protein, DNA, and siRNA delivery into cells.[4]  For Tat-based systems, it has been 
shown that guanidine functionality, but not specific secondary structure, is critical for uptake,[5] 
providing a set of basic parameters for a variety of synthetic mimics.  Despite the wide-ranging 
utility of PTDs and their mimics, their uptake mechanism is still under considerable debate.[6-
12]  How much of their activity is due to endocytosis, how the molecules are able to cross 
phospholipid membranes, and what structural components are necessary for optimal activity 
are just some of the questions that remain largely unanswered.  
 While the understanding of PTD(M)-membrane interactions is still in its adolescence, we 
have a more mature understanding of a close cousin in antimicrobial molecules.  These 
peptides, small molecules and polymers possess a similar requirement for a balance between 
their cationic nature, water solubility, and hydrophobicity.  The techniques used to study these 
polymer/peptide-membrane interactions is quite robust, and much of the polymer design and 
characterization techniques can be (but largely still hasn’t been) applied to the PTDM literature. 
 This opening chapter will give an introduction to the current understanding of cationic 
polymer-membrane interactions, looking at both antimicrobial polymers and PTD(M)s. While 
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the rest of this document does not spend much time explicitly discussing the antimicrobial 
literature, much of the work herein is inspired by techniques and polymer designs created for 
that field.  A proper grounding in the PTDM literature, then requires the context of the 
antimicrobial literature. The entirely of the antimicrobial literature is vast.  There are already 
excellent resources dedicated to the understanding of the entire field.[13-15]  Instead, the first 
half of this introduction will focus on the narrower field of polymer antimicrobials and biocides 
and the studies of their interaction with lipid membranes.  There is a particular focus on 
highlighting both the diversity of polymer structures created and the techniques used to study 
them. 
 The second half of this chapter will recount a general history of the study of 
guanidinium-rich PTDs and PTDMs.  The focus here will be on the evolution of our 
understanding of the interaction of PTD(M)s with the cell membrane, with a focus on areas that 
still need more attention.   
1.1 Phospholipid Membranes and Model Systems 
Since this section revolves around interactions with biological or biomimetic 
membranes, a brief discussion of the membrane is worthwhile. A more detailed primer focused 
on biological structure can be found in most introductory biochemistry textbooks,[16] while a 
physical view of lipid membranes can be found in books by Israelachvili[17] and Cevc and 
Marsh.[18] The biological membrane is composed of a self-assembled bilayer of phospholipids 
(20–50%), proteins (20–70%), and sterols (0–20%) and is usually 5–8 nm thick. These self-
assembled lipids provide the structural basis for the membrane. Membrane lipids are 
amphiphilic, containing a hydrophilic headgroup and a hydrophobic tail. In mammals, most of 
these lipids are glycerophospholipids, which link the headgroup to the tails by glycerol, and 
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contain a phosphate ion as part of the headgroup. Mammalian membranes are dominated by 
lipids containing the zwitterionic headgroups phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE). Anionic lipids such as phosphatidylserine are also present, but 
in smaller quantities. These lipids contain fatty acid chains of different lengths and degrees of 
saturation. Natural systems contain a mixture of many lipid tails. The two other significant 
components of mammalian membranes are cholesterols, which control the stability and fluidity 
of the membranes, and proteins, which add ion channels, receptors, connections between the 
membrane and cytoskeleton, and other functionalities to the membranes. Bacterial membranes 
contain no cholesterol and their lipid headgroup composition is dominated by the anionic 
phosphatidylglycerol (PG), diphosphatidylglycerol (DPG),[19] also known as cardiolipin, and 
zwitterionic PE. 
Apart from the biological activity of the membrane components, the structural and 
physical properties of the membrane are uniquely complex. First, these lipids can be solid-like or 
liquid-like, depending on their chemical composition and temperature. For example, PC lipids 
containing saturated chains of 16, 18, and 20 carbons melt from a gel (or solid-like) to a fluid 
(liquid-like) state at 41, 55, and 66 °C, respectively. The temperature of this transition is usually 
denoted as Tm. PC containing 18 carbon saturated acyl chains (DSPC) melts at 55 °C, while PC 
containing 18 carbon acyl chains with one cis-double bond (DOPC) melts at –22 °C. Mixtures of 
lipids have a marked effect on their melting behavior. Egg PG (with mixed lengths and mixed 
degrees of unsaturation in the acyl tails) has a broad, heterogeneous melting transition around 
10-20 °C, pure DPPC (saturated tails) gives a much sharper transition at 40–50 °C, and a 50:50 
mixture of the two melts over the range of 20-30 °C.[20] 
Above Tm, the membrane is fluid, allowing the individual lipid molecules to diffuse 
within the self-assembled structure. Lateral diffusion of lipids within the plane (or one leaflet) is 
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rapid, while flip-flop (one leaflet to another) has a much higher energy barrier and, thus, 
requires longer timescales. The fluid nature of the membrane also means that interactions with 
outside forces can influence this phase-mixed or phase-separated state. The fluid nature also 
allows fluctuations to occur, which lead to both transient and irreversible responses. When two 
lipid components are present, lipids can be phase-mixed or phase-separated, depending on both 
intermolecular affinity as well as the thermodynamic states of the lipids. ‘Lipid rafts’ are formed 
when lipids are phase-separated, and one of the lipids is below its melting point. These rafts are 
most often gel-like, but are able to move freely through the fluid phase of the membrane. These 
heterogeneities are proposed to be an essential function of biology. Thus, the membrane, even 
in its simplest form, is dynamic and complex. 
Much of the literature uses simpler synthetic mimics of cell membranes, consisting of 
vesicles (also known as liposomes) and occasionally flat bilayers supported on a substrate. Most 
contain no protein in order to focus on polymer–lipid interactions. Membranes meant to mimic 
mammalian membranes generally consist of PC and may include some cholesterol. Red blood 
cells (RBCs) also serve as a model system, as they do not divide. Gram-positive bacteria mimics 
generally consist of PG and cardiolipin, while gram-negative bacteria mimics have PE and PG. 
1.2 Antimicrobial/Biocidal Polymer-Membrane Interactions 
1.2.1 Cations in the Main Chain 
Polymers containing cations in the main chain were extensively examined by Ikeda et al. 
through the 1980s and 1990s. The biguanide polymers were based on well-known commercial 
biocides, while the quaternary phosphonium and ammonium salts provided more easily 
adjustable structures to study structure–function relationships. Small-molecule biguanides were 
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initially developed for use as antimalarial drugs, but were found to have significant activity 
against a broad spectrum of bacteria.[21, 22] 
A polymeric analog of these small molecules, poly(hexamethylene biguanide 
hydrochloride) (PHMB), was synthesized and found to have stronger biocidal activity than the 
small molecules (Figure 1.1).[23, 24] The first membrane investigations were performed by 
Ikeda et al.,[25] who demonstrated with fluorescence depolarization that the addition PHMB to 
lipid mixtures containing PG lipids increased fluidity of the bilayers. Simple binding of the 
polymer to anionic lipids in the membrane would create a local lipid–polymer complex that 
would be expected to have a slower rate of diffusion due to the increased mass and rigidity 
created by the binding. To explain the increase in fluidity, the authors suggest that the 
hexamethylene region inserts into the bilayer, increasing the spacing between PG lipids. 
 
Figure 1.1. Polymers with cations in the main chain 
In a separate paper, Ikeda et al.[20] used DSC to show that PHMB induced phase 
separation in PC–PG membranes, suggesting that the PHMB selectively bound to the anionic 
lipids.  DSC gives the heat capacity of the polymer/lipid mixtures, showing distinct peaks at the 
melting point (Tm) of the mixture.  PHMB and its monomeric form, when added to pure PG lipid, 
reduced the melting temperature of the lipids, concurring with the earlier finding that PHMB 
increases membrane fluidity.  This is in contrast to magnesium, which also binds lipids together 
but increases Tm, indicating a decrease in fluidity. The authors suggest that the hydrophobic 
regions of the polymer may insert into the bilayer, weakening the interactions between the acyl 
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tails. When PHMB is added to the lipid mixture, the characteristic peak for a mixture is present, 
as well as a peak that more closely resembles the peak seen for pure egg PG. This indicates that 
the polymer induces phase separation in the lipid, creating a PHMB/PG-complex region and a 
DPPC-rich region. Since neither the monomer form (which is less biocidal) nor divalent 
magnesium induces such phase separation, the authors hypothesized that this may be an 
important component of the biocidal activity. On the basis of the observed phase separation 
and the increased fluidity caused by the biocide, the authors hypothesized that a combination of 
hydrophobic and hydrophilic components were necessary for effective polymer biocides. 
 Ikeda et al.[26, 27] synthesized polymers with quaternary ammonium salts in the main 
chain. As with PHMB, the addition of DPH to bilayers containing anionic PA lipid caused 
increased fluidity. As with the biguanide polymers, the increase in fluidity was hypothesized to 
correlate with antimicrobial activity. 
 Similar synthetic methods were used to prepare a wide variety of quaternary cation 
structures with varying hydrophobicity and rigidity.[26] Antimicrobial activity was measured by 
the minimum inhibitory concentration (MIC), the lowest concentration of polymer needed to 
inhibit bacterial growth. Later literature often defines the term MIC90 as the concentration at 
which 90% of bacterial growth is inhibited. MIC values for the polymers were lowest for the 
rigid, hydrophobic structures, and highest for the flexible, hydrophilic backbones. Polymers with 
flexible, hydrophobic backbones between charges had intermediate activity. There was also a 
small reduction in activity when p-xylylene spacers were exchanged for o-xylylene spacers, but 
this may be due to the change in MW (40–24 kg/mol) of the polymers more than the change in 
functionality. Hemolysis by these polymers was not measured, but activity against eukaryotic 
fungi was not substantially different than against bacteria.  Extensive DSC studies were also 
performed on this polymer series. As with the biguanide polymers, the p-phenylene polymers 
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appeared to induce significant phase separation in mixed PA/PC lipid membranes. While 
evidence of phase separation was observed for the other, less effective polymers, it was less 
pronounced, and roughly correlated with antimicrobial activity.  From this evidence, the authors 
hypothesized that antimicrobial activity was correlated with both the rigidity and hydrophobicity 
of the charged polymers. 
 Kanazawa et al.[28] synthesized polymers containing quaternary phosphonium cations 
with aromatic side groups on the phosphonium sites and aliphatic separators. Several different 
spacers were used, but their syntheses were similar.  Polymers of varying MWs and spacer 
lengths were added to cultures of Escherichia coli and Staphylococcus aureus each containing 
∼108 cells/ml. Across the board, polymers had increased antibacterial activity with increasing 
MW and spacer length (hydrophobicity). The more effective samples needed <10 μg/ml polymer 
to kill both strains of bacteria. 
1.2.2 Acrylic Polycations 
 As a companion to the biguanide main-chain polymers, acrylic polymers with biguanide 
pendant groups were also synthesized (Figure 1.2) (polymer 4).[29] Polymers were synthesized 
by free radical polymerization, both as homopolymers and as copolymers of the biguanide 
monomer with acrylamide. MIC values for these polymers were substantially higher than for the 
monomer. The authors hypothesized that these results may be due to the fact that the polymers 
complex with anionic components in the culture media. As a comparison to this approach, the 
authors also performed killing assays in sterile solution. In these assays, a more expected result 
was shown: the monomers were significantly less effective than the polymers in killing S. aureus. 
Furthermore, the activity of the polymers was far higher, with the aniline homopolymer killing 
all S. aureus in culture in concentrations as low as 14 μg/mL. There was no significant difference 
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in activity between the homopolymer and copolymer (when measured by biguanide 
concentration), indicating that the acrylamide segments have no effect – positive or negative. 
This approach to bacterial testing eliminates the problem of polymer complexation with media; 
however, real-world use of these polymers would involve the presence of similar anions. Thus, 
while the data in sterile water may be simpler to explain from a mechanistic point of view, it 
may not correlate to real-world effectiveness. 
 
Figure 1.2.  Acrylic Polymers 
 The most thorough examination of the interaction of cationic methacrylates and 
phospholipid membranes has been made by Kuroda et al.[30-34]  Initial work combined butyl 
methacrylate and aminoethyl methacrylate monomers to generate a series of polymers with 
varying MWs and hydrophobic/cationic ratios (6).[30]  Polymers with low MW and 17% butyl 
methacrylate content exhibited some selectivity (HC50 to MIC, or ratio of lysis to antimicrobial 
inhibition greater than 1), but relatively high MIC values of around 60 μg/mL. 
 This repertoire of polymers was vastly expanded to include methyl, ethyl, hexyl, and 
phenyl side groups.[34] These polymers showed a step-like relationship between hydrophobic 
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content and MIC, but a more continuous trend in hemolytic data.  Between these two extremes, 
there were some polymers with reasonable selectivity. Most notably, polymers with about 50% 
methyl methacrylate showed excellent antimicrobial activity, with a MIC of less than 10 μg/mL 
and a selectivity index of around 10. The authors presumed that the amount of hemolysis 
caused by the polymers was directly related to the hydrophobic content of the polymers. To test 
this hypothesis, they used a theoretical octanol–water partition coefficient (P) as a relative 
measure of hydrophobicity. As a scaling between the different alkyl side chains, the authors 
used the known linear P relationship between methanol, ethanol, butanol, and hexanol. To 
measure the relative hydrophobicity of an entire polymer, they added the logarithm of the 
partition coefficients for all of the polymers (ΣlogP). The plot of ΣlogP against HC50 values 
provided remarkably consistent results across the series of polymers. 
 To understand the antimicrobial ability and selectivity of these polymers, Kuroda et al. 
looked at polymer binding affinity with membranes containing different lipid compositions. To 
determine the binding constants to lipid membranes, a fluorescent dansyl functional group was 
added to the end of the polymer. This group emits increased fluorescence in hydrophobic 
environments, so an increase in fluorescence is interpreted as a binding of the polymer to lipid 
vesicles. These data were fitted to a binding model to give a dissociation constant value.  Binding 
to POPC vesicles increased with hydrophobic content of the polymer, which was expected. More 
surprising, however, was the ‘reduction’ of binding to both POPC/POPE and POPC/POPG vesicles 
compared to binding with POPC. Both lipids are far more common in bacteria than the outside 
of mammalian cells. Furthermore, POPG is anionic, which would be expected to have a stronger 
binding to a cationic polymer than the other zwitterionic lipids. This is also in stark contrast to 
some of the literature available for cationic peptides.[35-38] 
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 Further work by Palermo and Kuroda[32] extended the library of molecules to include 
tertiary amine- and quaternary ammonium-functionalized methacrylates. For this series, 
cationic monomers were polymerized with methyl and butyl acrylate monomers. As with the 
styrene-based polymers of Gelman et al., the quaternary ammonium series was much less 
antimicrobial and somewhat less hemolytic than the primary and tertiary amine series. Again, 
titration of the polymers showed that there is partial deprotonation of the amine functionalities 
at neutral pH. The deprotonated moieties are more hydrophobic than the ammonium salts, and 
thus increase the membrane activity of the polymers. No explanation was given, however, for 
the increased activity of the primary amine polymers over the tertiary amine polymers. 
1.2.3 Peptide-Based Polycations 
Similar to the work by Kuroda et al. with methacrylate polymers and Sambhy et al. with 
pyridinium polymers, Mowery et al.[39] created a series of random β-peptide copolymers 
containing cationic and hydrophobic residues (7).  Polymers were synthesized by ring-opening 
polymerization using tert-butylbenzoyl chloride and lithium bis(trimethylsilyl) chloride. Polymers 
containing 30–100% cationic lactam were synthesized, and MIC and minimum hemolytic 
concentration (MHC) values were reported. MHC represents the lowest concentration of 
detectable hemolysis and is somewhat more sensitive than the HC50. The polymers with the 
highestselectivity resided in the 60–65% cationic monomer range, with MIC values of 12–25 
μg/mL against S. aureus and E. coli. MHC values were in the 100–1000 μgml−1 range, depending 
on the exact monomer ratio. 
11 
 
 
Figure 1.3.  Peptide-based antimicrobial polymers. 
 The polymer containing 60% cationic residues was used in studies with lipid vesicles 
mimicking mammalian and bacterial cell membranes by Epand et al.[38] The authors loaded the 
vesicles with a dye (ANTS) and a concentration-dependant quencher (DPX). The released ANTS 
fluoresces, allowing determination of the extent of leakage. The 100% leakage level is set using a 
surfactant. The polymer permeabilized vesicles of DOPE:DOPG 80:20 (E. coli mimic), DOPG:CL 
58:42 (S. aureus mimic), and DOPG:DOPE:CL 84:12:4 (B. subtilis mimic) at very low 
concentrations, but did not cause leakage from POPC (mammalian mimic) vesicles. The authors 
attribute the difference to the presence of anionic lipids in the bacterial membrane mimics. To 
demonstrate that the polymer binds to anionic lipids, ITC and DSC experiments were performed. 
ITC showed evidence of binding to DOPE:DOPG vesicles, but not to DOPC vesicles, indicating 
binding to the bacterial mimic, but not the mammalian mimic. 
 DSC was first run with a DPPG:CL lipid mixture. Pure DPPG has a gelation temperature of 
65 °C which is reduced by the addition of cardiolipin. The DSC of the lipid mixture shows a broad 
peak at around 50 °C. With the addition of polymer, which does not have a thermodynamic 
transition in this range, two peaks become evident in the heating trace, indicating possible 
phase separation. The effect does not show up in subsequent traces, possibly because of 
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polymer degradation at high temperature. To remedy this, the experiment was attempted with 
POPE:CL, which has a gelation temperature of 20 °C. Addition of the polymer increased the 
gelation point on the heating curve, and created two peaks on the cooling curve. The authors 
argue that this is evidence that the polymer binds to cardiolipin and forces separation of the 
lipids into CL-rich and PE-rich phases. 
 To observe permeation through both the inner and outer membranes of gram-negative 
bacteria, Epand et al. used two probes on a modified strain of E. coli. The E. coli strain was 
modified to lack lactose permease and express a β-lactamase.  The first probe was a 
chromogenic β-lactam antibiotic.  The antibiotic can only cross the outer membrane once the 
membrane is permeabilized, where it is then opened by the β-lactamase residing in the 
periplasm. The ring-opened form of the antibiotic absorbs at 486 nm which can be monitored. 
The cells show a gradual permeabilization of the outer membrane over the course of an hour. 
Melittin, by contrast, permeabilizes the outer membrane very quickly. To monitor inner 
membrane permeabilization, o-nitrophenyl-3-D-galactoside (ONPG) is used. ONPG cannot cross 
the inner membrane by itself but cleaves in the cytoplasm to o-nitrophenol, which absorbs at 
420 nm. In the presence of melittin, the inner membrane is permeabilized quickly, with almost 
no delay from the outer membrane pore formation. With the antimicrobial polymer, however, 
the inner membrane was very slowly permeabilized, and only after a substantial delay from the 
outer membrane.  Surprisingly, the inner membrane was only permeabilized at low polymer 
concentrations. The experiment was repeated with bacteria capable of actively transporting 
ONPG across the inner membrane, and the result was the same. ONPG was hydrolyzed in the 
cells at low polymer concentrations, but stopped at higher concentrations. The authors suggest 
that the polymer is somehow inhibiting transport of ONPG across the outer membrane at higher 
polymer concentrations. 
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 Lastly, the authors used a SYTO 9/propidium iodide assay to test the overall membrane 
integrity after exposure to the polymer. At low doses, the membrane becomes more porous to 
the propidium iodide, but at high doses, the permeability of the membranes is again reduced. It 
should be noted, however, that this result did not correspond with cell death. Thus, it was 
suggested that some other method of cell toxicity must be at work for higher polymer 
concentrations. 
1.2.4 Imide-Based ROMP Polycations 
 Ring-opening metathesis polymerization provides a platform on which to create living 
polymers with varied biologically active functionalities.[40-42]  These polymers have been used 
both for antimicrobial and cell-penetrating peptide mimic purposes.  The first class of ROMP 
polymers made used an imide-functionalized oxanorbornene structure.[40] Ilker et al.[43] 
designed a series of monomers with amine side chains and varying degrees of backbone 
hydrophobicity (Figure 1.4).  This arrangement was meant to mimic the facially amphiphilic 
structure of magainin, an antimicrobial polymer found in frogs. Magainin has an α-helical 
structure, with largely cationic residues displayed on one side and hydrophobic residues on 
another side.[44]  Previous work had shown that small molecules containing a facially 
amphiphilic structure could be similarly antimicrobial without a helical structure.[45, 46]  In this 
motif, each individual monomer is facially amphiphilic across the backbone, instead of using 
comonomers or placing both the hydrophobic and cationic regions on the same side chain 
(Figure 1.4). 
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Figure 1.4.  Imide-based ROMP antimicrobials. 
 The backbone was made with four different increasingly hydrophobic functionalities 
(series 8). Polymerization by ring-opening metathesis polymerization used modified Grubbs’ 
catalysts. The boc groups were removed postpolymerization with trifluoroacetic acid. 
Homopolymers made from the first monomer were relatively inactive against bacteria and 
nonhemolytic. Polymer 8-(2) was only weakly antimicrobial, but still not hemolytic. Polymers 
made from the third monomer were somewhat effective against bacteria and very hemolytic. 
Polymers made from the most hydrophobic monomer were hemolytic but less antibacterial. 
None of the homopolymers were highly antibacterial and selective.  Copolymers of 8-(2) and 8-
(3), however, were antimicrobial and strongly selective, suggesting that the proper degree of 
amphilicity was to be found between the two monomer types. The best performing of these 
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polymers had an MIC of 40 μg/mL against both B. subtilis and E. coli and a selectivity ratio of 
over 100. 
 As an alternative to forming copolymers of 8-(2) and 8-(3), both of which were partially 
active, Colak et al.[47] took the toxic 8-(3) and introduced hydrophilic comonomers to increase 
the polymer selectivity. 8-(3) was polymerized with different comonomers containing sugar, 
carbobetaine, and PEG functionalities, respectively. The 50:50 8-(3):carbobetaine copolymer had 
substantially improved selectivity, with MICs of 150 μg/mL against S. aureus and 200 μg/mL 
against E. coli. 
 The interaction of the homopolymers of this series with biomimetic vesicles was 
examined by Gabriel et al.[48] to understand the mechanism of antimicrobial activity and 
selectivity.  Dye leakage of quenched calcein-filled vesicles was measured upon exposure to 
polymers of series 8. The vesicles consisted of 3:1 POPE:POPG lipids to mimic the composition of 
E. coli membranes. Across the series, dye leakage correlated with antimicrobial activity, 
suggesting the polymers may operate by permeabilizing the cell membranes. The interaction of 
the polymers with these vesicles was also examined under dynamic light scattering. Polymers 8-
(2) and 8-(3), which had some antimicrobial activity, caused the vesicles to aggregate, while 
polymer 8-(1), which was not antimicrobial, did not create any aggregation, despite its cationic 
nature. This aggregation behavior also contrasts with a detergent, which simply lyses vesicles 
and does not create vesicle aggregation. This aggregation behavior was also observed for both 
live E. coli and vesicles by fluorescence microscopy. 
 Binding of the polymers to E. coli vesicle mimics was measured quantitatively by ITC. 
Polymers 8-(1) and 8-(4), which were not antimicrobial, showed little binding. Polymers 8-(2) 
and 8-(3), which showed more activity, showed a strong binding endotherm. This indicates that 
the hydrophobic nature of the polymers is necessary to properly bury the polymer into the 
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membrane, while polymer 8-(4) preferred self-association over membrane binding. From these 
studies, the antimicrobial polymers were shown to bind to E. coli vesicle mimics and insert into 
the membrane causing the vesicles to aggregate. The nonactive polymers shared none of these 
attributes.  
This class of polymers was expanded by Al-Badri et al.[49] to include polymers with 
multiple cationic groups. It was found that for hydrophobic 9-(3), doubling the cationic content 
reduced hemolysis while leaving antibacterial activity unaffected.  For the less hydrophobic 
polymer 9-(1), the increasing cationic nature improved activity against gram-positive S. aureus, 
but not gram-negative E. coli, while leaving hemolytic activity unaltered. 
ROMP polymers with alkyl pyridinium moieties were also synthesized (13).[50]  The 
ethyl and butyl pyridinium polymers were not only nonhemolytic but were also not strongly 
active against either E. coli or B. subtilis. Polymers with longer alkyl chains were not only 
antibacterial but also moderately hemolytic. The most selective polymer found was the hexyl 
polymer, with MIC values of 12.5 μg/mL against E. coli and 4 μgml−1 against B. subtilis, with an 
HC50 of 202 μg/mL. 
Similar to the above work with methacrylates and β-peptides, polymers containing 
random combinations of hydrophobic and hydrophilic side groups were created by Gabriel et 
al.[51]  Both cationic and hydrophobic monomers possessed an oxanorbornene base. A large 
variety of hydrophobic alkyl side groups were used for the hydrophobic monomers. In contrast 
to the results for other polymers, none of the created copolymers showed selective 
antimicrobial activity. All of the created polymers were either nonantimicrobial or hemolytic.  
The authors suggest that the result stresses the importance of local over global amphilicity. 
 Gabriel et al.[52] also synthesized guanidine-rich oxanorbornene polymers (PGON) (12). 
Unlike the amine version of the same polymer, the PGON homopolymer was found to be both 
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antimicrobial and selective, with a selectivity ratio of 125 against S. aureus and 250 against E. 
coli. It was expected that like the other antimicrobial polymers described above, PGON would 
induce leakage in E. coli mimic POPE/POPG vesicles but not mammalian mimic POPC vesicles. 
Surprisingly, PGON did not induce leakage in the POPE/POPG vesicles, indicating that the 
antibacterial mode of action is not membrane disruption like the other polymers, but instead 
some other mechanism. The cause of PGON’s antimicrobial activity is still being investigated. 
1.2.5 Ester- and Amide-Based ROMP Polycations 
In addition to the imide-based structures listed above, both single- and double-armed 
ester structures have been examined in contact with lipid membranes. Lienkamp et al.[41, 53, 
54] introduced double-armed ester-based ROMP polymers (14) (Figure 1.5). The imide-based 
antimicrobial molecules have the disadvantage of requiring significant synthesis. Instead of 
giving the polymers amphiphilicity across the backbone, these polymers contain cationic and 
hydrophobic ‘arms’, which likely segregate in solution.[41] 
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Figure 1.5.  Ester-based ROMP antimicrobials. 
Biological activity of the homopolymers was measured by inhibitory assays of E. coli and 
S. aureus bacteria and hemolysis of RBCs. The methyl polymers were inactive and nontoxic, the 
propyl polymers were active and toxic, and the ethyl polymers were selective but not 
impressively so. MW was found to be exceptionally important. Higher MW propyl polymers 
were more active against E. coli as well as more toxic, but were progressively less effective 
against S. aureus. This effect was attributed to stronger binding of longer polycations to the 
peptidoglycan layer of the gram-positive bacteria. Copolymers of methyl, ethyl, and propyl 
monomers were synthesized. The methyl/propyl copolymers were especially effective against S. 
aureus, with a selectivity of over 500. What was surprising (and previously unprecedented) was 
that while these polymers were very effective against S. aureus, they possessed no antimicrobial 
activity against E. coli. 
This same synthetic approach was also used to create diamine ROMP monomers.[54]  
The homopolymers were again selective for S. aureus, but not for E. coli. Since the diamine 
monomers closely resembled the methyl monomers in terms of hydrophobicity, copolymers of 
these two monomers were used to examine the importance of charge density. There was a 
significant increase in S. aureus activity with increasing diamine content from 0% to 10%, but a 
 
R=methyl, ethyl, propyl
butyl, ethyl ammonium
O
O
O
O
O
R
+H3N
14
19 
 
slow decrease in activity at higher ratios. It was thus hypothesized that the polymer needed to 
overcome a ‘threshold’ of cationic content to be active, but that additional cations do not 
improve antimicrobial activity. 
The diamine polymers were used to investigate the cause of this ‘double selectivity’ 
further.[53] Gram-positive and gram-negative bacteria have significant differences in membrane 
composition. Gram-positive bacteria have a single phospholipid membrane containing 
significant amounts of cardiolipin (DPG), with a thick peptidoglycan layer on the outside. Gram-
negative bacteria have two phospholipid membranes consisting of PE and PG lipids, with a thin 
peptidoglycan layer between them and a lipopolysaccharide (LPS) layer on the outside. There 
are thus features of E. coli which might inhibit activity: the number of membranes, membrane 
composition, and the LPS layer. The first possibility was tested by perforating the outer 
membrane of E. coli with EDTA and running the usual MIC90 experiment. Removing the outer 
layer made the polymer antimicrobial, with an MIC90 of 100 μg/mL. Dye leakage experiments 
were performed with CF-loaded vesicles of E. coli- and S. aureus-like lipid compositions and no 
significant differences were observed. In a similar dye leakage experiment, LPS was incubated 
with the polymer for varying lengths of time before injection in the vesicle solution.  LPS did 
inhibit dye leakage, but only after 15 min of incubation with the polymer before injection into 
the vesicle solution. This means that the ‘double selectivity’ is likely due to the outer membrane 
limiting polymer exposure to the inner membrane, and possibly retarding LPS binding. 
The study also approached the earlier question of why longer polymers had lower 
activity against S. aureus. To test the original hypothesis that the polymer was binding to the 
peptidoglycan layer, the polymer was incubated with peptidoglycan extract.  Binding of the 
polymer to peptidoglycan does reduce dye leakage, but only after long incubation of the 
peptidoglycan with the polymer before injection into the vesicle solution. The conclusion is that 
20 
 
binding to the peptidoglycan layer is likely not the cause of the reduced activity of the larger 
molecules. The authors hypothesize that the reduction in activity may instead be due to the 
peptidoglycan layer acting as a sieve for larger molecules. 
1.2.6 Conjugated Polycations 
 The use of conjugated polymers has been thoroughly investigated by Schanze and 
Whitten. Chemburu et al.[55] created a series of polyphenylene ethynylene (PPE) biocidal 
polymers (Figure 1.6). Conjugated polymers containing quaternary ammonium and oligo-
ethylene glycol side chains were made (15), as well as polymers containing doubly cationic 
DABCO-based side chains (17). Both classes of molecule were polymerized by Sonogashira 
coupling. These polymers were shown to have significant bactericidal activity at relatively low 
concentrations. They were less effective, however, when incubated without light exposure. 
Infrared spectroscopy showed the presence of singlet oxygen generated in solution by the 
polymer after exposure to visible light. The authors thus suggest that the polymer, upon light 
exposure, generates singlet oxygen that adds to the killing efficiency of the polymer. This 
process is not likely to be selective. As an expansion of this concept, the authors coated silica 
particles with the quaternary ammonium polymer using a grafting from process. The DABCO 
polymers were physisorbed onto negatively charged silica particles. These polymer beads were 
found to successfully attract and kill bacteria, causing the beads to quickly become coated in 
dead bacteria. The DABCO-PPE-coated beads were shown to be similarly effective when made 
by a layer-by-layer deposition when combined with an anionic PPE.[56] 
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Figure 1.6.  Conjugated Polycations 
 Further work involved the creation of a conjugated polymer with quaternary ammonium 
side chains and an alternating phenylene–ethynylene–thiophene–ethynylene backbone 
(16).[57] These polymers were also physisorbed onto silica beads. As with the other polymers, 
they showed the ability to attract and kill bacteria. Unlike previous polymers, however, light 
exposure appeared to inhibit bacterial growth. Furthermore, free polymer in solution appeared 
to be far more effective at killing P. aeruginosa than previous polymers.  Infrared spectroscopy 
studies showed that the thiophene-containing polymer produced less singlet oxygen in water 
upon light exposure, an event attributed to reduced solubility of the polymer, and thus less 
exposure of the polymer to molecular oxygen dissolved in the water. 
 This hypothesis was tested by extensive examination of polymer–lipid interactions by 
Ding et al.[58] Both 16 and 17 showed an increase in fluorescence emission when combined 
with DOPG vesicles in solution, indicating that the polymer binds to the vesicle preferentially 
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over remaining in solution. An aqueous quencher was introduced to determine if the polymer 
sits on the inside or outside of the vesicles.  Without vesicles, AQS quenched the fluorescence of 
both polymers almost completely. When 16 was combined with DOPG vesicles, very little 
quenching was seen, even after 5 min. With 17, fluorescence was quenched for an hour. This 
indicates that 17 stays on the outside of the lipid membrane much longer and takes longer to 
insert itself. Studies of the interactions of both polymers with DMPG lipids at the air/water 
interface also suggested far stronger and kinetically faster interactions with 16 than 17. 
 To examine polymer selectivity, the same tests were run with 16 and vesicles containing 
different lipid headgroups.[59] As before, the polymer was shown to bind and insert into DPPG 
vesicles. When the polymer was left in a solution of zwitterionic DPPE and DPPC vesicles, the 
fluorescence was strongly reduced by the aqueous quenching agent, indicating that the polymer 
does not insert into these vesicles. The fact that these polymers inserted into anionic lipids 
common in bacteria but not into zwitterionic lipids common in mammalian cells suggested 
possible selectivity. This was later confirmed by fluorescein leakage from vesicles.[60] 
DOPG/DOPE (bacterial mimic), E coli lipid extract, and DOPC/cholesterol (mammalian mimic) 
vesicles were loaded with quenched fluorescein dye and exposed to all three polymers created 
above. All three polymers caused significant leakage in the DOPG/DOPE vesicles and very little 
leakage of the DOPC/cholesterol vesicles. For the E. coli lipid vesicles, 17 induced significant 
leakage, while the other two polymers induced only minor leakage. This further promotes the 
hypothesis that these polymers may indeed be selective towards killing bacteria and not 
mammalian cells. 
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1.2.7 The State of Antimicrobial and Biocidal Cationic Polymer Research 
As is clearly evident from the work above, there is a rich diversity of cationic polymer 
structures available, and strong structure-property relationships have been established.  To be 
active antimicrobials, polymers need sufficient cationic content and hydrophobicity to penetrate 
bacterial lipid membranes.  To be selective, however, there also needs to be a limit to those 
components so that they do no penetrate mammalian lipid membranes.  This means that there 
is often a “sweet spot” or ideal balance of functional group content that leads to effective 
antimicrobial polymers. 
Additionally, much headway has been made in understanding the nature of the 
interaction between these polymer and bacterial lipid membranes.  Differences in lipid content 
are clearly linked to antimicrobial activity and selectivity.  A selective antimicrobial polymer will 
induce dye release in a bacterial lipid membrane mimic (usually containing a 
phosphatidylenthanolamine/phosphatidylglycerol mixture or cardiolipin), but not a mammalian 
one (usually phosphatidylcholine), suggesting that the differences between these lipid systems 
are critical to activity and selectivity. While bacterial membranes generally contain more anionic 
content than mammalian ones, binding studies often conflict over whether anion/polycation 
binding is critical to activity.  The answer is more likely to be found in the work of Wong and 
colleagues, with small molecule- and peptide-based antimicrobials.[61-65]  Here, there is a 
clearly established relationship between the formation of negative Gaussian curvature phases in 
bulk membrane systems and antimicrobial activity.  The difference between activity in bacterial 
membranes and inactivity in mammalian ones lies in the negative intrinsic curvature contributed 
by phosphatidylethanolamine and cardiolipin.[61-63]  This feature is discussed in more detail in 
section 1.3.2 of this introduction and chapters 4 and 5 of this work. 
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This work on cationic antimicrobials constitutes a framework for understanding PTDMs.  A 
combination of binding studies, dye release experiments, and membrane curvature studies like 
those found in the antimicrobial literature above will be used in this thesis to better understand 
PTDM-membrane interactions. 
 
1.3 Protein Transduction Domains and their Synthetic Mimics 
1.3.1 Cell Studies of PTDs 
 The protein transduction domain Tat was simultaneously and independently discovered 
by Frankel and Pabo[66] and Green and Loewenstein.[67]  Tat had previously been well 
understood as a trans-activator protein that enhances the expression of HIV genes.  As a 
method to quantifiably measure this trans-activation process, Frankel and Pabo scrape-loaded 
cells with purified Tat.  The scrape loading damaged the cell membrane sufficiently to allow 
protein into the cells.  As a control, however, they also simply introduced purified protein into 
an undamaged cell culture.  To their surprise, Tat was able to induce trans-activation in the 
latter control case, although it required about an order of magnitude more protein to achieve 
the same result. This was relatively unheard of, as 86 base-pair molecules such as Tat are 
generally not capable of passing through cell membranes.  Green and Loewenstein were 
similarly attempting to understand how trans-activation occurs, and were using microinjection 
to deliver both the HIV plasmid and purified Tat protein.  Strong binding between the plasmid 
and Tat, however, limited the activity of the Tat protein.  Rather than depend on sequential 
microinjections, the authors attempted to use microinjections for the plasmid and simply add 
Tat to the cell medium.  To their surprise, much like Frankel and Pabo, they found that Tat was 
successfully able to cause trans-activation by simple introduction to the cell medium.  
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Furthermore, through the use of deletion mutants, they showed that region II (residues 38-48) 
and region III (residues 49-57) were both necessary and sufficient to cause trans-activation.  The 
authors speculated that region II was the portion that caused trans-activation and that region III, 
which was highly basic and included 6 arginine residues, was necessary for membrane transport 
and nuclear localization. 
 Fawell et al.[68] subsequently determined that Tat37-72, was capable of carrying cargo 
into cells when covalently bound together.  Truncated Tat was in separate experiments 
covalently bound to β-galactosidase and horseradish peroxidase (HRP).  After exposure to the 
conjugate, the cells were then fixed and exposed to stains.  Several different cell lines were 
tested, and all showed similar uptake, with punctuate endosomal uptake as well as diffuse 
staining in the cytosol.  This was the first case of what would become the now-standard 
procedure of covalently bonding PTDs to desired cargo. 
 Vivès et al.[69] further narrowed the region of importance for cellular uptake.  The 
authors used truncated peptides conjugated to fluorescein dye.  HeLa cells were incubated with 
the dye-labeled peptides, fixed, and imaged under a confocal microscope.  Peptides with only 
residues 48-60 showed no reduction in uptake, but others that truncated this region were 
unable to deliver to cells.  Unlike previous studies, this was also the first case where Tat uptake 
in a cell was imaged directly.  Most impressively, the imaged showed diffuse cytosolic uptake in 
addition to the regions concentrated inside endosomes.  This uptake was maintained for cells 
both when the cells were cooled to 4°C and when endocytosis was chemically inhibited. 
 The major discovery in terms of understanding the necessary structural elements of this 
peptide was made by Wender et al. in 2000.[5]  While previous studies all focused on small 
modifications and truncations of the natural peptide sequence, this study demonstrated that 
the major contributing element was the presence of arginine residues, and no other structural 
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or chemical contribution by other residues was necessary.  Cellular uptake of fluorescein-labeled 
peptides was measured by flow cytometry.  Deletion studies of Tat demonstrated that uptake 
was greatly diminished upon the deletion of any basic residue, but not the uncharged glutamine.  
Furthermore, oligomers of arginine showed improved uptake over Tat49-57 and the non-natural 
D-oligomers showed higher uptake still.  This latter attribute was due to the lack of enzymatic 
degradation of non-natural peptide, but was also an exceptionally important discovery.  If 
natural peptides were unnecessary, than it is likely only the primary structure—more 
specifically, the presence of guanidinium side groups—that is required for polymer uptake. 
 This discovery of “arginine magic”, that all that was necessary for cellular uptake was a 
chain of guanidinium moieties, created an enormous boom of non-natural structures known as 
protein transduction domain mimics (PTDMs).  Guanidinium-rich molecules in the form of 
peptides, β-peptides, peptoids, dendrimers, and polysaccharides were created to be used in 
delivery.[3]  This array of molecules is too vast and wide ranging to be recounted in detail here, 
and is well-covered in the review listed.  A more detailed review of synthetic polymer PTDMs is 
supplied in later sections of this introduction. 
 As mentioned above, most of the studies up to this point showing high cytosolic delivery 
in cells used a fixation step before determining the location of uptake.  A 2003 study by Richard 
et al.[6] determined that much of the apparent cytosolic delivery was due to the use of 
formaldehyde as a fixing agent.  The authors performed experiments similar to Vivès, except 
comparing uptake to that done without a fixation step.  Cells that were not fixed showed 
polymer only in endosomes, an indication that uptake was limited largely to those regions.  
Furthermore, flow cytometry studies were performed with the use of trypsin to remove peptide 
accumulated on the surface of cells that has not been internalized.  While cells incubated at 
37°C still had significant uptake, cells incubated at 4°C or with depleted ATP levels had greatly 
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reduced uptake.   This led the authors to conclude that cellular uptake was predominantly due 
to endocytosis. 
 This explanation was not wholly satisfying, however.  In order for Tat to function in the 
way initially described by Frankel, Pabo, Green and Loewenstein, Tat must be definition be able 
to pass into the cytosol intact while the cell is still alive.  There must be some amount of 
peptide, then, that is able to escape the endosome.  Indeed, the continued use of Tat and 
related peptides as a delivery system belies this fact. This class of molecules has been widely 
used for the delivery of biologically active molecules,[4, 70, 71] which would not be possible 
without endosomal escape.  It is also worth noting that in the Richard study, while the uptake of 
Tat at 4°C was nearly 0, the uptake of oligoarginine was still present (albeit only 10%).[6]  This 
suggests that while only a small fraction of the uptake may be energy independent, it was still a 
possibility. 
 With a revised set of standards in mind, several studies confirmed that the majority of 
uptake of Tat and related peptides was by endocytosis.  HeLa cell incubation, trypsinization and 
FACS of the oligoarginine peptide R8 showed a significant decrease in cellular uptake, much as in 
the Richard study.[72]  In this case, however, a more substantial fraction (70%) of the activity 
remained.  There is relatively little commentary on this difference, and it is uncertain whether 
the residual peptide uptake is due to energy-independent uptake incomplete inhibition of 
endocytosis.  The authors also note that the macropinocytosis inhibitor EIPA reduces R8 uptake 
by a small but statistically significant amount, suggesting that at least some of the energy-
dependent uptake is due to this process.  Another study shows similar results, again showing 
that lowering cellular temperature to 4C causes a measurable drop in Tat uptake, although again 
not to 0.[73]  Upon exposure to numerous macropinocytosis inhibitors, peptide uptake is 
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decreased by as much as 60%, suggesting that raft-mediated endocytosis.  Macropinocytosis 
was cited in additional other studies as well, under similar circumstances.[74, 75] 
 This view, that the remaining activity after cooling cells to 4°C is due to energy-
independent uptake, has persisted, as repeated tests have shown that some amount of activity 
remains.  In fact, in two cases involving the bone marrow leukemia cell line KG1a, uptake was 
strangely shown to increase at 4°C.[7, 76]  While this also calls into question the effectiveness of 
cooling cells to inhibit endocytosis (Chapter 2 of this thesis will focus on that), it also suggests 
that a substantial fraction of peptide uptake may indeed be independent of endocytosis and 
macropinocytosis.  Attention then turned to precisely how these peptides are able to cross the 
cell membrane.  Unfortunately, living cells presents complicated systems.  Not only must 
energy-dependent processes like endocytosis be accounted for, but the membrane itself, as 
described earlier, contains proteins, sterols, polysaccharides, and other components that make 
direct, mechanistic observations difficult.  Thus, much of the biophysical studies performed fort 
this class of molecule involves model membrane systems, generally just consisting of 
phospholipids.  While they do not encompass the full complexity of cell membranes, they are 
simple enough that real, mechanistic observations can be made with them. 
1.3.2 Biophysical Studies of PTDs 
 Some of the most pioneering work in this field came from the Matile Group of the 
Université de Genève.[77-79]  Two general experimental frameworks were used to examine the 
transport of the polymers across the lipid bilayer.  The first is what is called the “U-tube 
experiment”.  Cloroform is placed in a U-shaped tube between two aqueous regions, so that the 
only way a substance could pass from one region to the other is through the hydrophobic 
chloroform phase.  This region of chloroform was used as a model for the membrane.  While 
29 
 
such a system lacks either the chemical composition or the dimension of a lipid bilayer, it has 
the advantage of a much larger distance, meaning that any the hydrophobic phase can be 
directly sampled in a way not possible with a bilayer.  Carboxyfluroescein, a hydrophilic, anionic 
dye, was placed in one aqueous region, and diffusion into the hydrophobic phase was 
monitored.  Not surprisingly, carboxyfluorescein alone did not move into chloroform, nor did it 
move in the presence of polyarginine.[77]  However, when polyarginine was mixed with an 
amphphilic anion before addition, dye was seen inside the chloroform phase.  This did not occur 
for polylysine, suggesting that the bitentate natue and higher pKa of the cation contributed to 
complexation.  Some chloroform was even found to transport across the hydrophobic phase 
into the trans aqueous region. 
The second techniques used was dye release from vesicles.  This is to some extent the 
simplest test of membrane activity possible.  As had been shown in the section on antimicrobial 
polymers, this test provides a simple model for the permeation of the cellular membrane.  Large 
unilamellar vesicles are filled with a quenched dye that becomes fluorescent upon escape.  This 
allows for direct monitoring of activity in real time, but it does not directly make any 
mechanistic claims, except that said activity is purely energy-independent.  Again, polyarginine 
alone did not cause much dye release, but adding instead a mixture of polyarginine and 
amphiphilic anions greatly increased dye release.[77, 78]  Perhaps most interesting, activity for 
polyarginine was even increased in the presence of egg yolk phosphatidylglycerol (EYPG) in the 
bilayer (rather than mixed with the polymer).  From this, the authors concluded that the 
polymer must bind to the anions, become integrated in the membrane, and the more 
hydrophobic mixture is allowed to pass through the hydrophobic bilayer.  This process was 
called “adaptive translocation.”   
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The use of these amphiphilic anions was applied to HeLa cells.  Pyrenebutyrate was 
found to be particularly effective, and its combination with GFP and polyarginine allowed for 
rapid delivery to the cytosol.[79]  While this approach is not practical, as competition with 
anions present in serum reduces the effectiveness of delivery, it suggests that the biophysical 
studies are an accurate descriptor of what happens in a cell culture. 
Dye release was also used to examine the interaction of the amphiphilic PTD 
transportan with phospholipid membranes.[37]  The kinetic data, along with measuring the 
change in tryptophan fluorescence upon interaction with the bilayer, allowed the authors to 
create a kinetic model for peptide interaction involving booth surface binding and insertion of 
the peptide into the membrane.  The authors found that while the peptide did bind more 
strongly to anionic 2:8 POPS:POPC membranes than to zwitterionic POPC membranes, this did 
not result in significantly different rates of dye release.  This, they argue was because the 
limiting step to dye release was not surface association by insertion, and those rates were 
determined to be fundamentally similar.  These results are fundamentally different from the 
above ones for polyarginine, though it is important to note that transportan contains fewer 
arginines and more lysines and hydrophobic monomers, meaning that its mechanism of activity 
may be fundamentally different from arginine-rich PTDs. 
Similarly, penetratin and R9 were shown to bind more strongly to anionic lipid-
containing membranes than purely zwitterionic ones.  Plasmon waveguide resonance (PWR) 
spectroscopy of the amphiphilic PTD penetratin showed that it bound more than twice as 
strongly to EYPG vesicles as EYPC ones.[80]  Isothermal titration calorimetry (ITC) gave strong 
binding traces for R9 with DSPG vesicles, but no measurable trace with DSPC vesicles.[81]  
Neither of these studies, though, are able to make more generalized statements about the 
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implications of this difference in binding for membrane activity.  We thus have an incomplete 
story of the importance of anionic lipid in PTD activity. 
Work examining the ability of PTDs to form negative Gaussian curvature phases has its 
roots in the antimicrobial literature.  The formation of a toroidal pore in a phospholipid 
membrane is exceptionally difficult to observe directly, both because of the dimensions involved 
(the bilayer is ~5nm thick) and the fluid nature of the membrane.  Such pores, though, do have 
geometric constraints.  A bisection of the inside of a toroidal pore matches the shape of saddle, 
with orthogonal positive and negative curvatures.  Since the product of these two signs is 
negative, such shapes are said to have negative Gaussian curvature. Much of the antimicrobial 
literature for a long time assumed it was the higher anionic content of bacterial cells that made 
them selectively susceptible to cationic antimicrobial compounds.  Bacteria also differ in the 
intrinsic curvature content of their lipids, however.  The lipid content of mammalian cells is 
dominated by the phosphatidylcholine, which has nearly zero intrinsic curvature.[82]  (Figure 
1.7)  Bacteria, however, contain large quantities of phosphtidylethanolamine (PE) lipids and 
cardiolipin (CL), which have a negative intrinsic curvature.  By creating bulk phases of these 
lipids, it can be shown that antimicrobials are able to form negative Gaussian curvature phases 
only in the presence of high negative intrinsic curvature lipid content.[61-63, 65]  This means 
that the antimicrobials are capable of producing positive curvature, but not negative curvature, 
and that they are thus able to form pores in membranes containing high quantities of PE, but 
not those high in PC. 
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Figure 1.7.  Lipids and intrinsic curvature. 
It turns out that there is a strong resemblance between antimicrobial peptides (AMPs) 
and PTDs.  A survey of both naturally-occurring PTDs and AMPs show that there is a general 
trade-off between the number of arginine residues in CPPS and the number of both lysine and 
hydrophobic residues.[83]  It is perhaps not surprising, then, that PTDs like Tat and oligoarginine 
are able to induce negative Gaussian curvature phases in high-PE lipid systems.[11, 84]  Less, 
clear, however, is the link between this behavior and activity in mammalian cells.  As mentioned 
before, mammalian cells lack high quantities of PE, and PTDs do no form such phases in PC 
lipids.   
1.3.3 Molecular Dynamics Simulations 
 While the molecular dynamics has only lightly explored the world of PTD-membrane 
interactions, some important contributions have been made. Of particular note is the work of 
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the Deserno group. The first work examines how the shape of particles influences how they 
interact with membranes.[85]  Such work is important for understanding endocytotic processes, 
membrane protein aggregation, viral attachment, and lipid scavenging. Thirty-six spherical ‘caps’ 
were placed on a tensionless membrane. Small caps only cause a small perturbation, but larger 
caps cause clustering and then vesiculation of the membrane.  For yet larger caps, vesiculation 
begins before the caps have aggregated into a single mass, leading to several vesiculations and 
the formation of sealed pockets beneath the new membrane containing the caps. When full, 
spherical capsids were tested, the effect was even more exaggerated. The authors comment 
that this type of aggregation and vesiculation is likely to be very common in cellular processes. 
 A separate study by Herce and Garcia[86] shows a similar mode of uptake of the Tat 
peptide in a simulated mammalian membrane. As with the antimicrobials, this model requires 
that multiple Tat peptides penetrate the membrane together. The crowding of peptides cause a 
thinning of the membranes, and then the peptides begin to insert into the membrane. The 
insertion of the peptides results in the formation of a narrow 3 nm pore. 
1.3.4 Polymer-Based PTDMs 
 While the above works have provided some insight into the interaction of PTDs with 
cellular membranes, they are handicapped by a lack of structural diversity.  While many of the 
studies alter peptide length and make individual sequence alterations, polymers allow for a 
vastly greater diversity of structures.  As has been seen in earlier sections of this chapter, 
antimicrobial polymers have taken on enormously diverse structures and enormous insight into 
their function has been gained by subtle alterations in their composition.  By comparison, the 
world of polymeric protein transduction domain mimics (PTDMs) is much smaller and less 
diverse.  There are only a few groups actively pursuing polymer PTDMs and fewer still are 
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creating polymers with highly controlled functional and architectural properties.  Using this kind 
of polymer template, we are able to more deeply understand the effects of hydrophobicity, 
charge, aromaticity, architecture, and length in a way not previously available, leading to both a 
better fundamental understanding of PTDM-membrane interactions as well as design rules for 
better delivery vectors. 
The first polymer PTDMs were both based on ring-opening metathesis (ROMP) and were 
introduced by the Tew and Kiessling groups.  Kolonko et al.[87] used a postpolymerizaton 
approach to create guanidine-rich norbornene-based polymers (18). An activated ester 
norbornene monomer was polymerized using a modified Grubbs’ catalyst. The ester was 
substituted with a guanidine moiety postpolymerization. A dye was also added to the end of the 
polymer via a ketone-containing polymerization quenching agent attached to the end of the 
polymer. The interaction of the dye-labeled polymer with HeLa cells was tracked by confocal 
microscopy. The polymers were shown to both accumulate in endosomes and diffuse in the 
cytoplasm when incubated at room temperature. Cells were also incubated with the polymer at 
4 °C to halt endocytosis, which the authors report demonstrated no intake. It was thus 
presumed that the polymer enters the cells only by energy-dependent pathways. This polymer 
template was expanded to include separately functionalizable random and block 
copolymers.[42]  These polymers were shown to have similar uptake properties, suggesting 
viability as drug carriers. 
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Figure 1.8.  Amide and Imide-based ROMP PTDMs. 
The poly(guanidinium-rich oxanorbornene) (PGON, 19) had previously been introduced 
by the Tew group as an antimicrobial polymer capable of killing bacteria without causing 
substantial membrane disruption.[52]  These polymers were shown by Hennig et al to also 
present many similar properties to polyarginine.[88] Similar to polyarginine, their ability to cross 
the lipid membrane and cause dye release from vesicles was greatly increased when the 
polymer was allowed to complex with activating counterions.  An important distinction from 
polyarginine, however, was that the presence of EYPG inhibited dye release from the vesicles. 
The reason for this difference between polyarginine and PGON is unknown. 
This library was expanded to include an ester based design similar to that used for 
antimicrobial polymers, but with a guanidinium functionality.  The dual-armed nature of the 
monomer allowed for the comparison of the activity of a singly-functionalized polymer (21-(1)) 
to one with dual guanidinium moieties per residual monomer unit (21-(3)).  Combining this with 
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length adjustments, it was possible to account for the relationship between membrane activity 
and guanidinium density.  These polymers were labeled with NBD dye and their uptake was 
measured in HEK293T cells.  To distinguish between polymer simply accumulated on the surface 
of the cell and polymer inside the cell proper, the cell cultures were washed with sodium 
dithionite solution.  Overall cell association scaled with polymer length, but the di-functionalized 
polymers outperformed similar-length mono-functionalized ones with lower toxicity at 4°C.  This 
suggested that high guanidinium density improved overall cellular uptake. 
While the ability of polyarginine to cross phospholipid membranes requires 
complexation with amphiphilic anions, polymers can incorporate hydrophobic moieties directly 
into the main chain.[89]  Furthermore, these hydrophobic moieties can themselves be tuned, 
allowing for easily scalable hydrophobicities. Both imide and ester structures were examined. 
(20-(1), 21-(1))  Their activity was measured as a function of dye release from vesicles.  In both 
series, activity was improved by additional hydrophobicity only up to a point. Once the 
hydrophobic moieties was stronger than a butyl group, the polymer began to have reduced 
activity, most likely due to precipitation in solution. 
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Figure 1.9.  Ester-based ROMP PTDMs. 
The importance of aromatic functionality was also examined.  Trans membrane proteins 
generally have unusually high quantities of aromatic residues, especially concentrated in so-
called “aromatic belts” at either end of the transmembrane region.[90-92]  Additionally, 
aromatic peptide residues interact more strongly with phospholipid bilayers than would be 
expected based purely upon their hydrophobicity.  A comparison of octanol-water to 
phospholipid-water partitioning demonstrated that aromatic residues associate unusually 
strongly with phospholipids.[93]  This suggests that there is some important interaction 
between the aromatic residues and the polar regions of the phospholipid membrane.  The exact 
cause of this favorability is uncertain, although NMR studies[92] suggested that it may be due to 
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a combination of the flat geometry of the aromatic ring as well as the shared electronic 
structure and its various interactions with charged and polar molecules.  Dye release studies of 
similarly hydrophobic aromatic and non-aromatic PTDMs (20(2-5)) suggested that the aromatic 
structures may have slightly higher activity.[94] 
A fundamentally new class of polymer PTDM was created for the purpose of non-
covalent delivery of PTDMs.  Most delivery schemes for the delivery of biomolecules by PTD 
involve covalently bonding the peptide to the desired delivery component.[4]  This is not 
convenient, however, as it requires specialized synthesis of your cargo and delivery vector.  
Much preferable would be a system where the PTD(M) and cargo could simply be mixed in 
solution in preparation for delivery.  This is much the way Pep-1, a chimeric peptide, 
functions.[95]  Similar to that, a PTDM block copolymer structure containing a guanidinium-rich 
region and a hydrophobic region was created.[96] (22) The unique construction allows the 
polymer to combine with the cargo in solution, while maintaining its capacity for uptake.  First, 
uptake of FITC-labeled siRNA was measured, and it was shown that dye was present in cells both 
at 37°C and at 4°C (although greatly reduced in the latter).  Uptake of the FITC-siRNA was also an 
order of magnitude higher for the block copolymer than the homopolymer.  More impressive 
was the actual knockdown data.  The block copolymer-siRNA combination was able to knock 
down NOTCH1 expression in Jurkat T cells by 50%, while no other delivery system was able to 
achieve any knockdown at all. 
On strong difference between the homopolymer and the block copolymer was that the 
homopolymer was far less hydrophobic than the block copolymer.  Was the improved activity 
really due to the architecture, or was it due to the hydrophobicity?  Sgolastra et al. created a 
series of polymers with identical hydrophobic content but different polymer architectures.[97]  
A block copolymer structure was similar to the one studied above, (24) but alongside that were 
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examined a homopolymer where one arm was hydrophobic and the other a guanidinium moiety 
(21-(2)) and a “gradient” copolymer, where guanidinium and hydrophobic moieties were 
polymerized together to give a partially segregated system.(23)  While dye release of these 
polymers generated similar EC50 values, the maximum amount of dye released varied widely.  
For some reason, the block copolymer only release about 50% dye at maximum, while the 
homopolymer released 90%, with the gradient polymer was in-between.  Similar results were 
seen in cellular uptake studies, where the block copolymer was the least effective of the three.  
If should be cautioned, however, that uptake is different than active cargo delivery, and as-yet 
unpublished data shows that the block copolymer is still superior to the homopolymer for 
protein delivery.[98] 
In addition to the ROMP-based structures described above, ring-opened carbonate 
polymers containing guanidine functionality have also been synthesized by Cooley et al. 
(C31).[99] The fluorescently labeled oligomer was shown to have comparable uptake to 
oligoarginine in Jurkat cells by flow cytometry. 
Confocal microscopy showed that the oligomer was internalized into the cells, though it 
did not show definitive evidence of escape of the polymer into the cytosol. To verify the ability 
of this drug delivery system to introduce cargo to the cytosol, luciferin was attached to the 
initiator thiol group. In the cell, if the system is effective, the thiol bond is broken, and luciferin is 
converted to oxyluciferin, releasing light. Thus, by measuring the light output of the system, the 
kinetics of drug release can be measured. While the delivery was shown to be effective, drug 
release was not as quick as with similarly fashioned octaarginine peptides. Delivery appeared to 
be hindered by high potassium salt concentrations. 
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Figure 1.10.  Carbonate-Based PTDMs. 
1.4 The Scope of this Thesis 
The combination of cell and biophysical studies using both peptide and polymer systems 
has led to important progress in the understanding of PTDMs and their interactions with cell 
membranes.  At the core, guanidinium-rich peptides have high uptake in cells, much higher than 
for other charged macromolecules.  This activity is generally not driven by exact secondary 
structure or receptor-specific activity, and is transferrable to guanidinium-containing polymers 
with different backbones.  Membrane activity of these polymers is increased in biophysical 
experiments by the addition of hydrophobicity to the polymer, either through the complexation 
of amphiphilic anions, of by the addition of hydrophobic moieties to the backbone.  The use of 
block copolymers allowed for the transport of large macromolecular cargo into cells without the 
use of covalent bonding. 
Despite this progress, however, there is still a lack of detailed understanding of how this 
PTDM uptake occurs, and how features such as hydrdrophobicity and charge contribute to 
polymer activity.  How much of PTDM uptake is energy-dependent versus energy-independent is 
still hotly debated, and the intermolecular driving force for such energy-independent uptake is 
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still unknown.  This thesis will focus on three important aspects of PTDM-membrane 
interactions: membrane phase, anionic lipid content, and negative curvature generation.  
Cooling cells to 4°C is a widely used technique in distinguishing between energy dependent and 
energy-independent uptake processes.  Between 4°C and 37°C, however, mammalian lipid 
membranes undergo a phase transition, and the effect of that transition on PTDM activity is 
unknown.  Previous work has not critically examined this relationship, and instead simply 
assumes that the change in temperature has no measurable effect on energy-independent 
uptake.  Chapter 2 examines the activity of a range of polymers against membranes both in the 
fluid as well as gel phases, demonstrating that cooling lipid membranes has a substantial effect 
on their permeability to PTDMs, and that these considerations must be taken into account when 
considering the prevalence of energy-independent uptake. 
 As mentioned above, the literature discussing the importance of anionic lipid content is 
not straightforward.  While anionic lipid content is generally seen as necessary for “adaptive 
translocation”, empirical evidence supporting this claim is conflicting for different classes of PTD 
(as shown in section 1.3.2).  Additionally, while peptide systems have been examined, the effect 
of anionic lipids in polymer PTDM activity has not been determined.  Chapter 3 will examine the 
effect of anionic lipid content on ROMP-based PTDM activity.  The results contradict the 
adaptive translocation model for this subset of polymers and instead suggest that anionic lipid 
content inhibits PTDM activity.  This has important implications both for our mechanistic 
understanding as well as for the design of improved molecules. 
 The final two chapters examine the ability of ROMP-based PTDMs to induce negative 
Gaussian curvature in bulk lipid systems.  The variables of polymer length, hydrophobicity, 
aromaticity, and architecture are all examined.  It is shown that all but aromaticity play key roles 
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in determining how these polymers are able to induce curvature.  It is still unclear, however, 
how much this ability is linked to membrane activity. 
 This thesis, then, presents a step forward in our understanding of the interaction of 
guanidinium-rich polymers with phospholipid membranes.  The final section describes some of 
the remaining gaps in our knowledge, and suggests approaches to explore and fill those gaps. 
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CHAPTER 2  
THE LOW TEMPERATURE UPTAKE OF PROTEIN TRANSDUCTION DOMAIN MIMICS IS AFFECTED 
BY LIPID PHASE 
2.1 Introduction 
Protein transduction domains (PTDs), also known as cell-penetrating peptides, are 
cation-rich protein segments capable of high uptake into cells.[1-3]  Several varieties of these 
molecules, including the arginine-rich Tat peptide from HIV, have been extensively used as 
vectors for protein, DNA, and siRNA delivery into cells.[4]  For Tat-based systems, it has been 
shown that guanidine functionality, but not specific secondary structure, is critical for uptake,[5] 
providing a set of basic parameters for a variety of synthetic mimics. These include discrete 
oligomers and macromolecules based on oligoarginines, β-peptides, peptoids, dendrimers, 
polysaccharides, and synthetic polymers, comprising a class of protein transduction domain 
mimics (PTDMs).[3]  To this wide array of designs, our research group has contributed a library 
of polyoxanorbornene-based polymers.[6-10] 
Despite the wide-ranging utility of PTDs and their mimics, their uptake mechanism is still 
under considerable debate.[11-17]  Most critically, there has been much research comparing the 
amount of cellular uptake by energy-dependent (endocytosis, macropinocytosis) and energy-
independent (pore formation, membrane diffusion, translocation) mechanisms.[8, 11, 12, 15, 
18, 19]  This is an important distinction because molecules internalized by energy-dependent 
means are entrapped in endosomes, potentially limiting their value as carriers.  One common 
method for distinguishing between these two forms of internalization is to compare PTDM 
uptake in cells at physiological conditions to that in cells with inhibited endocytotic pathways, 
either by ATP depletion or by cooling the cells to 4°C.  Sodium azide inhibits mitochondrial 
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oxidative phosphorylation, reducing the amount of available ATP in the cell, thus retarding 
cellular metabolism.[20]  Cooling cells to 4°C also reduces cellular metabolism.[21] While both 
approaches are fairly common, there is little data directly comparing the two, particularly within 
the realm of PTDMs.[11]  Without such a direct comparison, it is difficult to tell if either 
experiment is influencing the purported outcome beyond simply reducing endocytosis.  As 
demonstrated here, however, these two methods produce inconsistent results, suggesting that 
indeed reducing membrane temperature also affects energy-independent uptake. 
Of particular concern is the effect temperature plays on the ability of PTDMs to interact 
with the cell membrane.  Phospholipid membranes undergo phase transitions at temperatures 
specific to their lipid composition (acyl chain lengths and degrees of unsaturation).  The 
reduction in lipid lateral mobility that occurs below the liquid-to-gel transition causes an 
increase in membrane rigidity, as well as a decrease in the amount of penetration by non-ionic 
pluronics.[22, 23] 
Reports show that Chinese hamster lung cells have a broad liquid-to-gel transition 
between 7 and 37°C, while bovine oocytes have their temperature transition in the 10 to 20°C 
range.[24, 25]  Since the process of cooling cells from 37°C to 4°C crosses both of these 
temperature regions, it is important to understand the effect of these temperature transitions 
on PTDM-membrane interactions. The effects of temperature and membrane phase on vector 
internalization are not well studied, but it is reasonable to consider that molecules whose 
uptake is primarily driven by membrane interactions would be more strongly affected by lipid 
phase transitions. 
These experiments establish that reducing membrane temperature greatly reduces the 
membrane activity of ROMP-based PTDMs.  While increased polymer hydrophobicity is able to 
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overcome this barrier, this effect of temperature must be taken into account in experiments 
designed to distinguish energy-dependent and energy-independent uptake. 
2.2 Materials and Methods 
2.2.1 Materials 
Maleic anhydride, maleimide, furan, 4-dimethyl aminopyridine (DMAP), 1-(3-
Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC), methanol, 1,3-Di-Boc-2-(2-
hydroxyethyl)guanidine, benzyl alcohol, ethyl vinyl ether and trifluoroacetic acid (TFA) were 
obtained as reagent grade from Aldrich, Fluka or Acros and used as received. 3rd generation 
Grubbs catalyst (Dichloro-di(3-bromopyridino)-N,N’-Dimesitylenoimidazolino-Ru=CHPh; G3) was 
synthesized as described previously by Grubbs et al.[26]  The HPLC grade solvents, ethyl acetate, 
pentane and hexane, were purchased from Aldrich, Fisher Scientific or Acros and used as 
received. Tetrahydrofuran (THF) (HPLC grade, Fisher Scientific) was distilled from 
sodium/benzophenone under nitrogen. Dichloromethane (DCM) (HPLC grade, Fisher Scientific) 
was distilled from CaH2 under nitrogen. Spectra/Por
® Biotech Cellulose Ester (CE) dialysis 
membranes with the molecular weight cut off (MWCO) of 100-500 and 1000 were purchased 
from Spectrum Medical Industries. Egg yolk phosphatidylcholine (EYPC) and 
dipalmitoylphosphatidylcholine (DPPC) were purchased from Avanti Polar Lipids Inc. and 5(6)-
carboxyfluorescein (CF) was purchased from Fluka. Pen/Strep antibiotics were purchased from 
Lonza. 2-Deoxy-D-glucose was from Sigma-Aldrich. 
2.2.2 Instrumentation 
1H and 13C NMR spectra were recorded at 300 MHz and 75 MHz respectively, using a 
Bruker DPX-300 NMR spectrometer. Chemical shifts (δ) are reported in ppm and coupling 
51 
 
constants (J) in Hz. The abbreviations for splitting patterns are: s, singlet; d, doublet; dd, doublet 
of doublets; t, triplet; q, quartet; m, multiplet; br, broad. Mass spectral data were obtained at 
the University of Massachusetts, Mass Spectrometry Facility from a JEOL JMS 700 instrument 
(JEOL, Peabody, MA). Gel permeation chromatography was measured on an Agilent 1260 series 
GPC setup with a PL Gel 5 μm guard column, two 5 μm analytical Mixed-C columns and a 5 μm 
analytical Mixed-D column (Agilent), incubated at 40 °C.  THF was used as the eluent at a flow 
rate of 1.0 mL/min. Polystyrene standards were used for the calibration and toluene as flow 
marker.  Vesicle experiments were performed using a Biotek SynergyMx fluorescence plate 
reader and an Horiba Scientific FluoroLog-3 spectrophotometer. 
2.2.3 Monomer Synthesis 
Figure 2.1 shows the monomers used to synthesize the polymers for this study.  All 
procedures have been previously been reported in the literature. [8, 9, 27-29]  
 
 
Figure 2.1.  Monomers used in this study. 
2.2.4 Polymer Synthesis 
Unlabeled polymers were synthesized by ring-opening metathesis polymerization with 
Grubbs 3rd generation catalyst using previously reported methods.[7, 8, 27, 29]  As a general 
a.
d.
b.
c.
e.
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procedure, 200 mg of monomer and the desired amount of catalyst were separately dissolved in 
dry dichloromethane and placed in Shlenck flasks.  The flasks were flooded with nitrogen and 
the solutions degassed by the freeze-pump-thaw method.  The degassed monomer was 
transferred to the catalyst flask and the reaction was allowed to proceed for 40 minutes at 25°C, 
after which time the reaction was quenched by 1 mL of ethyl vinyl ether.  The imide monomer-
based polymers were then precipitated in ether or an ether-pentane mix to separate the 
polymer from the catalyst, while the diester polymers were precipitated in pentane. 
The boc-protected polymers were deprotected in 5 mL 1:1 trifluoroacetic acid 
(TFA):dichloromethane overnight. TFA was removed by repeated azeotropic distillation with 
methanol. All polymers were suspended in water and lyophilized for three days, with diester 
polymers first being dialyzed in water using dialysis membranes with MWCO 100-500 Da. 
Dye-labeled polymers were prepared by a similar method, with minor variations.  One 
molar equivalent activated ester monomer was placed in a Schlenk flask with dichloromethane 
and freeze-pump-thawed, the same as the monomer and catalyst solutions.  The activated ester 
monomer was added to one molar equivalent of Grubbs 3rd generation catalyst.  After five 
minutes, 10 equivalents of the desired diester monomer were added to the polymerization 
reaction.  After 60 minutes, the polymerization was quenched with 1 mL of ethyl vinyl ether.  
The resulting polymer was then precipitated in pentane. 
The activated ester polymer was then dissolved in DMF with the TFA salt of [2-(7-
nitrobenz-2-oxa-1,3diazole)-aminoethyl] ammonium (NBD-ethylenediamine) at a molar ratio of 
1:1.5 and allowed to stir overnight protected from light.[8]  The modified polymer was then 
precipitated in water, filtered, subsequently deprotected as previously described while 
protected from light. 
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Boc-Protected G16: 
1H-NMR (300 MHz, CD2Cl2): δ=11.49 (1H, br), 8.45 (1H, br), 7.27 (0.3H, m) 
6.08 (trans) and 5.80 (cis) (2H total, br), 5.02 (cis) and 4.48 (trans) (2H total, br), 1.52 (9H, s), 
1.47 (9H, br) 
 
G16:  
1H-NMR (300 MHz, DMSO-d6): δ=7.88 (1H, br), 7.36 (4H, br), 5.96 (1H, br), 5.74 (1H, br), 
4.92 (1H, br), 4.43 (1H, br) 3.47 (4H, br). 
 
Boc-Protected G16-r-Ph4: 
1H NMR (300 MHz, CD2Cl2): δ=11.46 (16H, br), 8.44 (16H, br), 7.21 
(20H, br), 6.05 (trans), 5.76 (cis) (40H total, br), 4.99 (40H, br), 4.46 (32H, br), 4.08 (8H, br),  3.73 
(48H, br),  3.38 (40H, br) 2.91 (8, br) 1.52 (144H, br), 1.47 (144H, br) 
 
G16-r-Ph4: 
1H NMR (300 MHz, DMSO-d6):  δ = 7.27 (20H, br), 5.96-5.72 (40H, br), 4.88 (32H, br), 
4.43 (8H, br), 4.10 (8H, br), 2.85 (8H, br) 
 
Boc-Protected G16-r-Ph8: 
1H NMR (300 MHz, CD2Cl2): δ=11.46 (16H, br), 8.44 (16H, br), 7.21 
(48H, br), 6.05 (trans), 5.76 (cis) (48H total, br), 4.99 (48H, br), 4.46 (16H, br), 4.08 (8H, br),  3.73 
(80H, br),  3.38 (48H, br) 2.91 (16, br) 1.52 (144H, br), 1.47 (144H, br) 
 
G16-r-Ph8:
  1H NMR (300 MHz, DMSO-d6):  δ = 7.27 (20H, br), 5.96-5.72 (48H, br), 4.88 (32H, br), 
4.43 (16H, br), 4.10 (16H, br), 2.85 (16H, br) 
 
Boc-Protected, Unlabeled dG9: 
1H NMR (300 MHz, CD3CN): 11.52 (br, 2H), 8.35 (br, 2H), 7.31 (br, 
0.47H, end group), 5.86 (br, 1H), 5.05 (br, 1H), 4.65 (br, 1H), 4.17 (br, 4H), 3.55 (br, 4H), 3.15 (br, 
2H), (2.76, 0.4H), (1.44, 36H) 
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Unlabeled dG9:
 1H NMR (300 MHz, DMSO-d6): δ = 7.99 (br, 2H), 7.43 (br, 4H), 5.83 (br, 1H), 5.60 
(br, 1H), 4.96 (br, 1H) and 4.62 (br, 1H), 4.05 (br, 4H), 3.40 (br, 4H), 3.27 (br, 2H), 2.92 (br, 0.4H). 
 
Boc-Protected, Activated Ester-Labeled dG9: 
1H NMR (300 MHz, CD3CN): 11.52 (br, 2H), 8.35 (br, 
2H), 7.31 (br, 0.47H, end group), 5.86 (br, 1H), 5.05 (br, 1H), 4.65 (br, 1H), 4.17 (br, 4H), 3.55 (br, 
4H), 3.15 (br, 2H), (2.76, 0.4H), (1.44, 36H) 
 
Dye-Labeled dG9:
 1H NMR (300 MHz, DMSO-d6): δ = 7.99 (br, 2H), 7.43 (br, 4H), 5.83 (br, 1H), 
5.60 (br, 1H), 4.96 (br, 1H) and 4.62 (br, 1H), 4.05 (br, 4H), 3.40 (br, 4H), 3.27 (br, 2H), 2.92 (br, 
0.4H).  
 
Boc-Protected, Unlabeled PhG10: 
 1H NMR (300 MHz, CD2Cl2): δ 11.48 (br, 1H), 8.38 (br, 1H), 7.32 
(br, 5.5H, Ph + end group), 5.85 (br, 1H), 5.58 (br, 1H), 5.08 (br, 3H), 4.64 (br, 1H), 4.03 (br, 2H), 
3.47 (br, 2H), 3.12 (br, 2H), 1.44 (d, J = 5.3 Hz, 18H). 
 
Unlabeled PhG10: 
1H NMR (300 MHz, CD3CN): δ 7.82 (br, 1H), 7.33 (br, 5.5H, Ph + end group), 
7.08 (br, 3H), 5.83 (br, 1H), 5.61 (br, 1H), 5.07 (br, 3H), 4.63 (br, 1H), 3.97 (d, J = 41.8 Hz, 2H), 
3.26 (br, 4H), 2.73 (br, 0.1H). 
 
Boc-Protected, Activated Ester-Labeled PhG10: 
 1H NMR (300 MHz, CD2Cl2): δ 11.48 (br, 1H), 8.38 
(br, 1H), 7.32 (br, 5.5H, Ph + end group), 5.85 (br, 1H), 5.58 (br, 1H), 5.08 (br, 3H), 4.64 (br, 1H), 
4.03 (br, 2H), 3.47 (br, 2H), 3.12 (br, 2H), 2.78 (br, 0.4H), 1.44 (d, J = 5.3 Hz, 18H). 
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Dye-Labeled PhG10:  
1H NMR (300 MHz, CD3CN): δ 7.82 (br, 1H), 7.33 (br, 5.5H, Ph + end group), 
7.08 (br, 3H), 5.83 (br, 1H), 5.61 (br, 1H), 5.07 (br, 3H), 4.63 (br, 1H), 3.97 (d, J = 41.8 Hz, 2H), 
3.26 (br, 4H), 2.73 (br, 0.1H). 
2.2.5 Cell Culture and Uptake Studies 
Jurkat T cells (human T lymphocyte leukemia cell line) were grown in RPMI 1640 + 
GlutamaxI (GIBCO-Invitrogen), supplemented with 10% (v/v) FBS (GIBCO-Invitrogen), 100 U/mL 
penicillin and 100 U/mL streptomycin (Lonza). Cells were incubated at 37 °C with 5% CO2 and 
passaged the day before the treatment.  
On the day of the experiment, Jurkat T cells were harvested, centrifuged, counted, and 
resuspended in complete growth medium to a density of 1x106 cells/mL (1 mL final volume, 12-
well plate). Cells were incubated with the specific reagent at 37°C for 30 min. Then cells were 
harvested, centrifuged and washed 2 times with ice-cold PBS, resuspended in 500μL of ice-cold 
FACS buffer (PBS with 0.2% BSA) and analyzed by flow cytometry (Becton Dickinson LSR II, BD 
Biosciences). Cell-associated fluorophores were excited at 488 nm, and fluorescence was 
measured at 530 nm. The fluorescence signal was collected for 10,000 cells exhibiting a normal 
morphology to obtain a histogram of fluorescence intensity per cell. The calculated median 
fluorescence intensity (MFI) of the distribution represented the amount of total cell-associated 
molecules.  
For measuring fluorescence from internalized molecules exclusively, after the last 
washing step, cells that were treated with 50 nM of fluorescein conjugate transferrin (Molecular 
Probes-Invitrogen) or 4 µM of nonarginine R9 (FAM-GRRRRRRRRR-NH2, customized from Peptide 
2.0) were incubated with 0.1% trypsin at 37 °C for 5 min then washed and resuspended in 500μL 
ice-cold FACS buffer for flow cytometric analysis., Cells that were treated with 4 µM of NBD-
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labeled D9 or H10 were incubated with 1 mM of freshly prepared sodium dithionite solution (in 
1M TRIS, pH=10) for 5 min at room temperature to quench NBD.  Cells were subsequently 
washed and resuspended in 500μL ice-cold FACS buffer for flow cytometric analysis. The MFI 
measured after trypsin or dithionite treatment represented the amount of internalized cell-
associated molecules. 
For cellular uptake experiments in energy-depleted conditions, the cells were harvested, 
centrifuged and resuspended in either ATP-depleting media (RPMI without glucose, 10% FBS, 25 
mM 2-deoxy-D-glucose and 10mM NaN3) at 37°C or in standard complete RPMI media at 4°C  
and let equilibrate for 30 min before the addition of the reagents. 
2.2.6 Dye Release Studies 
2.2.6.1 Vesicle Preparation 
25mg egg yolk phosphatidylcholine (EYPC) or dipalmitoylphosphatidylcholine (DPPC) 
lipid in 3 mL of chloroform was evaporated onto the wall of a 10 mL flask using a rotary 
evaporator, then placed under vacuum overnight.  The lipid film was resuspended in buffer 
containing 10 mM Tris and 50 mM carboxyfluorescein dye, titrated to pH 7.5.  The buffer was 
allowed to sit for an hour, vortexing every 15 minutes.  The DPPC vesicles were swelled in a 
water bath set to 50°C during this time.  The vesicle solution was then put through six freeze-
thaw cycles.  The solution was then extruded nine times through a 100 nm pore membrane.  The 
DPPC vesicles were warmed with a heat gun during the extrusion process.  Dye-loaded vesicles 
were separated from free dye by size exclusion chromatography (Sephadex G-50 superfine, 
Sigma Aldrich) in Tris saline buffer (10 mM Tris, 107 mM NaCl, pH 7.5). 
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2.2.6.2 Vesicle Concentration Calibration 
 Lipid concentration for a serial dilution of vesicles was measured using a Wako 
Phospholipids C diagnostic kit.  The same serial dilution was also measured for fluorescence in 
Tris buffer with 0.05% Triton-X 100.  68,000 counts in the Biotek Synergy Mx fluorescence plate 
reader was found to correspond to an in-well phosphatidylcholine concentration of 2.5 μM.  
This was the standard for further fluorescence measurements. 
2.2.6.3 DPPC and EYPC Dye Release at 25°C 
Experiments similar to those published previously[27] were performed using a Biotek 
Synergy Mx fluorescence plate reader.  All Fluorescence measurements were taken at an 
excitation wavelength of 492 nm and emission wavelength of 517 nm.  1,960 μL Tris buffer (10 
mM Tris, 107 mM NaCl, pH 7.5) was added to the wells of a 12-well plate.  20 μL of 250 μM 
vesicle solution (as defined above) was added to each well, creating an in-well concentration of 
2.5 μM.  The plate reader was heated to 25°C before continuing.  The plates were shaken at 
25°C and after three minutes a baseline fluorescence measurement, F0, was taken.  20 μL 
polymer/DMSO solutions containing varying concentrations (0.01-1000 μL) of polymer were 
added to wells with stirrers, and the plate was returned to the reader for 10 minutes of shaking.  
After 10 minutes, another reading, F10, was taken.  20 μL 5% Triton X-100 in DMSO was added to 
the wells and after three minutes a final measurement, FT, was taken.  FT and F0 allowed use to 
normalize fluorescence to measure the fractional dye release: 
   	 
/ 	 
 
The fractional dye release Y was then fitted as a function of concentration, c, to the Hill equation 
by a least-squares method: 
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Where EC50 is the concentration of 50% of maximal dye release and n is a fitting parameter. 
2.2.6.4 DPPC Dye Release at 50°C 
Experiments were performed similar to the above except that the plates were allowed 
to incubate in the plate reader at 50°C for 10 minutes before proceeding, to ensure that the 
vesicles were at the desired temperature. 
2.2.6.5 EYPC Dye Release at 4°C 
Experiments were performed using an Horiba Scientific FluoroLog-3 spectrophotometer.  
Experiments were similar the ones above and to previously reported work,[7, 9] but adjusted to 
match the equipment and experimental conditions.  20 μL 250μM vesicle solution was added to 
1,960 μL Tris buffer in a cuvette with a stir bar.  The solution was allowed to cool for 20 minutes 
before proceeding.  Fluorescence was continually measured over the 800s experiment, as 20 μL 
polymer/DMSO solution was added at 100 s and Triton X-100 was added at 700 s.  From this 
kinetic curve, we have F0=F(t=0s), F10=F(t=700s), and FT=F(t=800s)  and we can use these values 
to get the fractional dye release Y.  Repeated experiments allow us to build the previously 
described Hill plot. 
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2.3 Results and Discussion 
2.3.1 Polymer Design 
 
Figure 2.2.  PTDMs used for this study.  a) Polymer structures, with guanidinium moieties 
colored blue and aromatic/hydrophobic moieties colored green.  m=4 or 8.  b) Cartoon 
representations of G16-r-Ph4 (left) and PhG10 (right) with the same coloring scheme.  Dye-labeled 
analogs of PhG10 and dG10 were also synthesized. 
Our diverse library of polymer structures (Figure 2.2), combined with biophysical and in 
vitro cell experiments, provided us a unique framework for understanding how cooling cells to 
4°C alters PTDM-membrane interactions.  We first compared the effects of ATP depletion and 
temperature changes on uptake in cellular experiments by measuring the degree of dye-labeled 
PTDM internalization in Jurkat T-cells.  Next, we measured PTDM-promoted dye release from 
G16 G16-r-Phm
dG9 PhG10
a. b.
G16-r-Ph4 PhG10
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single-component lipid vesicles of dipalmitoylphosphatidylcholine (DPPC) in both their gel and 
liquid phases, to show clearly how changes in lipid phase alter polymer-membrane interactions.  
DPPC vesicles provide the simplest possible model for membrane transitions, as they contain 
just one type of head group (the zwitterionic phosphatidylcholine) as well as a single acyl tail 
type.  This latter feature ensures a narrow, well-defined set of phase transitions.  It was thus 
expected that any alterations to membrane activity would be most evident in this system.  As a 
bridge between the simple DPPC system and the more complicated cell membrane, we also 
measured PTDM-promoted dye release from egg yolk PC (EYPC).  EYPC contains a mixture of 
lipid tails and thus has a very broad phase transition, but also more closely resembles the lipid 
composition found in cell membranes.[30]  Through these three lipid systems (DPPC, EYPC, cell 
membranes), we are able to examine the connection between a trait seen in a simple, single 
component systems and the more nuanced response of cell membranes.  
The representative polymer library used in this study spans two important design 
parameters: hydrophobicity and guanidinium density.  While guanidine content alone is enough 
to produce some amount of activity, additional hydrophobicity has been shown to greatly 
increase activity when either complexed with the PTDM[31, 32] or incorporated directly into the 
chain.[7, 10, 27]  Additionally, although it has not yet been demonstrated for such systems, it 
was hypothesized that more hydrophobic polymers might more readily cross gel-phase 
membranes, as they would have a stronger insertion potential.  The imide series (G16, G16-r-Phm) 
consists of repeat units bearing either guanidinium or phenyl moieties.  Polymers were 
synthesized with a fixed number of guanidinium groups (16) and varying numbers of 
hydrophobic groups (0, 4, and 8) randomly interspersed throughout the polymer chain.  This 
allowed us to vary hydrophobicity across a series of polymers with the same charge content.  
The di-ester series (dG9, PhG10) consists of dual-functional repeat units containing either a 
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guanidinium and a phenyl group or two guanidinium groups.  This allowed us to exchange 
guanidinium for aromatic groups while maintaining constant chain length.   Between these two 
series, we can account for the effects of polymer chain length, charge content, and 
hydrophobicity (Figure 2.2b).  All polymers were synthesized by ring-opening metathesis 
polymerization (ROMP) using previously reported protocols[7, 8, 27, 29] and were labeled with 
NBD dye for cellular experiments or left unlabeled for the liposomal dye release experiments.   
2.3.2 Cellular Uptake Studies 
To measure the effect of ATP depletion and reduced temperature on cellular 
internalization, we measured the uptake of dye-labeled macromolecules into Jurkat T cells, a 
hard-to-transfect cell line, in a manner similar to previous reports.[8, 10, 29]  As a positive 
control for endocytotic inhibition, we used Transferrin (Tf), a non-PTD protein which enters 
exclusively by endocytosis.[33, 34]  As our reference to the PTD literature, we used nonaarginine 
(R9), one of the most widely explored PTDs.[3]  Both Tf and R9 were labeled with FITC dye and 
detailed procedures are provided in the Supporting Information (SI).  Briefly, cells were 
incubated for 30 minutes either with sodium azide or at 4°C in order for them to equilibrate, and 
then treated with a dye-labeled reagent for another 30 minutes. To eliminate any fluorescence 
response from molecules on the outer layer of cells, cells were then exposed to either trypsin 
(for Tf and R9) or sodium dithionite (for PTDMs).  Trypsin digests any protein outside the cell, 
while sodium dithionite quenches the NBD dye on the polymers.  The median fluorescence 
intensity (MFI) of the cells, representing molecular uptake, was then measured by flow 
cytometry (Figure 2.3a). 
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Figure 2.3.  Internalization studies. Jurkat T cells (1x106 cells/mL) were incubated for 30 min with 
the indicated compound either after cellular ATP depletion (with 10 mM NaN3, purple) or at 4°C 
(blue) and compared to uptake under normal conditions (37 °C, red dotted line). a) 
Representative flow cytometry analysis for the cellular uptake of 50 nM Transferrin-FITC (Tf-
FITC), as a control, at the indicated conditions; b) Relative uptake values are normalized to the 
cellular uptake (in MFI) at 37°C in normal growth media. Each point represents the mean±SE 
(standard error) of three independent experiments. *** (p<0.001); n.s. (p>0.05), as calculated 
by unpaired two-tailed student t-test. 
Figure 2.3b shows relative uptake after ATP-depletion (purple bars) and temperature 
reduction (blue bars) as a percentage of the uptake measured under normal conditions (red 
dotted line).  Raw MFI values are reported in the SI. Transferrin, our negative control for energy-
independent uptake, showed a decrease in uptake under both ATP-depleted and 4°C conditions.  
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However there was significantly lower uptake in ATP-depleted cells (2%) than in cells at 4°C 
(43%), suggesting that cooling did not entirely inhibit endocytosis.  These data are consistent 
with results previously reported for K562 Leukemia cells.[15]  The results for R9, dG9, and PhG10 
further highlight the discrepancies between these two methods.  While the relative uptake of 
dG9 was similar for both methods (18% and 29%), the uptake for the other two molecules was 
significantly different.  Uptake for R9 in ATP-depleted conditions was very low (23%) while 
uptake at 4°C (173%) was even higher than at 37°C.  While these results appear anomalous, R9 
has a history of strongly cell-type-dependent uptake.  The acute myelogenous leukemia cell line 
KG1 similarly showed an increase in the total MFI of internalized peptide at 4°C.[12, 35, 36]  
Most cell lines, however, have shown a decrease in uptake at 4°C.  Another leukemia-based 
suspension cell line, K562, shows dramatically reduced uptake under the same conditions.[12, 
36]  Likewise, the adherent HeLa and A549 cell lines,[19, 36] along with the wild-type Chinese 
hamster ovary (CHO-K1) cells,[18] showed a significant drop-off in activity at 4°C.  Since this 
anomaly was not present for the polymers presented here, it is likely that there is some 
interaction specific to both the peptide and the cell line.  By contrast, uptake of PhG10 under 
ATP-depleted conditions was 114% relative to normal conditions, suggesting it is ATP-
independent, but its internalization was significantly reduced at 4°C (32%).  If both methods only 
inhibited endocytosis, then they would be expected to produce similar results. As that is 
distinctly not the case, these results strongly suggest that the two methods do not create the 
same set of cellular conditions. 
2.3.3 DPPC Dye Release 
A reasonable explanation for this discrepancy is that cooling cells to 4°C causes changes 
beyond simply inhibiting endocytosis.  One possible change is that the energy-independent 
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transport across the membrane is also altered at lower temperatures.  The phase diagram for 
phospholipids reveals many different phase states,   including the gel and liquid phases.[30]  The 
gel phase is more rigid and individual lipid molecules have far less lateral mobility than in 
membranes above the transition temperature. To understand the effect of this phase transition 
on PTDM membrane activity, we looked at dye release from single-component 
dipalmitoylphosphatidylcholine (DPPC) vesicles.  In the dye release experiment, large 
unilamellar vesicles (LUVs) containing a high concentration (50mM) of carboxyfluorescein dye 
were exposed to varying concentrations of polymer.  Inside the vesicle, the dye is self-quenched 
due to high concentration so that any dye released becomes fluorescent upon dilution.  This 
approach is well established as an analog for energy-independent membrane activity.[6, 32]  
Dye release data was then fit to the Hill equation.   
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Figure 2.4.  Dye release from single-component DPPCCF LUVs.  Values represent fraction of 
dye released from vesicles at 600s after the addition of PTDM.   Red triangles were taken at 
50°C, which is above the liquid-to-gel transition.  Blue squares were taken at 25°C, which is 
below the liquid-to-gel transition.  Red lines and blue dashes are least-squares fits to the Hill 
Equation. 
 
DPPC has two well-defined, narrow phase transitions: a gel-to-ripple phase transition at 
34°C and a ripple-to-liquid transition at 42°C.[37, 38]  We therefore measured dye release at a 
temperature firmly in the gel phase (25°C) and another well into the liquid phase (50°C).  R9, as 
shown in the SI, did not induce more than 20% dye release under either condition.  This is not 
particularly surprising, given previous literature.[9]  Transferrin was not tested, as its uptake is 
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exclusively by endocytosis.[33, 34]   Figure 2.4 shows results and Hill plot fits for our PTDM 
series. The largest discrepancy between PTDM-membrane activity in gel phase and liquid phase 
occurred with G16. In the liquid phase G16 induced 70% dye release with an EC50 of 0.011μM, 
while in the gel phase it never exceeded 10% release.  dG9 showed similar results, with 
substantial differences above and below the phase transition. It is difficult, however, to assess 
the exact maximum release and EC50 in the gel phase since the curve did not reach a plateau 
even at very high concentrations (>>10μM). The magnitude of the effect decreased with 
increasing PTDM hydrophobicity.  The intermediately hydrophobic polymer G16-r-Ph4 had a gel 
phase EC50 (0.006μM) that was 70 times higher than in the liquid phase EC50 (0.12μM, Figure 
2.5).  Continuing this trend of decreasing EC50 ratios (gel phase EC50/liquid phase EC50), the most 
hydrophobic polymers were less sensitive to changes in lipid phase.  The copolymer G16-r-Ph8 
had an EC50 in the gel phase (0.52μM) that was 20 times higher than the one in the liquid phase 
(0.026μM), and the homopolymer PhG10 had an EC50 in the gel phase (0.11μM) that was only 4.8 
times larger than that in the liquid phase (0.023μM).  It is also noteworthy that with the 
exception of dG9, the EC50 values in the liquid phase, but not in the gel phase, were roughly 
independent of hydrophobic content.  
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Figure 2.5.  Dye release from DPPCCF LUVs.  Values represent fraction of dye released from 
vesicles at 600s.   Red triangles were taken at 50°C, above Tg.  Blue squares were taken at 25°C, 
below Tg.  Red lines and blue dashes are least-squares fits to the Hill Equation.  a) and c) 
compare the same polymer with and without dye, showing little difference in their release 
profile. 
These sets of data suggest that all of the polymers used in this study were able to 
penetrate the DPPC vesicle membrane in the liquid phase, but increased hydrophobic content 
was necessary to induce efficient dye release below the transition temperature.  In vitro study 
results also suggest that, since cooling cells to 4°C has an effect on the overall membrane 
rigidity, the cellular internalization efficiency would be expected to differ from other methods 
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that inhibit endocytosis without inducing phase transitions.  The cellular membrane is extremely 
complicated, including but not limited to the presence of proteins, cholesterol, mixed acyl lipids 
and other components that lead to broad phase transitions that produce multiple phases and 
lipid rafts. This makes it challenging to directly compare to much simpler single-lipid systems.  
While the effects of the membrane transition on dye release are obvious for DPPC, we wanted 
to better understand whether a mixed-acyl system which better resembles the biological 
membrane displayed similar behavior.  To this end, we created dye-filled vesicles consisting of 
mixed-acyl chain egg yolk PC (EYPC), which shows a broad transition ranging from -7 to 25°C.[38-
40]  Dye release was measured for these vesicles at 4°C and 25°C, representing both bounds for 
the temperature transition. 
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2.3.4 EYPC Dye Release 
 
Figure 2.6.  Dye release from mixed-acyl chain EYPCCF LUVs.  Values represent fraction of dye 
released from vesicles at 600s after the addition of PTDM.  Red triangles were taken at 25°C.  
Blue squares were taken at 4°C.  Red lines and blue dashes are least-squares fits to the Hill 
Equation. 
The EYPC dye release curves shown in Figure 2.6 globally resemble those collected from 
experiments with DPPC, with some reduction in separation across the temperature range.  As 
with DPPC, G16 showed substantial dye release at 25°C, while release never rose above 10% at 
4°C.  dG9 showed release at both temperatures, with an EC50 ratio greater than 25.  The more 
hydrophobic polymers G16-r-Ph8 and PhG10 had little measurable differences between dye 
release at 4°C and 25°C (each having EC50 ratios of just 1.8).  Also in line with the DPPC data, the 
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intermediate polymer G16-r-Ph4 showed behavior between G16 and G16-r-Ph8, with an EC50 ratio 
of 19 (Figure 2.7).  All polymer samples showed similar EC50 values at 25°C (from 0.0073μM for 
G16 to 0.021μM for PhG10), while the EC50 values at 4°C showed a sizable structure-property 
relationship across varying hydrophobicities.  There was little difference between the dye 
release behavior of a shorter polymer with fewer charges (PhG10) and a longer polymer with 
more charges (G16-r-Ph8), suggesting that neither of these factors were critical to membrane 
behavior within the range examined. 
 
Figure 2.7.  Dye release from EYPCCF LUVs.  Values represent fraction of dye released from 
vesicles at 600s.  Red triangles were taken at 25°C, above Tg.  Blue squares were taken at 4°C, 
below Tg.   Red lines and blue dashes are least-squares fits to the Hill Equation. a) and c) 
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compare the same polymer with and without dye, showing little difference in their release 
profile. 
Table 2.1.  Compiled dye release data for all polymers.  With increasing hydrophobic content, 
the EC50 values above and below Tg converge.  The ratios are larger for the single-lipid DPPC 
system than the mixed-acyl EYPC 
Dye Release EC50 Values (μM) 
 EYPC DPPC 
Polymer 4C 25C Ratio 25C 50C Ratio 
R9-FITC  >10 >10 n/a >10 >10 n/a 
G
16 
 >10 0.0073 >1300 >10 0.011 >900 
dG
9 
 0.77 0.017 45 >10 0.86 >11 
G
16
-r-Phi
4 
 0.12 0.006 19 2.9 0.041 >25 
G
16
-r-Phi
8 
 0.026 0.015 1.8 0.52 0.026 20 
PhG
10 
 0.037 0.021 1.8 0.11 0.023 4.8 
PhG
10
-NBD  0.032 0.020 1.6 0.118 0.017 6.8 
2.4 Conclusions 
It is clear that for hydrophilic polymers like G16 and dG9, the stark reduction in 
membrane activity caused by altering the lipid phase conditions through cooling is robust across 
both single- and mixed-acyl lipid systems.  In both cases, lowering temperature across the 
vesicle phase transition greatly altered dye release.  This effect decreased with increasing 
polymer hydrophobicity.  It is likely that increased lipid packing and reduced mobility 
heightened the barrier for polymer insertion into the membrane, a barrier that could be 
overcome by increasing the number of hydrophobic moieties.  This conclusion, while intuitive, 
has implications for both PTDM design and the methodology used in measuring cellular uptake. 
For PTDM design, it makes clear that energy-independent uptake requires polymers 
hydrophobic enough to insert into the membrane.  While dG9 releases dye in liquid-phase 
vesicles, it still only has minimal uptake in Jurkat T cells under ATP-depleted conditions.  This 
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suggests that while the polymer is able to insert into pure liquid phase phospholipids, the multi-
component cell membrane requires a higher hydrophobicity threshold for insertion.  Indeed, the 
more hydrophobic PhG10 has a much higher uptake under ATP-depleted conditions, but still 
struggles below the membrane transition at 4°C.  We would then hypothesize that a still more 
hydrophobic PTDM would be required to for energy-independent uptake at 4°C.  Since gel-phase 
lipids are not like present in cells at 37°C, PhG10 can be considered sufficiently hydrophobic for 
energy-independent uptake under most procedures. 
On the characterization side, chilling cells to 4°C has been a popular method for 
differentiating between energy-independent and energy-dependant uptake mechanisms, but 
has potential pitfalls.  The claim that measurements at 4°C represent only energy-independent 
uptake presupposes that chilling does not alter membrane activity.  As our vesicle studies show, 
this is not necessarily the case.  The clear change of membrane behavior in dye release studies, 
when combined with the difference in activity between cellular uptake at 4°C and in ATP-
depleted media strongly suggest that chilling alters the membrane properties and thus the 
ability of the polymers to cross the membrane.  This may bias uptake tests towards favoring 
polymers with increased hydrophobicity.  In order to avoid this kind of bias, we recommend that 
future studies use ATP depletion over cooling as a means of more accurately measuring energy-
independent uptake.  
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CHAPTER 3  
ANIONIC LIPID CONTENT PRESENTS A BARRIER TO ROMP-BASED PTDM ACTIVITY 
3.1 Introduction 
 The mechanism of cellular uptake of PTDs and their synthetic mimics is a widely debated 
and still largely uncertain topic.  As described in the previous chapter, the fraction of the 
polymer that enters cells through energy independent means is a matter of intense study.[1-6]  
However, there is compelling evidence that at least some polymer is able to cross the lipid 
bilayer, either from outside the cells or to escape endosomal entrapment.  Primary among this 
evidence is that it is possible to deliver functional biomolecules to the interior of a cell.  Our 
group has previously demonstrated siRNA knockdown of the NOTCH1 protein through the 
delivery of sequence-specific siRNA.[7]  More recent work has also demonstrated delivery of 
fully-functional CRE recombinase enzyme for the knockout of a GFP reporter gene located 
between two loxP sites.[8]  Studies by other research groups have also demonstrated the 
delivery of functional biomolecules by covalently-bound PTDs.[9-12]  Such delivery would only 
be possible in a system where the cargo, at least, is able to cross the bilayer membrane and 
enter the cytosol.  Further supporting this position are biophysical and simulation studies that 
demonstrated the ability of these polymers to cross lipid bilayers without the need for 
endocytosis.[13-21]  These studies were outlined in more detail in the introduction of this 
manuscript. 
 Among those biophysical studies, there is a strong consensus of the importance of the 
interaction between the cationic nature of the polymer and the anionic surface of the cell.  
Matile and coworkers have demonstrated that oligo- and polyarginine has dramatically 
increased membrane activity when the polymers are complexed with amphiphilic anions.[4, 13-
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15]  This even applies to polyarginine even when the amphphiles are lipids integrated into the 
vesicle bilayer, as an increase of anionic egg yolk phosphatidylgylcerol (EYPG) content in 
otherwise zwitterionic EYPC membranes leads to a dramatic increase in dye release activity.[13]  
Isothermal calorimetry studies of the binding energy associated with nonaarginine show that 
while the peptide has a strong association with anionic DSPG vesicles, they do not measure any 
such association with zwitterionic DSPC vesicles.[21]  Similarly, plasmon waveguide resonance 
studies of the PTD penetratin with EYPC and EYPG lipid bilayers shows a higher affinity for the 
anionic EYPG membrane.[18]  Small-angle x-ray scattering studies with PTDs and PTDMs have 
assumed anionic content as necessary, and examinations of their pore-forming activity have 
focused on bi-dentate hydrogen bonding interactions of the guanidinium group with anionic 
phosphate groups on anionic lipids.[22, 23] 
 There are also exceptions to this notion, however.  Detailed kinetic analysis of the 
interaction of the PTDM tp10 with vesicle systems revealed that while the tp10 has stronger 
binding to anionic vesicles, the actual rate of dye efflux was not measurably different.[24]  This 
is because the rate of dye efflux was more dependent on the amount of time the polymer spend 
integrated into the bilayer, which was similar for both anionic and zwitterionic systems.  It is 
worth noting, however, that tp10 is an amphiphilic, helical peptide that is lysine, rather than 
arginine, rich.  Perhaps most relevant to this investigation is work by Henning et. al. with a 
polymer very similar to polymer 1 used in this study.[15]  As with polyarginine, dye release was 
measured against a series of vesicles with progressively increasing amounts of EYPG.  Unlike the 
previous study, however, dye release dramatically decreased with increasing anionic content.  
This clearly suggested that this class of guanidinium-rich ROMP polymers interacted 
fundamentally differently with lipid bilayers than arginine-rich peptides, and required its own, 
separate analysis of its interaction with lipid bilayers. 
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 There then seem to be two separate classes of PTDs and PTDMs; those, like 
polyarginine, that have an increased uptake in the presence of anionic lipids and those, like tp10 
and ROMP PTDMs that have a decreased activity in their presence.  It is not understood why this 
latter class of polymers is different in this way, nor is it clear why this class of polymers is 
fundamentally different from the first.  This chapter will use a combination of polymer 
chemictry and biophysical experiments to explore these questions. 
 The following study examines the effect of anion lipid content on the interaction of a 
series of guanidinium-rich ring-opening metathesis (ROMP) polymers with phospholipid 
membranes.  It begins with more complete dye release studies characterizing the effect of 
anionic lipid content on membrane permeablization.  Next, the surface charge and aggregation 
of polymer-vesicle mixtures is examined, demonstrating that surface association is independent 
of anionic lipid content.  Lastly, surface plasmon resonance (SPR) experiments quantify the 
relative effects of anionic lipid content and polymer hydrophobicity on membrane association. 
3.2 Materials and Methods 
3.2.1 Polymer Synthesis 
Polymers in this study are the same as the imide series in chapter 2.  Synthetic details are 
provided therein. 
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3.2.2 Dye Release Studies 
3.2.2.1 Vesicle Preparation 
3.2.2.1.1 EYPC and DOPC Vesicles 
25mg egg yolk phosphatidylcholine (EYPC) or dioleoylphosphatidylcholine (DOPC) lipid 
in 3 mL of chloroform was evaporated onto the wall of a 10 mL flask using a rotary evaporator, 
then placed under vacuum overnight.  The lipid film was resuspended in buffer containing 10 
mM Tris and 50 mM carboxyfluorescein dye, titrated to pH 7.5.  The buffer was allowed to sit for 
an hour, vortexing every 15 minutes.  The DPPC vesicles were swelled in a water bath set to 
50°C during this time.  The vesicle solution was then put through six freeze-thaw cycles.  The 
solution was then extruded nine times through a 100 nm pore membrane.  The DPPC vesicles 
were warmed with a heat gun during the extrusion process.  Dye-loaded vesicles were 
separated from free dye by size exclusion chromatography (Sephadex G-50 superfine, Sigma 
Aldrich) in Tris saline buffer (10 mM Tris, 107 mM NaCl, pH 7.5). 
3.2.2.1.2 80:20 EYPC:Brain PS and 80:20 DOPC:DOPS Vesicles 
20mg EYPC or DOPC was combined with 5mg porcine brain phosphatidylserine (brain 
PS) or dioleoylphosphatidylserine (DOPS), respectively, in 3mL chloroform.  The mixture was 
rotary evaporated onto the wall of a 10mL flask and placed under vacuum overnight.  The rest of 
the vesicle formation was performed as above. 
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3.2.2.2 Vesicle Concentration Calibration 
Lipid concentration for a serial dilution of vesicles was measured using a Wako 
Phospholipids C diagnostic kit.  The same serial dilution was also measured for fluorescence in 
Tris buffer with 0.05% Triton-X 100.  68,000 counts in the Biotek Synergy Mx fluorescence plate 
reader was found to correspond to an in-well phosphatidylcholine concentration of 2.5 μM.  
This was the standard for further fluorescence measurements. 
3.2.2.3 Dye Release Experiments 
Experiments similar to those published previously[23] were performed using a Biotek 
Synergy Mx fluorescence plate reader.  All Fluorescence measurements were taken at an 
excitation wavelength of 492 nm and emission wavelength of 517 nm.  1,960 μL Tris buffer (10 
mM Tris, 107 mM NaCl, pH 7.5) was added to the wells of a 12-well plate.  20 μL of 250 μM 
vesicle solution (as defined above) was added to each well, creating an in-well concentration of 
2.5 μM.  The plate reader was heated to 25°C before continuing.  The plates were shaken at 
25°C and after three minutes a baseline fluorescence measurement, F0, was taken.  20 μL 
polymer/DMSO solutions containing varying concentrations (0.01-1000 μL) of polymer were 
added to wells with stirrers, and the plate was returned to the reader for 10 minutes of shaking.  
After 10 minutes, another reading, F10, was taken.  20 μL 5% Triton X-100 in DMSO was added to 
the wells and after three minutes a final measurement, FT, was taken.  FT and F0 allowed use to 
normalize fluorescence to measure the fractional dye release: 
   	 
/ 	 
 
The fractional dye release Y was then fitted as a function of concentration, c, to the Hill equation 
by a least-squares method: 
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Where EC50 is the concentration of 50% of maximal dye release and n is a fitting parameter. 
3.2.3 Dynamic Light Scattering and Zeta Potential Measurements 
3.2.3.1 Vesicle Preparation 
Vesicles were prepared in a similar manner to the dye release experiments above, but 
without carboxyfluorescein dye and omitting the size exclusion step.  For DOPC vesicles, 25mg 
DOPC lipid dissolved in chloroform was added to a flask that was then rotary evaporated to form 
a lipid film on the inner wall.  After placing the film under high vacuum overnight, the film was 
hydrated with a 1mL buffer solution containing 107mM NaCl, 10mM Tris, and titrated to pH 7.5.  
After an hour of periodic vortex agitation, the vesicles were subjected to six freeze-thaw cycles 
and then extruded nine times through a 100nm membrane.  The resulting 25mg/mL was then 
appropriately diluted in the same buffer for use.  80:20 DOPC:DOPS vesicles were prepared 
identically, except with 20mg DOPC and 5mg DOPS. 
3.2.3.2 Particle Mean Size and Zeta Potential Measurement 
Measurements were made using a Malvern Zetasizer Nano Z.  As with the dye release 
experiments above, varying concentrations of polymer were added to a vesicle solution 
containing 2.5µM lipid under constant agitation.  After 10 minutes, the solution was injected 
into a Malvern DTS 1061 folded capillary cell and dynamic light scattering measurements were 
immediately made and the number average mean size of the particles in solution was made.  
Zeta potential was then measured on the same sample. 
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3.2.3.3 Surface Plasmon Resonance Experiments 
3.2.3.4 Materials 
HEPES, sodium chloride and 1 M NaOH solution were obtained from Sigma 
Aldrich(Germany). Polycarbonate membranes (0.2 μm and 0.05 μm) and the lipids 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium 
salt) (DOPS) were obtained as solutions (10 mg/ mL chlorofom) from Avanti Polar-Lipids 
(Alabaster/AL, USA).  Filter with a hydrophilic PTFE membrane and 0.2 µm pore size were 
obtained from Millipore.  
3.2.3.5 Working conditions and apparatus: 
Experiments were performed at 20 °C. All SPR measurements were performed on a RES-
TEC RT2005 (Res-Tec, Mainz, Germany) with SF10 sensor chips (unmodified gold on high 
refractive index glass, XanTec bioanalytics, Duesseldorf, Germany) equipped with a flow cell 
(10 µL, teflon, Res-Tec, Mainz, Germany) and a peristaltic pump IsmatecReglo ICC (Idex, 
Wertheim, Germany). Plasmon excitation was effected in Kretschmann configuration[25] with a 
He-Ne-Laser (λ= 632.8 nm). 
Injection of vesicles as well as polymer-lipid interactions was followed by measuring the 
intensity of the reflected laser beam every 0.5 seconds. The incidence angle was between 55.35 
and 55.60° for the formation of the lipid film and between 55.85 and 56.77° for the polymer-
lipid interaction. The angles were chosen to obtain the same initial intensity of the signal.  Signal 
measurements are given in reflectance units (RU). 
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3.2.3.6 Lipid vesicles 
All manipulations were performed with immaculately clean, grease-free glassware. 2.5 
mL lipid solution (10 mg/mL pure DOPC or DOPC/DOPS 4:1 by volume in chloroform) was placed 
in a small vial. The solvent was evaporated under reduced pressure and the vial was gently 
shaken until a lipid film was formed on the vial walls. The film was then dried at high vacuum 
(10-3 mbar) for at least 4 h. The lipid film was then hydrated with 1.0 mL HEPES buffer (10 mM, 
107 mM NaCl, pH = 7.4) and shortly vortexed (4 times, every 15 min). The vesicle solution was 
then subjected to seven freeze-thaw cycles, which yielded unilamellar vesicles. To obtain small 
vesicles with even size distribution, this solution was extruded six times through a 
polycarbonate membrane with 200 nm pore-size and seven times through a polycarbonate 
membrane with 50 nm pore-size at 65 °C. Prior to use, the solution was diluted with HEPES to 
1 mM vesicle concentration (0.05 mL vescile solution + 1.45 mL buffer).  
3.2.3.7 Polymer solutions 
Polymer (4·10-4 mmol) was dissolved in 100 µL DMSO and diluted with HEPES buffer to a 
concentration of 10 µM.  
3.2.3.8 SPR  
Prior to use, all solutions were freshly prepared and filtered (0.20 µm). The SPR chip was 
mounted into the SPR flow cell and connected to the peristaltic pump. The lipid film on the SPR 
chip was produced by flowing the vesicles solution over the chip (3 µL/min) until a plateau was 
reached (at least 3600s contact time, which corresponds to 18x the flow cell volume). A short 
injection of10 mM NaOH (30 µL/min, 240 s, 12x flow cell volume) was used to remove loose 
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vesicles, followed by rinsing with HEPES buffer (30 µL/min, 240 s and 5 µL/min, 300 s) to obtain 
a stable signal.  The surface was kept under buffer.  In a control measurement, it was tested that 
injection of DMSO in buffer at the same concentrations as in the polymer solution does not 
influence the lipid film.  For each measurement, a fresh chip was used. HEPES buffer was 
pumped over the vesicle surface to obtain a stable signal (5 µL/min, 600 s), followed by the 
polymer solution (5 µL/min, 1200 s, 10x flow cell volume). Finally, HEPES buffer was injected 
until a stable signal was reached (5 µL/min, at least 3600 s). The amount of bound polymer was 
measured in RU under the same conditions as with the lipid measurements. 
3.2.3.9 Curve Fitting 
To fit the SPR data to a transport-limited kinetic model both the binding and unbinding 
curves were used.  First, the dissociation curve was fit to a simple exponential: 
   	 
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Where [AB] is the bound polymer concentration (proportional to the signal response), [AB]0 is 
the initial bound polymer concentration, [AB]∞ is the bound polymer after infinite time, and kd is 
the dissociation constant.  The data from the dissociation curve was fit to this function but a 
least-squares method in Mathematica. 
 To fit the binding curves, the approximation used by Myszka et al.[26] was implemented.  
In this two compartment model, polymer concentration within a distance hi from the surface 
(C(t)) is seen as the polymer concentration available for binding.  This creates a to-stage binding 
relation: 
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Where A0 is the polymer concentration in the injected solution, A is the polymer concentration 
near the surface, B is the number of binding sites available, ka is the association constant, and kM 
is the transport coefficient. 
Under this system, the binding behavior can be described by a pair of differential 
relations: 
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Here, we assume a state of quasi-equilibrium where d[A]/dt=0, in which case the values of ka, kd 
and kM become independent of hi.[26, 27]  For ease of calculation, then, we set hi=1RU/M and 
measure [AB] in RU.  This gives us the similar relationship: 
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Where 0  /'(, 31 4  /'(, and +0.  +./'(.  These differential equations are 
solved analytically and fit to the data using a least-squares method in Mathematica. 
3.3 Results and Discussion 
3.3.1 Polymer Design 
The polymer library used for this study (Figure 3.1) is identical to the imide series 
presented in chapter 2.  These polymers present a sequence of varying hydrophobicity with an 
average of 16 charges per polymer molecule.  Polymer 1 consists of only guanidinium-containing 
polymer with no additional hydrophobic moieties.  Polymer 2 has an additional average of four 
phenyl-containing monomer units, for a hydrophobic residue fraction of 20%.  Polymer 3 
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contains an average of 8 phenyl-containning units, for a hydrophobic fraction of 33%.  As a 
result, all polymers in this system would be expected to have similar electrostatic interactions 
with anionic surfaces but different water and lipid solubilities. 
 
Figure 3.1.  The polymer design used for this study.  (Top) Cartoon representation of random 
copolymer 2.  (Middle) Generic polymer structure for the series.  
 
3.3.2 Dye Release Studies 
The dye release profile of polymer 1 with EYPC (Figure 3.2a, Table 3.1) has a clearly-
defined EC50 value (7.3nM), unlike dye release from 80:20 EYPC:Brain PS vesicles, which has 
some small amount of dye release (less than 15% at 7µM) but no defined EC50.  This result runs 
counter to conventional wisdom for most guanidinium-rich PTD(M)s, where anionic lipid 
content is generally deemed necessary for membrane activity.  Indeed, the opposite effect has 
1: m=0 2: m=4 3: m=8
Hydrophobicity
a.
b.
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previously been noted for polyarginine, where addition of anionic EYPG to an otherwise 
zwitterionic EYPC vesicle system increased dye release.[13]  That polymer 1 has reduced 
membrane activity upon the addition of anionic lipid content was previously reported, but no 
further study of such behavior was made.[15] Polymers 2 and 3 (Figures 3.2b and 3.2c) 
demonstrate how this effect changes with increased polymer hydrophobicity.  Polymer 2 has a 
similar EC50 to polymer 1 against EYPC vesicles (6.4nM), with a higher maximum fluorescence 
(65% vs. 35%).  Against 80:20 EYPC:Brain PS vesicles, however, the EC50 for polymer 2 (85nM) is 
much closer to the EYPC value.  This trend of convergence continues with polymer 3, where the 
EC50 values (14nM for EYPC, 67nM for 80:20 EYPC:Brain PS) are closer to one another than for 
the other polymers.  It is thus clear that for the most hydrophilic polymer 1, the presence of 
anionic lipid in lipid vesicles strongly reduces membrane activity, but that this effect decreases 
with increasing polymer hydrophobic content.  This effect was also examined for polymer 2 
against DOPC and 80:20 DOPC:DOPS vesicles to ensure lipid phase was not causing this 
difference. (Figure 3.3)  Both DOPC and DOPS have very low spontaneous curvature values,[28] 
so it is unlikely that the addition of 20% DOPS has any meaningful effect on the ability of these 
membranes to form negative Gaussian curvature.[22] 
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Figure 3.2.  Dye release for the polymers a) 1 b) 2 and c) 3 from carboxyfluorescein-loaded EYPC 
(green squares) and 80:20 EYPC:Brain PS (red triangles) vesicles.  Green lines and red dashes are 
fits to the Hill Equation. 
 
Figure 3.3.  Dye release of polymer 2 from DOPC (green squares) and 80:20 DOPC:DOPS (red 
triangles) vesicles.  Green lines and red dashes are fits to the Hill Equation. 
Table 3.1.  EC50 values for the dye release experiments. 
 EC50 (µM) EC50 (µM) 
Polymer EYPC 80:20 EYPC/Brain PS Ratio DOPC 80:20 DOPC/DOPS Ratio 
1 0.0073 >7 >900    
2 0.0064 0.085 13.4 0.016 0.117 7.12 
3 0.014 0.067 4.68    
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3.3.3 Size and Zeta Potential 
The “adaptive translocation” model generally supposes that cation-anion binding is 
critical to membrane activity.[1]  To compare surface association behavior with membrane 
activity, we looked at size and zeta potential of vesicles under similar conditions to those used in 
the dye release experiments. (Figure 3.4)  100nm vesicles at the same concentration as used in 
the dye release experiments (2.5µM lipid) were exposed to varying quantities of polymer 2, and 
both zeta potential and dynamic light scattering mean size were measured.  The isoelectric point 
(IEP) and the aggregation behavior of the vesicles can be used to demonstrate the point at 
which surface charge neutralization occurs, while the high-concentration plateau of the zeta 
potential gives the surface-association saturation point.  For reference to these data points, the 
EC50 values for DOPC (green dashed line) and 80:20 DOPC:DOPS (red dashed line) are shown. 
 
Figure 3.4.  a) Number mean particle size by dynamic light scattering and b) zeta potential 
measurements for the interaction of varying concentrations of polymer 2 with phospholipid 
vesicles.  Green squares represent data for zwitterionic DOPC vesicles, while red triangles 
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represent data for anionic 80:20 DOPC:DOPS vesicles.  Green and red dashes represent the dye 
release EC50 values for the DOPC and 80:20 DOPC:DOPS vesicle systems, respectively. 
Several clear, important trends become noticeable.  The first is that the both the 
zwitterionic and anionic lipid systems have a typical sigmoidal zeta potential response to the 
addition of polymer.  This is typical of polyelectrolyte adsorption onto an oppositely-charged 
surface.[29, 30]  The zwitterionic vesicles appear to maintain some small amount of negative 
charge before the addition of polymer, although this level is considerably lower than for the 
anionic lipid system.  The isoelectric points of these two systems is similar; 0.2 µM for the 
zwitterionic system and 0.4 µM for the anionic system.  Perhaps more importantly, the zeta 
potential for both systems reaches a plateau at around the same concentration (2 µM) and at 
the same zeta potential value (20mV), suggesting that the total accumulated amount of polymer 
on the surface is similar.  The mean size data (Figure 3.4a) supports the notion of similar binding 
behavior, as the two vesicles systems demonstrate similar aggregation properties, with 
maximum aggregation around the isoelectric point.  This is consistent with studies of the 
interaction of cationic polymers with anionic particles, which show a maximum rate of vesicle 
aggregation at charge neutralization, with reduced rates at both lower and higher polymer 
concentrations.[29-31]  These two data sets combined mean that while membrane activity (as 
shown through dye release) is highly differentiated between anionic and zwitterionic lipid 
systems, the initial binding behavior is not.  For DOPC vesicles, the EC50 value is an order of 
magnitude below the isoelectric point, while for 80:20 DOPC:DOPS, the EC50 and isoelectric 
points are only a factor of 2 apart, suggesting that the difference in activity is due to membrane 
interaction aspects other than surface association rates. 
Light scattering data also tells us two other important features.  The first is that while 
the dye release studies do not distinguish between dye released by membrane permeablization 
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and dye released by vesicle disruption, the light scattering data suggests that these vesicles 
remain largely intact at concentrations relevant to dye release.  This suggests that the dye 
release studies function by some process other than simple membrane disruption.  Secondly, 
light scattering of the polymer in buffer solution alone (Figure 3.5) demonstrates that some 
amount of aggregate material is present for each polymer used. The aggregates are larger for 
polymer 3, though, indicating that this polymer is less soluble in solution than the others. 
 
Figure 3.5.  Dynamic light scattering of 10µM polymer in buffer solution. 
3.3.4 Surface Plasmon Resonance 
To examine the relationship between binding, bilayer insertion, and membrane activity, 
we turn to surface plasmon resonance (SPR).  SPR relies on the plasmon resonance 
phenomenon, where for a specific incidence angle light cast on to a gold-plated chip is adsorbed 
in an evanescent wave.[32-34]  When material accumulates on the surface of the chip, the 
refractive index of the chip is altered and the incidence angle changes.  By monitoring the 
reflectivity at a single angle on the leading slope of the reflectivity dip, it is possible measure the 
real-time surface adsorption of an analyte.  While the dye release and zeta potential 
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experiments had identical lipid and polymer concentrations, SPR is performed fundamentally 
differently.  The concentration of polymer in solution remains fixed due to continuous flow, 
meaning that the only limits on the amount of polymer interaction with the lipid bilayer is the 
kinetics of interaction and the amount of polymer that is able to adsorb onto the lipid layer. 
 
Figure 3.6.  Surface plasmon resonance binding and unbinding curves for 10µM of polymer (a) 1,  
(b) 2 and (c) 3.  Green lines represent binding to the zwitterionic DOPC lipid system, while red 
DOPC 80:20 DOPC:DOPS
a.
b.
c.
0 20 40 60
20
25
30
35
40
45
R
e
fle
ct
ivi
ty
 
(%
)
Time (min)
0 20 40 60
20
25
30
35
40
45
R
e
fle
ct
ivi
ty
 
(%
)
Time (min)
0 20 40 60
20
25
30
35
40
45
R
e
fle
ct
ivi
ty
 
(%
)
Time (min)
93 
 
lines represent binding to the anionic DOPC:DOPS system.  The bilayer was exposed to a 
continuous flow of polymer solution starting at t=0 and then flushed with buffer starting at t=20 
minutes.  Black lines represent model fits. 
Table 3.2.  Peak and final change in reflectance for SPR experiments. 
 DOPC DOPC:DOPS 
Polymer Peak (RU) After Buffer (RU) Peak (RU) After Buffer (RU) 
1 4.7 2.5 5.7 3.7 
2 10.6 7.2 12.1 9.1 
3 15.8 13.3 21.3 19.4 
 
 The SPR data here (Figure 3.6, Table 3.2) corroborates the size and zeta potential data 
from Figure 3.4. In each case, a phospholipid bilayer is exposed to a continuous flow of 10µM 
polymer.  While for all three polymers the polymer binds slightly more strongly to the anionic 
lipid system than the purely zwitterionic one, this effect is dwarfed by the increase in binding 
due to the differences in polymer hydrophobicity.  After 20 minutes, polymer 1 increases the 
SPR signal by a total of 4.7 reflectance units (RU) on the DOPC bilayer, and by 5.7 RU for the 
80:20 DOPC:DOPS bilayer, for an increase of 21%.  Polymer 2 shows a signal of 10.6 RU with the 
DOPC bilayer, a 126% increase in signal over polymer 1.  While polymer 2 is 12.1 RU with the 
DOPC:DOPS bilayer, this is only a 14% increase over the signal with the DOPC bilayer.  For 
polymer 3 with the DOPC bilayer, there is a signal of 15.8 RU, and increase of 48% over that for 
polymer 2.   For the DOPC:DOPS bilayer, polymer 3 contributes 21.3 RU, an increase of 34% over 
the signal for the zwitterionic DOPC bilayer.  It’s worth noting, however, that the amount of 
polymer removed from the membrane after a prolonged buffer flow was relatively independent 
of both membrane composition and polymer hydrophobicity.  In each case, a drop of 1.9-3.4 RU 
was recorded, with the largest drops occurring for polymer 2. 
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Table 3.3. Fitting parameters for transport (kM), association (ka), and disassociation (kd) for all 
three polymers.  Fitting was performed using a transport-limited rate model. 
 DOPC DOPC:DOPS 
Polymer kM (RU cm M
-1 s-1) ka (M
-1 s-1) kd (s
-1) kM (RU cm M
-1 s-1) ka (M
-1 s-1) kd (s
-1) 
1 8517 984 3.09x10-3 8517 351 1.89x10-3 
2 8517 255 2.19x10-3 8517 549 9.22x10-4 
3 8517 2192 1.75x10-3 8517 1229 1.94x10-3 
 
 The kinetic curves from the SPR data were fitted to a mathematical model. The 
unbinding curve gave the dissociation constant kd, which was then folded into a transport-
limited binding model,[26] where the transport rate constant (kM) was fitted to a single value 
over the series.  The data for this fitting is shown in Table 3.3, and the curves themselves are 
shown in Figure 3.6.  There is a fair bit more variation in the kinetic data than there was in the 
peak and final reflectance values.  Additionally, the quality of the fits is very high for polymer 1, 
but polymers 2 and 3 show poorer fits. Two trends are evident, however.  One is that the 
dissociation constants are fairly similar across the board, not changing within a series by much 
more than a factor of two.  The dissociation values are also slightly higher as a whole for the 
DOPC lipid system than the DOPC:DOPS system.  The association values are less consistent with 
the DOPC system, but in both sets polymer 3 shows much stronger binding than polymers 1 or 
2. 
 From the SPR data, it is clear that while anionic content increases the membrane 
association of all polymers, this effect is far smaller than the effect of increased polymer 
hydrophobicity.  After flushing with buffer for 40 minutes, there is 5.3 times as much polymer 3 
bound to the DOPC membrane as polymer 1.  By comparison, polymer 1 shows the largest 
fractional increase of binding due to anionic content, with the DOPC:DOPS layer containing 1.5 
times as much polymer as DOPC alone.  It is then reasonable to state that membrane 
association is primarily driven by hydrophobic interactions with electrostatics playing a 
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secondary, ancillary role.  This has major implications for how we consider PTDM-membrane 
interactions for this class of polymer.  The first is that while it is clear from the dye release data 
that anionic lipid content acts as a barrier to membrane activity, it does not greatly affect initial 
association of the polymer to the membrane.  This means that the anionic content must affect 
other stages of membrane interaction—namely, the ability of the polymer to transport across 
the membrane and provide release for the dye.  This is in direct contradiction to the “adaptive 
translocation” model that is frequently proposed for PTDs and PTDMs.  Instead of the anionic 
lipid assisting in polymer transport across the membrane, they instead pin the polymer to one 
side and prevent movement across the bilayer. 
 The second implication is that cationic nature of these polymers may not be critical for 
energy-independent transport.  Net positive charge has previously been assumed to be 
necessary to allow anionic amphiphiles to assemble around the polymer and integrate it into the 
membrane.[13]  It has also been proposed that the special bidentate hydrogen bonding 
capabilities of guanidinium ions with phosphate groups allows for improved membrane 
integration.[13, 14, 22, 23]  However, if the polycation-anionic surface interactions are 
detrimental to membrane transport, it is possible that a neutral polymer containing a similar 
balance of water and lipid solubility could be equally if not more effective at membrane 
transport.  Neutral polymers have the advantage of generally being considered less toxic than 
cationic polymers.[35-37]  In particular, a polymer containing a guanidinium group and overall 
zwitterionic nature may provide the optimum balance of activity and low toxicity. 
 The association kinetics of the polymers 1 and 3 to the membrane in the SPR 
experiments are so rapid that they are transport limited, meaning that their kinetic profile is 
limited by the rate of polymer introduction to the surface.   A transport-limited rate model was 
introduced to account for this effect.  While this model generated excellent fits for polymer 1, it 
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is apparent that this model is still not an excellent fit for polymers 2 or 3.  This suggests further 
complexity.  This is particularly noticeable when looking at the kinetic traces for polymer 2.  
While the association of polymers 1 and 3 to the membrane is very rapid, approaching 
saturation before 10 minutes, polymer 2 shows a slower kinetic trace.  All three polymers have 
very narrow polydispersities and show no tailing or shoulders, (Figure 3.7, Table 3.3) so this 
difference isn’t likely due to synthetic irregularity or defect.  The most likely explanation of the 
difference in these traces can be found in a two-step binding model.  Polymer 1 shows rapid 
surface binding—the first step—but saturates quickly as very little of the polymer sits in the lipid 
layer.  Polymer 3 shows rapid surface binding and rapid integration into the membrane, allowing 
it a much higher binding capacity but still rapid kinetics.  Polymer 2, on the other hand, still has a 
rapid first step, but a slow second step, resulting in the high total membrane association but 
slower kinetics. 
 
Figure 3.7.  GPC traces of polymers 1, 2, and 3. 
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Table 3.4.  GPC molecular weights of the polymers. 
Polymer Mn (g/mol) Đ 
1 7400 1.08 
2 8050 1.10 
3 8400 1.06 
 
3.4 Conclusions 
The dye release data demonstrates conclusively that the introduction of anionic lipid to 
phospholipid membranes presents a barrier to ROMP-based PTDM activity, but that this barrier 
can overcome with the addition of hydrophobic moieties to the polymer.  Light scattering and 
zeta potential showed that polymer 2 had similar surface-association behavior with both anionic 
and zwitterionic lipid systems, and that this binding does not correlate with membrane activity.  
Surface plasmon resonance tells a similar story, where the increase in binding due to the 
presence of anionic lipid is far smaller than that due to added polymer hydrophobicity. 
From this data, then, a clearer picture of how these polymers are able to translocate 
phospholipid membranes begins to appear.  The first step is a membrane association driven by 
hydrophobic interaction.  Once on the lipid surface, anionic content on the surface will “pin” the 
polymer on that outer leaflet and prevent further penetration.  As polymer hydrophobicity is 
increased, however, the polymer is able to overcome that electrostatic interaction, reducing the 
gap in activity between purely zwitterionic and anion-containing lipid systems.  This concept of a 
membrane feature acting as a barrier to activity, but one that can be overcome by added 
hydrophobicity was previously explored with regards to membrane phase in chapter 2.  It is 
possible that a similar experimental model could be applied to other membrane components, 
such as protein content.  The result is a system where a “generic” zwitterionic, fluid-phase lipid 
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system may be easy for a hydrophilic polymer to penetrate, but that additional membrane 
components will increase the hydrophobicity threshold for activity.  
 It is important to remark that the implications of this study are limited to this particular 
PTDM design.  As mentioned in the introduction, similar studies of the effect of anionic lipid on 
the activity of oligo- and polyarginine have produced very different results.  While the exact 
reason for this discrepancy is still unclear, it is possible that the ROMP-based PTDM activity is 
more dominated by polymer hydrophobicity than polyarginine, which has substantially less 
hydrophobic content.  Thus, while the difference in membrane association between anionic and 
zwitterionic lipid systems and ROMP PTDMs is small, it may be much larger for polyarginine.  
Additionally, as was shown in chapter 2 (Figures 2.5 and 2.7), R9 does not induce dye release in 
EYPC vesicles, so it is perhaps no surprise that this polymer system produces mechanistically 
different results.  The results are nonetheless important, though, as they provide guidelines for 
the design of new and superior polymers for cellular uptake, as well as insight into the physics of 
this apparently unique membrane transporting molecules.   
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CHAPTER 4  
GUANIDINIUM-RICH POLYMERS DISPLAY LENGTH- AND HYDROPHOBICITY-DEPENDENT 
NEGATIVE GAUSSIAN CURVATURE GENERATION 
Note:  This work has been previously published as: 
Schmidt N., M. Lis, K. Zhao, G. Lai, A. Anastassia, G. Tew, G. Wong.  (2012)  Molecular 
basis for nanoscopic membrane curvature generation from quantum mechanical models 
and synthetic transporter sequences. Journal of the American Chemical Society, 134, 
19207 
The computational modelling sections of this publication are not featured below, as the author 
did not contribute to that work. 
4.1 Introduction 
Membrane-active peptides and proteins often use arginine to confer strong interactions 
with cell membranes. For example, hydrophilic arginine-rich cell penetrating peptides (CPP) such 
as the TAT peptide can efficiently translocate across cellular membranes.[1-6] Many types of 
antimicrobial peptides (AMP) like amphipathic α- and θ-defensins from mammals, which display 
potent in vitro activity against bacteria via membrane permeabilization, use arginine over 
lysine.[7-9] Due to their biological significance and complex interactions with cell membranes, 
much scientific effort has gone into understanding the observed structure–function 
relationships between arginine-rich peptides and biomembranes. 
There is substantial evidence that the guanidine side chain of arginine is responsible for 
its unique membrane interactions. For CPPs, the first indication of its importance was 
demonstrated when Vives[1] showed that an arginine-rich, 11AA sequence from the 
transactivator of transcription (TAT) protein of HIV, YGRKKRRQRRR, now referred to as the TAT 
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peptide, is sufficient for cellular uptake. It was soon realized by Wender[10] and Mitchell[11] 
that the uptake ability of the TAT peptide was due to its guanidinium ions as exemplified by 
their demonstrations that l- and d-arginine oligomers were more efficient than the TAT peptide, 
and homopeptides consisting of other cationic residues including histidine, lysine, and ornithine 
were less effective. They also showed that cellular uptake was a nonmonotonic function of poly 
arginine length[11] and depended on residue spacing.[12] As uptake is sensitive to the 
arrangement of arginine side chains a number of groups have designed synthetic guanidinium-
rich cell penetrating molecules, or molecular transporters, using oligoarginine peptoids,[10] and 
nonpeptidic versions including synthetic polymers,[13-18] oligocarbamates,[19] polyguanidino 
dendrimers based on diamino acid monomeric units,[20] and carbohydrate-based molecules like 
guanidinylated neomycin.[21] Many of these molecules displayed similar or better uptake than 
poly arginine and the TAT peptide, suggesting that synthetic guanidinium-rich molecular 
transporters have a rich potential for applications such as drug delivery and antibiotics. 
How CPP-membrane interactions promote uptake is not well understood at a 
fundamental molecular level. To explain the central role of the guanidinium group, Mitchell[11] 
originally cited its ability to form stable bidentate hydrogen bonds with anions such as 
phosphate or sulfate, which was believed to distinguish arginine from lysine and histidine. This 
was an interesting and conceptually powerful proposal. It implied that Arg-rich CPPs could in 
principle form strong complexes with anionic membrane components like phospholipid 
headgroups and enable uptake.[22] Conversely, the monodentate H-bonding abilities of Lys 
might be incapable of stabilizing strong complexes so Lys-rich peptides exhibit poor uptake.[22, 
23] As the CPP discourse has primarily focused on whether they enter cells by direct 
translocation[24-29] or endocytosis,[30-34] the prevailing explanation for why Arg-rich peptides 
have better uptake than Lys-rich peptides has remained in terms of qualitative H-bonding 
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descriptions.[29, 35-38] Despite the widespread description of Arg vs Lys in terms of bidentate 
vs monodentate H-bonding for cationic, membrane-active transporters, there is no molecular 
understanding of how the interactions of guanidinium groups with anionic membrane 
components lead to translocation, while the interactions of amine groups with these 
components do not. 
Recent work by the Wong group proposed a qualitative nanoscale model for 
understanding membrane curvature generation by CPPs[39] and AMPs.[40] Cationic polymers 
such as poly-Arg and poly-Lys can generate negative curvature via electrostatic interactions with 
anionic membranes.[41] For guanidinium groups, bidentate H-bonding[42] can in principle lead 
to enhanced steric effects that generate positive membrane curvature along a poly-Arg chain. 
Therefore, poly-Arg can generate negative Gaussian curvature, positive and negative curvature 
in orthogonal directions, which is necessary for active membrane permeation processes like 
pore formation and the membrane protrusions and invaginations present in endocytic 
processes.[41, 43, 44] This stands in contrast to presumed monodentate H-bonding of primary 
amine groups, the side chain of Lys, which cannot translocate across membranes. In this 
proposed qualitative model, the propensity for monodentate and bidentate H-bonding for lysine 
and arginine is assumed for simplicity. However, such propensity is likely complex because these 
interactions depend on the molecular details of the surrounding environment. Previous 
theoretical works[34, 35, 45, 46] on Arg-Arg and Lys-Lys associations in bulk water have shown 
that like-charge pairing is more stable between guanidinium groups than ammonium groups, 
and that interactions of guanidinium pairs are optimal when the side chains are in a stacking 
arrangement. Similar trends were observed at the level of potential of mean force from MD 
studies of guanidinium groups at the lipid bilayer-water interface.[47] What is not known is how 
these structural tendencies are expressed when Arg and Lys interact with phospholipid 
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headgroups, and how such tendencies are dependent on the effective spacing of the amino acid 
side chains. There is a significant need for a deeper understanding for how ensembles of side 
chains hydrogen bond to lipid headgroups. 
In concurrently presented research, we investigated the physical origin of peptide-
induced membrane curvature by contrasting differences between H-bonding interactions of Arg 
and Lys with phosphate groups using quantum mechanical (QM) calculations.[48]  This chapter 
presents a test of those results via engineered molecular transporters without the geometric 
constraints imposed by polypeptide backbones. Surprisingly, QM calculations suggested that 
individual Lys can coordinate two phosphates. However, they are not able to do so at small 
inter-Lys distances without drastic energetic penalties. In contrast, Arg are able to coordinate 
two phosphates stably down to interguanidinium distances of less than 5 Å, where guanidinium 
groups stack “face to face”. We hypothesize that the persistence of this stacking arrangement in 
poly-Arg allows it to “cross-link” lipid headgroups into composite objects with a large effective 
head area and generate positive intrinsic curvature via excluded volume interactions in a 
manner that poly-Lys cannot duplicate. In agreement with this hypothesis, poly-Arg can 
generate the positive membrane curvature necessary for inducing negative Gaussian curvature, 
whereas poly-Lys cannot. Also consistent with QM calculations, polyguanidine-oxanorbornene 
homopolymers (PGONs), which have the same guanidinium side-chains as poly-Arg but are not 
constrained by distances characteristic of polypeptide chains, showed that curvature generation 
is exquisitely sensitive to the guanidinium group spacing when the phosphate groups are near 
close packing. An increase of guanidinium group spacing from 3.6 to 5.8 Å decreased the 
maximum induced negative Gaussian curvature by 22%. Our study provides a unified molecular 
description for how guanidinium groups contribute to the established membrane translocation 
abilities of molecular transporters. 
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Nanoscale positive curvature generation by lipid headgroup coordination is distinct from 
hydrophobic insertion, a complementary strategy of generating such curvature by peptides.[40, 
49, 50] To examine how these two different mechanisms interact with one another, phenyl or 
butyl hydrophobic groups were added into guanidine-oxanorbornene polymers. In general, 
incorporation of hydrophobicity increased the amount of saddle-splay membrane curvature that 
was generated as well as broadened the range of lipid compositions where saddle-splay 
curvature was observed, showing that positive curvature generation by hydrophobicity can 
combine with lipid headgroup coordination by guanidinium to promote membrane permeation. 
Our results show that it is possible to design pore forming peptides with programmable 
membrane curvature generating abilities which influence their pore forming activities. 
4.2 Materials and Methods 
4.2.1 Synthetic Procedures 
4.2.1.1 Monomer Synthesis   
The guanidine monomer was synthesized similar to previous reports,[14] with minor 
modifications. The hydrophobic monomers were synthesized as described previously[16, 17] 
with no modification, and therefore their syntheses are not reported here. 
 
Figure 4.1.  Diels-alder synthesis of oxanorbornene imide. 
Oxanorbornene Imide.  10 g (103 mmol) of Maleimide and 10.0 g (10.6 mL, 146.8 mmol) furan 
were dissolved in 100 mL ethyl acetate. The Diels-Alder product was obtained by stirring at 90°C 
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for 3 h. The product precipitated upon cooling, and was filtered and dried under vacuum 
overnight. Yield=55%. 
 
Figure 4.2.  Synthesis of di-boc protected Guanidine monomer. 
Di-Bioc Protected Guanidine Monomer. 5 g (30 mmol) oxanorbornene imide, 5.6 g (35 
mmol) N-Boc-ethanolamine, and 8.0 g (30 mmol) triphenylphosphine were added to 100 mL dry 
THF and placed under nitrogen an into an ice bath. 6.3 mL (30 mmol) diisopropyl 
azodicarboxylate (DIAD) is added dropwise, after which the solution is removed from the ice 
bath and the reaction is left for 24 hours. The solvent is reduced by rotary evaporator, and the 
concentrated solution is precipitated twice in diethyl ether. The yield is 5.2 g (17 mmol, 56%). 
The product is then deprotected in neat trifluoroacetic acid (TFA) and precipitated again in 
diethyl ether. The protonated salt and 5 mL triethylamine were added to 100 mL of 
dichloromethane. To the solution was added 9.8 g (25 mmol) 1,3-Di-Boc-2- 
(trifluoromethylsulfonyl)guanidine, and was allowed to stir 12 h. The solution was concentrated, 
washed with 10% potassium hydrogen sulfate, then saturated sodium bicarbonate, and purified 
by column chromatography. The final yield was 6.5 g (14 mmol). 
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1H NMR (300 MHz, CDCl3): δ =11.42 (1H, s), 8.41 (1H, t), 6.51 (2H, s), 5.26 (2H, s), 3.70 (2H, m), 
3.60 (2H, m), 2.86 (2H, s), 1.47 (9H, s), 1.39 (9H, s). 
 
13C-NMR (75 MHz, DMSO-d 6 ): δ = 176.3, 156.6, 153.0, 136.5, 83.3, 80.9, 47.6, 39.0, 38.4, 28.3, 
28.1. 
HR-MS (FAB): calc. 451.49, found 451.22. 
4.2.1.2 Polymer Synthesis 
Polymer synthesis was performed similarly to reported procedures.[14, 16, 17, 51]  
Monomers were polymerized/co-polymerized by ring-opening metathesis polymerization 
(ROMP) using a 3rd generation Grubbs’ catalyst. The monomer (~200mg) and appropriate 
amount of catalyst were dissolved in dry dichloromethane in separate Schlenk flasks. The flasks 
were placed under nitrogen and degassed using a freeze-pump-thaw procedure. The monomer 
was transferred to the catalyst flask and the polymerization was allowed to proceed at 25°C for 
an hour, after which 1 mL ethyl vinyl ether was added to terminate the reaction. After an hour, 
the solution was concentrated and precipitated twice in 100 mL pentane. 
The  Boc-protected  polymers  were  deprotected  by  stirring  the  polymer  in  10  mL  1:1 
TFA:CH2Cl2 for 12 hours. The TFA was then removed by repeatedly co-evaporating with 
methanol in a rotary evaporator, then by placing under a vacuum for 4 h. The solid polymer was 
then suspended in water and freeze-dried for 3 days. 
 
Boc-Protected PGON.  1H-NMR (300 MHz, CD2Cl2): δ=11.49 (1H, br), 8.45 (1H, br), 6.08 
(trans) and 5.80 (cis) (2H total, br), 5.02 (cis) and 4.48 (trans) (2H total, br), 1.52 (9H, s), 1.47 
(9H, br), cis:trans ratio = 48:52. 
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PGON. 1 H-NMR (300 MHz, DMSO-d 6 ): δ=7.88 (1H, br), 7.36 (4H, br), 5.96 (1H, br), 5.74 (1H, 
br), 4.92 (1H, br), 4.43 (1H, br) 3.47 (4H, br). 
 
Boc-Protected Butyl-GON.  1H NMR (300 MHz, CD2Cl2): δ=11.49 (5H, br), 8.45 (5H, br), 6.08 
(trans) and 5.81 (cis)  (22H total, br), 4.99 (cis), 4.46 (trans) (22H, br), 1.52 (99H, br), 1.47 (99H, 
br), 1.32 (12H, br), 0.95 (18H, br); cis:trans ratio = 53:47. 
 
Butyl-GON. 1 H NMR (300 MHz, DMSO-d 6 ):  δ = 7.67 (5H, br), 7.27 (20H, br), 5.96 (11H, br), 
5.75 (11H, br), 4.88 (11H, br), 4.43 (11H, br), 1.45 (12H, br), 1.23 (12H, br), 0.83 (18H, br). 
 
Boc-Protected Phenyl-GON.  1H NMR (300 MHz, CD2Cl2): δ=11.46 (5H, br), 8.44 (5H, br), 7.21 
(30H, br), 6.05 (trans), 5.76 (cis) (22H total, br), 4.99 (cis), 4.46 (trans) (22H, br), 4.08 (12H, 
br), 2.91 (12, br) 1.52 (99H, br), 1.47 (99H, br); cis:trans ratio = 44:56. 
 
Phenyl-G.  1H NMR (300 MHz, DMSO-d 6 ):  δ =  7.27 (5H, br), 5.96-5.72 (4H, br), 4.88 (1H, br), 
4.43 (1H, br), 4.10 (2H, br), 2.85 (2H, br) 
4.2.2 Dye Release Studies 
4.2.2.1 Vesicle Preparation 
A lipid film was created by evaporating a 2mL chloroform solution containing 25mg egg 
yolk phosphatidylcholine (EYPC) in a rotary evaporator the under high vacuum overnight.  The 
lipid was then hydrated for 1 hr in a dye buffer (10mM Tris, 10mM NaCl, 50 mM calcein, pH 7.5) 
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accompanied by intermittent vortexing.  The resulting vesicles were placed under 6 freeze-thaw 
cycles (liquid nitrogen to 25°C water bath) and then extruded nine times through a 
polycarbonate membrane (400nm pore size).  Free dye outside the buffers was removed by size 
exclusion chromatography (Sephadex G-50 superfine, Sigma Aldrich) in Tris saline buffer (10 mM 
Tris, 107 mM NaCl, pH 7.5). 
4.2.2.2 Dye Release Experiments 
Dye release experiments were performed with a Biotek Synergy Mx fluorescence plate 
reader.  All fluorescence measurements were with an excitation frequency of 492nm and an 
emission of 517nm. 1960 µL tris saline buffer was added to each well in a 12 well plate.   20 µL 
vesicle solution (diluted to a post-triton fluorescence of 70,000 counts, or about 2.5 µM, in the 
well) was added to the wells and the plates were shaken at 25°C for 3 minutes when a baseline 
measurement, F0, was taken.   20 µL polymer solutions of varying concentrations were then 
added to the wells while stirring.  The plate was then allowed to shake for another 10 minutes 
and another reading, F10.  20 µL of 5% Triton X-100 in DMSO was then added to the wells to 
release all dye from the vesicles.  After 3 minutes of shaking, a final measurement was taken, FT.   
Results were normalized according to the baseline and Triton controls to yield fractional dye 
release: 
   	 
/ 	 
 
The fractional dye release Y was then fitted as a function of concentration, c, to the Hill equation 
by a least-squares method: 
  
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Where EC50 is the concentration of 50% of maximal dye release and n is a fitting parameter. 
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4.2.3 Antimicrobial and Hemolysis Testing 
Antimicrobial and hemolysis testing were done similar to previous procedures.[51] 
Bacterial strains of E. coli (D31) and S. aureus (ATCC 25923) were incubated in Mueller-Hinton 
Broth overnight at 37 °C. The culture was then diluted to 106 CFU/mL, as measured by OD600. 
Polymers were then dissolved in a stock solution of 40 mg/mL in DMSO. Serial dilutions were 
performed in phosphate-buffered saline (PBS). Antibacterial activity was expressed as the 
minimum inhibitory concentration (MIC90), the concentration at which bacterial growth was 
inhibited by at least 90% compared to growth in broth alone after 6 h at 37 °C, as measured by 
OD600. Hemolytic activity was measured using separated red blood cells. Thirty microliters of 
human blood was suspended in 10 mL PBS and centrifuged three times, resuspending in buffer 
each time. Polymers were dissolved in a stock solution of 40 mg/mL in DMSO. Serial dilutions 
are performed in PBS; 100 μL of these polymer solutions were added to 100 μL of the blood cell 
solutions. These suspensions were allowed to stir for 30 min, then centrifuged. The absorbance 
of the supernatant at 414 nm was used to measure the amount of hemoglobin release. The 
positive control (total hemolysis) was obtained by adding 10 μL 20% Triton X-100 solution to the 
red blood cells. The HC50 was reported as the concentration of polymer that causes 50% release 
of hemoglobin. 
4.2.4 SAXS Studies 
4.2.4.1 Liposome Preparation for X-Ray Measurements 
Liposomes were prepared as described previously.[40] Briefly, DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine), DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), and DOPS 
(1,2-dioleoyl-sn-glycero-3-phospho-l-serine (sodium salt)), lyophilized lipids from Avanti Polar 
lipids were used without further purification. SUVs were prepared by sonication. Individual stock 
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solutions of DOPS, DOPC, and DOPE were prepared in chloroform at 20 mg/mL. Ternary 
mixtures of these lipids were prepared at mass ratios, for example, DOPS/DOPE/DOPC = 
20/60/20 corresponds to a 1:3:1 mass ratio. Chloroform was evaporated under N2, and the 
mixtures were further dried by overnight desiccation under vacuum. The dried lipids were 
resuspended the next day in 100 mM NaCl or in Millipore H2O. Solutions were incubated at 37 
°C for 12–24 h and then sonicated until clear. Small unilamellar vesicles (SUV’s) were obtained 
via extrusion (0.2 μm pore Nucleopore filter). 
4.2.4.2 SAXS Experiments 
All polymers were resuspended in either 100 mM NaCl or in Millipore H2O. Lipids were 
thoroughly mixed with polymers at specific peptide to lipid ratios (P/L) in 100 mM NaCl. The 
solutions were hermetically sealed in quartz capillaries (Hilgenberg GmbH, Mark-tubes, Code 
No: 4017515). SAXS experiments at synchrotron sources were conducted at the Stanford 
Synchrotron Radiation Laboratory (BL 4–2), and the Advanced Light Source (beamline 7.3.3). 
Monochromatic X-rays with energies 9–11 keV were used at SSRL and 10 keV at ALS. The 
scattered radiation was collected using a Rayonix MX225-HE detector (pixel size, 73.2 μm) at 
SSRL and a Pilatus 100k detector (pixel size, 172 μm). Samples were also measured at the 
California NanoSystems Institute (CNSI) at UCLA using an in house setup. A compact SAXS light 
source (Forvis Technologies, Inc.) was used in conjunction with a mar345 image plate detector 
(pixel size, 150 μm). Identical samples were prepared and measured at multiple sources to check 
for and ensure mutual consistency. The 2D SAXS powder patterns were integrated using the 
Nika 1.48 package[52] for Igor Pro 6.21 and FIT2D.[53] 
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4.2.4.3 SAXS Data Fits 
A similar approach to the one described previously[40] was used to determine cubic 
phase lattice parameters. The measured cubic Q peak positions were related to the Miller 
indices h, k, and l, for the observed reflections using the equation for a powder averaged Pn3m 
cubic phase, Qmeas
Cubic = 2π√(h2 + k2 + l2)/a. The lattice parameter, a, was calculated from the 
slope of the trendline obtained from a linear fit of Qmeas
Cubic versus √(h2 + k2 + l2). For the plot of 
|<K>| versus Degree of Polymerization for poly-Arg and PGON, the lines that guide the eye were 
constructed via fits of the data to exponentially modified Gaussian functions. 
4.3 Results and Discussion 
The QM calculations published alongside this work provided precise atomistic insight 
into the complex interactions between the phosphates of lipid headgroups and guanidinium and 
amine groups.[48] Small angle X-ray scattering can complement the computational data since 
these experiments directly measure the nanoscale membrane curvature generated by 
guanidinium polymers. The QM calculations suggest that guanidinium groups of poly-Arg stack 
“face to face” when interguanidinium group separations are <5 Å. In this regime, changes in the 
interguanidinium group spacing should lead to changes in induced curvature. We explore 
membrane curvature generation as a function of interguanidinium group spacing using CPPs 
based on nonpeptide polyguanidine-oxanorbornene homopolymers (PGONs), which are not 
constrained to have the same geometric interguanidinium spacing as those based on 
polypeptide backbones. We present a systematic comparison between PGON and poly-Arg in 
the context of their membrane interactions. 
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Figure 4.3.  Generation of negative Gaussian curvature by guanidinium-rich polymers depends 
on average polymer length and average spacing between monomers. (A) Representative 
scattering spectra of PGONs with degree of polymerization 7, 18, and 50 (top to bottom) with 
DOPS/DOPE = 20/80 membranes at the polymer to lipid isoelectric point. Arrows indicate the 
first order reflection of the Pn3m cubic phase. A first order reflection at higher Q indicates the 
generation of greater negative Gaussian curvature. (B) Plots of polymer-induced average 
negative Gaussian curvature generation, |<K>|, versus polymer length for both PGON and poly 
arginine. The maximum amount of |<K>| occurs around Arg9 for poly arginine, while for PGON it 
is around an average degree of polymerization of 14. The lines are to guide the eye (see 
Experimental Section for details). (C) Schematic showing structural features of PGON and poly 
arginine, and effective spacing between guanidine groups. 
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4.3.1 SAXS Study of PGON Polymers with Lipid Membranes 
We use synchrotron small-angle X-ray scattering (SAXS) to characterize the interactions 
of model membranes with polyguanidine-oxanorbornene homopolymers (PGONs), which have 
been used as molecular transporters.[14, 16-18] PGON polymers substantially remodel small 
unilamellar vesicles (SUVs) into strongly scattering liquid crystalline structures as indicated by 
the appearance of sharp structure factor correlation peaks shown in representative spectra for 
PGON polymers with average degree of polymerization N = 7, 18, 50 (Figure 4.3A). For each 
polymer the scattering spectra contains peaks with Q positions at ratio √2: √3: √4, evidence of 
the presence of Pn3m “double-diamond” cubic phases. The Pn3m is a bicontinuous cubic phase 
composed of two nonintersecting tetrahedral water channels separated by the lipid bilayer. The 
midpoint of the bilayer traces out a minimal surface which has zero mean curvature and 
negative Gaussian curvature at every point. Geometrically, minimal surfaces locally have the 
shape of a saddle; the surface curves maximally upward and downward in orthogonal directions. 
Negative Gaussian curvature is ubiquitous in membrane permeation. It is present in the interior 
of toroidal pores, as well as at the base of blebs and the “neck” of budding events which are 
topologically identical and morphologically similar to the membrane protrusions and 
invaginations observed in endocytic processes. For example, the surface of a lipid-lined toroidal 
pore has the same shape as the surface surrounding the hole in a donut. The surface curves 
toward the hole as the interior of the pore is traced, while moving out of the pore the surface 
curves away from the hole; opposite curvatures in orthogonal directions just like in a saddle 
(Figure 4.4). Because negative Gaussian curvature is necessary for all these membrane 
destabilization processes, the generation of saddle-splay curvature by molecular transporters is 
a potent way to circumvent the barrier function of cell membranes and enable uptake into cells. 
Interestingly, although negative Gaussian curvature on a monolayer leaflet (as in a 
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transmembrane pore) is distinct from negative Gaussian curvature in a bilayer (as in a bud or 
bleb), there is strong correlation between peptide-induced membrane permeation and peptide-
induced formation of cubic phases,[39, 40, 54] which suggests that the root phenomenon of 
negative Gaussian membrane curvature generation by peptides can be expressed as different 
structural outcomes in isolated membranes under different conditions. By relating the peak Q 
positions to their Miller indices h, k, l, for each reflection using the equation for a powder 
averaged cubic phase, Qmeas = 2π√(h2 + k2 + l2)/a, we calculate lattice parameters aN=7 = 16.0 
nm, aN=18 = 15.0 nm, and aN=50 = 18.0 nm. Cubic phases are observed in PE-rich membranes for 
PGONs with N = 7, 9, 14, 18, 27, and 50, implying that generation of negative Gaussian curvature 
is a general feature of PGON polymers with N = 7–50. 
 Figure 4.4.  Illustration showing the connection between toroidal pores and saddle surfaces. The 
interior of a torus (top) has the same curvature as a ‘toroidal’ membrane pore. Close 
examination of the surface (bottom left) reveals that it bends in opposite directions at every 
point. This surface has saddle
orthogonal directions, as shown by rotating the surface (bottom right).
A nonmonotonic relationship between PGON length and cubic phase lattice parameter 
is observed (Figure 4.3A and B). This is strikingly similar to the trend found for poly
Since the minimal surface of a cubic phase has average negative Gaussian curvature <K> = 
2πχ/a2A0, where a is the measured cubic lattice parameter, χ is the Euler characteristic
the surface area per unit cell, the measured cubic lattice parameters can be used to extract the 
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<K> values for PGON polymers of different lengths.[55] Both PGON and poly-Arg generate 
maximum |<K>| at intermediate polymer lengths (Figure 4.3B). The polymer length where 
maximum |<K>| occurs for poly-Arg is around Arg9, whereas for PGON the maximum is shifted 
outward to an average degree of polymerization of about 14. The differences in |<K>| versus 
polymer length must originate from the different structural properties of their backbones which 
necessarily influence how the guanidinium groups interact with membrane lipids. 
The QM calculations presented previously[48] are consistent with the hypothesis that 
positive curvature generation by guanidinium group-directed lipid headgroup crowding can 
promote negative Gaussian curvature. This mechanism of generating positive curvature depends 
on a substantial degree of cooperativity, since both PGON and poly-Arg require a minimum 
number of guanidinium groups to induce such curvature. For example, the empirical 
observations that tetra-arginine, R4, induces an inverted hexagonal (HII) phase with negative 
mean curvature only and a minimum of 5 arginines is necessary before oligo-arginine can induce 
a Pn3m phase[39] implies that the structural tendency to form negative curvature is stronger 
than that to form positive curvature in short poly arginines. These results also suggest that two 
effects will progressively occur in the limit of dilute polymer to lipid molar ratios as the polymer 
chain length increases and thereby increases the amount of induced positive curvature. There 
will be a transition between inducing predominately negative membrane curvature to inducing a 
minimal surface with equal amounts of negative and positive curvature, or negative Gaussian 
curvature. The precise amount of induced negative Gaussian curvature depends on the relative 
amounts of positive and negative curvature generated, and achieves a maximum when the two 
are equal. Moreover, as the polymer length further increases, the excess induced positive 
curvature will interfere with generating the negative curvature component, and thereby 
ultimately limit the generation of negative Gaussian curvature. This is exactly what is observed 
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(Figure 4.3B) since the amount of negative Gaussian curvature initially increases, achieves a 
maximum as the curvatures are balanced, and eventually decreases. The precise polymer length 
that induces the maximum amount of negative Gaussian curvature depends on molecular 
details such as the effective guanidinium spacing, with closer spacings inducing more lipid head 
crowding and thereby more negative Gaussian curvature, which can also be seen in the 
comparison of polyarginine and PGON. 
The spacing between guanidinium groups in oxanorbornene polymers is 5.8 Å, 
approximately 60% larger than the 3.6 Å spacing in poly arginine (Figure 4.3C). The larger 
spacing in PGON along with its stiffer backbone compared to poly-Arg indicate that the average 
distance between guanidine side chains is greater in PGON than poly-Arg.[14] Not only does 
PGON require more guanidinium units to generate maximal negative Gaussian curvature 
compared to poly-Arg, the maximum average negative Gaussian curvature generated by PGON 
is 22% less than that for poly-Arg (Figure 4.3B).(74) These two observations are mutually 
consistent. Increasing the average distance between guanidinium groups has the effect of 
relieving stress from molecular crowding interactions between bulky composite headgroups that 
generate positive membrane curvature. Since negative Gaussian curvature requires both 
positive and negative curvature, reducing the amount of positive curvature will impair 
generation of negative Gaussian curvature. Therefore, PGON polymers with larger average 
spacing between guanidinium groups will be less effective in generating negative Gaussian 
curvature compared with poly-Arg. 
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Figure 4.5.  Hydrophobicity increases the amount of negative Gaussian curvature that 
guanidinium-rich polymers generate. (A) Butyl-GON polymer, N= 11, butyl/guanidine molar ratio 
= 6/5, generates Pn3m cubic phases in DOPS/DOPE = 20/80 membranes at peptide/lipid = 1/60 
and 1/30 molar ratios. The arrow points to the first (110) reflection of the Pn3m, which shifts to 
higher Q for greater P/L ratios. (B) A similar trend is observed for the phenyl-GON polymer, N = 
11, phenyl/guanidine molar ratio = 6/5. (C and D) Calculation of the Pn3m phase lattice 
parameters for butyl-GON (P/L = 1/30, red, P/L = 1/60, dark red) and phenyl-GON (P/L = 1/30, 
blue, P/L = 1/60, dark blue). Smaller lattices are seen for greater P/L ratios. (E) Average negative 
Gaussian curvature, |<K>|, versus polymer/lipid charge ratios for polymers of similar charges 
and sizes. The hydrophobic butyl-GON and phenyl-GON induce greater |<K>| than the 
hydrophilic PGONs. 
4.3.2 SAXS Study of Amphiphilic Butyl-GON and Phenyl-GON Polymers with Lipid 
Membranes 
Many pore forming peptides such as mammalian defensins contain both arginine and 
hydrophobic groups.[7-9] Since hydrophobicity is known to generate positive curvature[49] this 
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trend suggests that hydrophobicity might complement the cooperative positive curvature 
generation by guanidinium groups, and promote negative Gaussian curvature formation and 
membrane permeation. To examine this specific hypothesis on the role of hydrophobicity 
without the potentially confounding factor of facial am-phiphilicity, we added hydrophobic 
groups to these guanidinium-rich polymers by synthesizing random copolymers consisting of 
guanidinium groups with either hydrophobic butyl or phenyl side chains.[16, 17] SAXS 
experiments show that the strong induction of the Pn3m cubic phase is a general feature in the 
scattering spectra for both butyl-GON (Figure 4.5A) and phenyl-GON (Figure 4.5B). At 
peptide/lipid, P/L = 1/60 molar ratio, sharp correlation peaks at Q positions with ratios, 
√2:√3:√4:√6:√8:√9:√10:√11:√12, are seen for both butyl-GON and phenyl-GON. By fitting the 
peak Q positions to their respective reflections via linear trendlines (Figure 4.5C and D), we 
calculate Pn3m cubic lattice parameters of a = 19.4 nm for butyl-GON and a = 20.4 nm for 
phenyl-GON. Similar spectra are observed when the polymer concentration is doubled to P/L = 
1/30 (Figure 4.5A and B). The cubic phase reflections shift to higher Q values, however, 
indicating that greater polymer concentrations induce smaller cubic lattices. At P/L = 1/30, the 
lattice parameters shrink to a = 14.4 nm for butyl-GON (Figure 4.5C) and a = 15.4 nm for phenyl-
GON (Figure 4.5D). Since the cubic phase lattice parameter is inversely proportional to its 
average negative Gaussian curvature, increasing the polymer concentration increases the 
amount of negative Gaussian membrane curvature, as expected for polymers that generate 
such curvature. 
We plot the average negative Gaussian curvature over a range of peptide to lipid ratios 
for polymers with similar lengths and net charge (Figure 4.5E), to directly compare their abilities 
to generate curvature. Interestingly, |<K>| seems to increase linearly with polymer 
concentration over the range tested. Furthermore, while butyl-GON and phenyl-GON generate 
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roughly equivalent amounts of |<K>|, both amphiphilic polymers consistently generate more 
|<K>| than the N = 7, 9 PGON polymers. Therefore, the net effect of adding hydrophobicity to 
guanidinium-rich polymers is to increase the amount of negative Gaussian membrane curvature 
they induce. 
 
Figure 4.6.  Hydrophobicity broadens the range of lipid compositions where guanidinium-rich 
polymers induce negative Gaussian curvature. (A) At P/L = 1/30, amphiphilic butyl-GON and 
phenyl-GON polymers both generate Pn3m cubic phases in membranes with reduced amounts 
of negative spontaneous curvature lipids, DOPS/DOPE/DOPC = 20/70/10. Inset shows indexation 
of the Pn3m cubic for both polymers. (B–E). Phase diagrams for guanidinium-rich polymers over 
a range of lipid compositions, DOPS/DOPE/DOPC = 20/x/(80 – x) where x = %DOPE, and 
peptide/lipid ratios. The amphiphilic butyl-GON and phenyl-GON polymers generate cubic 
phases over a larger region of the phase diagram compared with the hydrophilic PGON 
polymers. 
Characterizing the effects of lipid composition on the curvature generating abilities of 
these guanidinium-rich polymers can elucidate their specific membrane permeating activities. 
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To do this, we use DOPS/DOPE/DOPC lipid compositions to perform a phase diagram study of 
polymer–lipid interactions. By changing the relative amounts of zwitterionic DOPC (spontaneous 
curvature, c0 = 0) and DOPE (c0 < 0) while holding constant the amount of anionic DOPS (c0 = 0) 
the amount of negative spontaneous curvature lipids in the membrane can be varied at constant 
membrane charge density. In DOPS/DOPE/DOPC = 20/70/10 membranes at P/L = 1/30, both 
butyl-GON and phenyl-GON generate Pn3m cubic phases with lattice parameters a = 20.5 nm 
and a = 20.0 nm, respectively (Figure 4.6A). These cubic lattices are larger than the ones for both 
polymers in 80% PE membranes, demonstrating that negative Gaussian curvature is more 
difficult to generate in membranes with lowered concentrations of DOPE lipids. Further reducing 
the amount of negative spontaneous curvature lipids to 60% DOPE suppresses cubic phase 
generation for both amphiphilic polymers (Figure 4.6B and C). Instead, pure lamellar phases are 
observed which consist of stacks of flat membranes with zero curvature. Comparing the phase 
diagrams for butyl-GON (Figure 4.6B) and phenyl-GON (Figure 4.6C) with the phase diagrams for 
N = 7 and 9, PGON (Figure 4.6D and E, and Figure 4.7) shows that, in general, the addition of 
hydrophobicity into guanidinium-rich polymers promotes saddle-splay curvature generation. 
Cubic phases are observed over a wider region of the phase diagram for the amphiphilic 
polymers, and the amphiphiles require less membrane PE content to generate negative 
Gaussian curvature. 
 Figure 4.7.  Phase diagrams of the PGON polymers used in this
Clearly, adding hydrophobicity to guanidinium
enhancement of their negative Gaussian curvature generation abilities. While polymers with 
guanidinium decorated monomers generally induce both positive and negative cu
two principal directions, the relative amounts of each type of curvature is in general not equal. 
Since incorporating hydrophobicity into PGON polymers enhances their ability to generate 
negative Gaussian curvature, this implies that short P
curvature than negative curvature. Supplying additional positive curvature via hydrophobicity 
effectively makes up the difference resulting in an amphiphilic polymer with better membrane 
destabilizing activity. This is consistent with our previously reported saddle
selection rules for cell-penetrating peptides
extreme case of positive curvature starved polymers such as poly lysine which generate negative 
curvature only,[54] even greater amounts of hydrophobicity will be required to optimize saddle
splay curvature generation. Therefore, while lipid 
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polymers can be a sufficient condition for generating positive curvature strain and therefore 
saddle-splay curvature, it can be enhanced by additional positive curvature strain from 
hydrophobicity. The addition of hydrophobicity, however, will in general make the membrane 
activity less specific in a broad range of peptides.[56-58] The curvature generating mechanism 
from hydrophobic insertion is inherently less specific than that from headgroup organization via 
cationic amino acids, since the latter interacts with headgroup chemistry, while the former 
interacts with the interior of the membrane. 
 
Figure 4.8.  Fractional calcein release from EYPC 400 nm vesicles as a function of polymer 
concentration. The polymer with added hydrophobes induces more release than any of the 
PGON samples. 
4.3.3 Biological Activity of PGON, Butyl-GON, and Phenyl-GON Polymers 
These design rules are evident in the biological activity of these polymers. Table 1 shows 
the hemolysis values for human red blood cells (RBC) along with the antibacterial activity against 
a gram-positive (S. aureus) and a gram-negative (E. coli) bacteria for a series of PGON-based 
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polymers. Comparing the HC50 values of the four polymers shows that the two PGON samples 
have higher values compared to the two samples designed with positive curvature generating 
components via hydrophobicity. Typically, the HC50 tracks most closely with membrane activity 
since the RBC is a nondividing cell type and the assay measures leakage of hemoglobin.[59] The 
antibacterial activity of the four polymer samples is similar and comparable to known 
antimicrobial peptides like Magainin. Understanding this activity is more complicated since the 
MIC is not a direct measure of membrane activity.[60] For example, it was shown previously that 
PGON is not strongly membrane active, yet displays MIC values in the range of 6–50 μg/mL.[51] 
Using simple dye release assays (Figure 4.8), a similar trend is observed for these polymers in 
which the butyl-GON polymer induces more dye release than any of the PGON derivatives. 
Consistent with this we recently showed that incorporation of hydrophobic moieties into cell-
penetrating peptides can change how they interact with membranes.[39] For example, while 
hydrophilic Arg6 (R6) crossed membranes via a rapid translocation mechanism, the addition of a 
single tryptophan into the peptide (R6W) was sufficient to induce slow dye leakage from intact 
vesicles. This change in behavior implies that incorporating hydrophobicity into hydrophilic 
peptides and polymers like poly-R and PGON can help to stabilize pore formation and increase 
membrane activity. 
Table 4.1.  Activity against Human Erythrocytes, S. aureus, and E. coli 
  MIC (ug/mL) 
Polymer HC50 (μg/mL) S. aureus E. coli 
P(GON)7 600 15 25 
P(GON)11 >750 25 25 
P(Ph-r-GON)11 30 15 25 
P(Bu-r-GON)11 45 20 25 
 
Our results raise the possibility of a mechanistic trade-off between activity from 
membrane disruption, and translocation across the membrane leading to activity from binding 
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intracellular targets. As shown above, hydrophobicity enhances saddle-splay curvature 
generation and therefore membrane activity, so association with cell membranes in the form of 
a stable pore inhibits an amphiphilic antimicrobial from reaching the cell interior. This implies 
that strong membrane activity may come at the expense of other forms of activity such as 
binding to intracellular targets. While hydrophilic guanidinium-rich polymers also generate 
sufficient saddle-splay curvature to permeate cell membranes, their membrane activity is 
reduced compared to their more hydrophobic counterparts. However, this decreases their 
likelihood of getting sequestered in the membrane, and upon crossing it, they are free to 
interact with intracellular targets and exact activity by inhibiting metabolic processes. 
4.4 Conclusion 
In summary we have shown that synthetic polyguanidine-oxanorbornene 
homopolymers, (PGONs), and amphiphilic phenyl-guanidine and butyl-guanidine random 
copolymers all generate saddle-splay curvature in membranes enriched with anionic lipids and 
negative spontaneous curvature lipids. QM calculations of the interactions of Arg with 
phosphate groups showed that guanidinium groups can coordinate two phosphates down to 
separations characteristic of poly-Arg via stacking adjacent diphosphated guanidinium 
complexes. Conversely, for Lys, two diphosphated amino groups cannot get closer than 7 Å 
without incurring a large energetic penalty. The stacking arrangement allows guanidinium-rich 
polymers to efficiently pack lipid headgroups, leading to steric crowding effects which generate 
positive curvature. This appears to be a key feature in its ability to organize lipid headgroups via 
H-bonding. Consistent with this result, poly-Arg and PGON generated saddle-splay curvature. 
The amount of curvature generated by PGON polymers was shown to be length dependent with 
maximal saddle-splay curvature generation occurring at intermediate polymer lengths, similar to 
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the trend observed for poly-Arg. However, in general, PGON generated less saddle-splay 
curvature than poly-Arg, and the polymer length that maximized saddle-splay curvature 
generation for PGON was longer than for poly-Arg. This occurs because the larger spacing 
between guanidine side chains in PGON and its stiffer backbone lessen the positive curvature 
strain due to guanidinium group-coordinated steric crowding effects, and supplying more 
guanidinium groups via longer PGON polymers only partially compensates. 
Different positive curvature producing mechanisms can be combined to enhance 
negative Gaussian curvature, since incorporation of hydrophobic butyl and phenyl groups into 
guanidinium-rich polymers increased the amounts of saddle-splay curvature they generate as 
well as broadened the range of lipid compositions over which it was observed. This implies that 
adding hydrophobicity to guanidinium-rich polymers can enhance their saddle-splay curvature 
generating abilities by supplying additional positive curvature to help balance the unequal 
amounts of positive and negative curvature produced by certain guanidinium group spacings 
and polymer lengths. For 5:6 guanidine/hydrophobe polymers negligible differences between 
the curvature generating abilities of the hydrophobic butyl and phenyl moieties were observed. 
We believe that these results provide engineering guidelines for designing membrane-active 
molecules with specific curvature generating properties which control their pore forming 
activities. 
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CHAPTER 5  
PTDM LENGTH, AROMATICITY AND ARCHITECTURE: SEARCHING FOR IDEAL PARAMETERS FOR 
NEGATIVE GAUSSIAN CURVATURE GENERATION 
5.1 Introduction 
 In the previous chapter, the effects of both length and polymer hydrophobicity were 
examined with regard to their ability to generate negative Gaussian curvature in bulk lipid 
systems.  Length was found to play a key role, as a the guanidinium-containing homopolymer 
was less active at low and high molecular weights, displaying peak curvature generation in the 
14-18 unit length range.  Hydrophobicity was also tremendously important in generating 
membrane curvature.  Not only did more hydrophobic copolymers generate more curvature, 
but they also were able to generate curvature in lipid systems containing only 70% negative 
intrinsic curvature phosphatidylethanolamine.  These hydrophobic copolymers, however, were 
also far more hemolytic than their homopolymer counterparts. Between this bounding of 
effectiveness and toxicity, along with optimal length, it appeared possible to achieve an “ideal” 
structure with the right intermediate combination of polymer length and hydrophobicity. 
 Aromaticity has also been explored as an important parameter for membrane 
interactions.  Trans membrane proteins generally have unusually high quantities of aromatic 
residues, especially concentrated in so-called “aromatic belts” at either end of the 
transmembrane region.[1-3]  Additionally, aromatic peptide residues interact more strongly 
with phospholipid bilayers than would be expected based purely upon their hydrophobicity.  A 
comparison of octanol-water to phospholipid-water partitioning demonstrated that aromatic 
residues associate unusually strongly with phospholipids.[4]  This suggests that there is some 
important interaction between the aromatic residues and the polar regions of the phospholipid 
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membrane.  The exact cause of this favorability is uncertain, although NMR studies[3] suggested 
that it may be due to a combination of the flat geometry of the aromatic ring as well as the 
shared electronic structure and its various interactions with charged and polar molecules.  
Preliminary work using ROMP-based PTDMs suggested that incorporation of aliphatic moieties 
may enhance the activity of these polymers over similar ones with aliphatic hydrophobic 
groups.[5] 
 Perhaps most important yet least explored parameter in terms of biophysical 
experiments is the effect of polymer architecture.    While previous studies examining PTD(M)s 
and negative Gaussian curvature generation have focused on peptides,[6] homopolymers, and 
random copolymers (Chapter 4),[7] tremendous success has been had in the use of block 
copolymer PTDMs for non-covalent delivery of macromolecular cargo to cells.[8-10]  This 
polymer design combines the best aspects of two important classes of molecules.  The 
guanidinium-rich block closely resembles the Tat-inspired PTDMs that have been studied in 
these preceding chapters, while the addition of the hydrophobic block gives it a structure 
resembling Pep-1, a chimeric peptide that has been widely used for delivery and is known 
commercially as ChariotTM.[11]  The polymers have only just begun to be investigated, and few 
studies compare their interaction with cells to polymers with similar hydrophobicities and 
different polymer architectures.[10, 12] 
 To this end, the following study examines the importance of length, aromaticity, and 
polymer architecture regarding their interaction with phospholipids.  Using our imide-based 
ROMP copolymer system, we are able to make guanidinium-rich polymers with an intermediate 
hydrophobicity, but varying length, aromaticity, and polymer architecture.  As standards for 
membrane activity, we look at the ability of these polymers to induce negative Gaussian 
curvature in bulk lipid systems using small-angle X-ray scattering (SAXS) as well as dye release 
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from egg yolk phosphatidylcholine (EYPC) vesicles.  The formation of negative Gaussian 
curvature, while not a direct measure of membrane transport, is necessary to create the kind of 
toroidal structure associated with pore formation or the insertion of a hydrophilic molecule into 
a lipid membrane.[6]  Dye release, rather than looking for a specific mechanistic component, 
strictly measures membrane permeation, regardless of how it occurs.[5, 13-17]  Thus, between 
these two measures, we are able to understand the effect of these changes in polymer structure 
on a specific mechanism suspected to be important in membrane activity, and then in turn 
measure how a change in that aspect alters overall dye release. 
5.2 Experimental Methods 
5.2.1 Monomer Synthesis 
Monomer syntheses were performed as by previous reports and Chapter 4.[5, 7, 16, 18] 
5.2.2 Polymer Synthesis 
Polymer synthesis was performed similarly to reported procedures.[5, 15, 16, 19]  
Monomers were co-polymerized by ring-opening metathesis polymerization (ROMP) using a 3rd 
generation Grubbs’ catalyst. The monomer (~200mg) and appropriate amount of catalyst were 
dissolved in dry dichloromethane in separate Schlenk flasks. The flasks were placed under 
nitrogen and degassed using a freeze-pump-thaw procedure. The monomer was transferred to 
the catalyst flask and the polymerization was allowed to proceed at 25°C for an hour, after 
which 1 mL ethyl vinyl ether was added to terminate the reaction. After an hour, the solution 
was concentrated and precipitated twice in 100 mL pentane. 
The  Boc-protected  polymers  were  deprotected  by  stirring  the  polymer  in  10  mL  
1:1 TFA:CH2Cl2 for 12 hours. The TFA was then removed by repeatedly co-evaporating with 
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methanol in a rotary evaporator, then by placing under a vacuum for 4 h. The solid polymer was 
then suspended in water and freeze-dried for 3 days. 
 
Boc-Protected G4n-r-Phn
1H NMR (300 MHz, CD2Cl2): δ=11.46 (4H, br), 8.44 (4H, br), 7.21 (5H, br), 
6.05 (trans), 5.76 (cis) (10H total, br), 4.99 (10H, br), 4.46 (8H, br), 4.08 (2H, br),  3.73 (12H, br),  
3.38 (10H, br) 2.91 (2, br) 1.52 (36H, br), 1.47 (36H, br) 
 
G4n-r-Phn: 
1H NMR (300 MHz, DMSO-d6):  δ = 7.27 (5H, br), 5.96-5.72 (10H, br), 4.88 (8H, br), 
4.43 (2H, br), 4.10 (2H, br), 2.85 (2H, br) 
 
Boc-Protected G4n-b-Phn
1H NMR (300 MHz, CD2Cl2): δ=11.46 (4H, br), 8.44 (4H, br), 7.21 (5H, br), 
6.05 (trans), 5.76 (cis) (10H total, br), 4.99 (10H, br), 4.46 (4H, br), 4.08 (1H, br),  3.73 (12H, br),  
3.38 (8H, br) 2.91 (2, br) 1.52 (36H, br), 1.47 (36H, br) 
 
G4n-b-Phn: 
1H NMR (300 MHz, DMSO-d6):  δ = 7.27 (5H, br), 5.96-5.72 (10H, br), 4.88 (8H, br), 
4.43 (2H, br), 4.10 (2H, br), 2.85 (2H, br) 
 
Boc-Protected G4n-r-Cyn
1H NMR (300 MHz, CD2Cl2): δ=11.46 (4H, br), 8.44 (4H, br), 6.05 (trans), 
5.76 (cis) (10H total, br), 4.99 (10H, br), 4.46 (8H, br), 3.73 (10H, br), 3.38 (10H, br), 1.68 (3H, br), 
1.52 (36H, br), 1.47 (36H, br), 1.18 (6H), 0.9 (4H) 
 
G4n-r-Cyn: 
1H NMR (300 MHz, CD3OD): δ = 6.08 (5H, br), 5.84 (5H, br), 5.02 (5H, br), 4.52 (5H, br), 
3.69 (8H, br), 3.46 (20H, br), 1.76 (2H, br), 1.45 (1H, br), 1.25 (6H, br), 0.96 (4H, 
br) 
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Boc-Protected G16-r-Oct4
1H NMR (300 MHz, CD2Cl2): δ=11.53 (4H, br), 8.49 (4H, br), 6.12 (trans), 
5.84 (cis) (10H total, br), 5.05(cis), 4.51 (cis) (10H total, br), 3.73 (18H, br), 3.42 (10H, br), 1.47 
(72H, br), 1.25 (12H, br), 0.9 (3H) 
 
G4n-r-Octn: 
1H NMR (300 MHz, CD3OD): δ = 5.94 (5H, br), 5.72 (5H, br), 4.86 (5H, br), 4.41 
(5H, br), 1.44 (2H, br), 1.21 (10H, br), 0.82 (3H, br) 
5.2.3 SAXS Studies 
5.2.3.1 Liposome Preparation for X-Ray Measurements 
Liposomes were prepared as described previously.[20] Briefly, DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine), DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), and DOPS 
(1,2-dioleoyl-sn-glycero-3-phospho-l-serine (sodium salt)), lyophilized lipids from Avanti Polar 
lipids were used without further purification. SUVs were prepared by sonication. Individual stock 
solutions of DOPS, DOPC, and DOPE were prepared in chloroform at 20 mg/mL. Ternary 
mixtures of these lipids were prepared at mass ratios, for example, DOPS/DOPE/DOPC = 
20/60/20 corresponds to a 1:3:1 mass ratio. Chloroform was evaporated under N2, and the 
mixtures were further dried by overnight desiccation under vacuum. The dried lipids were 
resuspended the next day in 100 mM NaCl or in Millipore H2O. Solutions were incubated at 37 
°C for 12–24 h and then sonicated until clear. Small unilamellar vesicles (SUV’s) were obtained 
via extrusion (0.2 μm pore Nucleopore filter). 
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5.2.3.2 SAXS Experiments 
All polymers were resuspended in either 100 mM NaCl or in Millipore H2O. Lipids were 
thoroughly mixed with polymers at specific peptide to lipid ratios (P/L) in 100 mM NaCl. The 
solutions were hermetically sealed in quartz capillaries (Hilgenberg GmbH, Mark-tubes, Code 
No: 4017515). SAXS experiments at synchrotron sources were conducted at the Stanford 
Synchrotron Radiation Laboratory (BL 4–2), and the Advanced Light Source (beamline 7.3.3). 
Monochromatic X-rays with energies 9–11 keV were used at SSRL and 10 keV at ALS. The 
scattered radiation was collected using a Rayonix MX225-HE detector (pixel size, 73.2 μm) at 
SSRL and a Pilatus 100k detector (pixel size, 172 μm). Samples were also measured at the 
California NanoSystems Institute (CNSI) at UCLA using an in house setup. A compact SAXS light 
source (Forvis Technologies, Inc.) was used in conjunction with a mar345 image plate detector 
(pixel size, 150 μm). Identical samples were prepared and measured at multiple sources to check 
for and ensure mutual consistency. The 2D SAXS powder patterns were integrated using the 
Nika 1.48 package[21] for Igor Pro 6.21 and FIT2D.[22] 
SAXS Data Fits 
A similar approach to the one described previously[20] was used to determine cubic 
phase lattice parameters. The measured cubic Q peak positions were related to the Miller 
indices h, k, and l, for the observed reflections using the equation for a powder averaged Pn3m 
cubic phase, Qmeas
Cubic = 2π√(h2 + k2 + l2)/a. The lattice parameter, a, was calculated from the 
slope of the trendline obtained from a linear fit of Qmeas
Cubic versus √(h2 + k2 + l2).  The minimal 
surface of a Pn3m cubic phase has the average negative Gaussian curvature: 
567 
29:
;<
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where a is the measured cubic lattice parameter, χ is the Euler characteristic, and A0 is the 
surface area per unit cell. 
5.2.4 Dye Release Studies 
5.2.4.1 Vesicle Preparation 
25mg egg yolk phosphatidylcholine (EYPC) in 3 mL of chloroform was evaporated onto 
the wall of a 10 mL flask using a rotary evaporator, then placed under vacuum overnight.  The 
lipid film was resuspended in buffer containing 10 mM Tris and 50 mM carboxyfluorescein dye, 
titrated to pH 7.5.  The buffer was allowed to sit for an hour, vortexing every 15 minutes.  The 
DPPC vesicles were swelled in a water bath set to 50°C during this time.  The vesicle solution 
was then put through six freeze-thaw cycles.  The solution was then extruded nine times 
through a 100 nm pore membrane.  The DPPC vesicles were warmed with a heat gun during the 
extrusion process.  Dye-loaded vesicles were separated from free dye by size exclusion 
chromatography (Sephadex G-50 superfine, Sigma Aldrich) in Tris saline buffer (10 mM Tris, 107 
mM NaCl, pH 7.5). 
5.2.4.2 EYPC Dye Release  
Experiments similar to those published previously[7] were performed using a Biotek 
Synergy Mx fluorescence plate reader.  All Fluorescence measurements were taken at an 
excitation wavelength of 492 nm and emission wavelength of 517 nm.  1,960 μL Tris buffer (10 
mM Tris, 107 mM NaCl, pH 7.5) was added to the wells of a 12-well plate.  20 μL of 250 μM 
vesicle solution (as defined above) was added to each well, creating an in-well concentration of 
2.5 μM.  The plate reader was heated to 25°C before continuing.  The plates were shaken at 
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25°C and after three minutes a baseline fluorescence measurement, F0, was taken.  20 μL 
polymer/DMSO solutions containing varying concentrations (0.01-1000 μL) of polymer were 
added to wells with stirrers, and the plate was returned to the reader for 10 minutes of shaking.  
After 10 minutes, another reading, F10, was taken.  20 μL 5% Triton X-100 in DMSO was added to 
the wells and after three minutes a final measurement, FT, was taken.  FT and F0 allowed use to 
normalize fluorescence to measure the fractional dye release: 
   	 
/ 	 
 
The fractional dye release Y was then fitted as a function of concentration, c, to the Hill equation 
by a least-squares method: 
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Where EC50 is the concentration of 50% of maximal dye release and n is a fitting parameter. 
 
5.3 Results and Discussion 
5.3.1 Polymer Design 
The polymer library used in this study (Figure 5.1, Table 5.1) presents range of polymer 
architectures, lengths, and types of hydrophobic moieties.  In all cases, these polymers have a 
fixed hydrophobic residue content of 20%.  To examine the effect of different types of 
hydrophobic residues, polymers containing phenyl, cyclohexyl, and octyl moieties were used.  To 
examine the effect of aromaticity on negative Gaussian curvature generation, phenyl, 
cyclohexyl, and octyl random copolymers were created.  Each hydrophobic moiety contains the 
same carbon content, but the phenyl monomer is aromatic while the cyclohexyl and octyl are 
not.  Previous studies of homopolymers[7] demonstrated that length played an important role 
in the amount of curvature these polymers are able to create in bulk systems.  The phenyl 
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random, phenyl block, and cyclohexyl series each have polymers of total average length 10, 20, 
and 40 to determine the effect of length for this series.  Lastly, there is a random phenyl and a 
block series to distinguish between the two different architectures. 
 
Figure 5.1.  Polymers used for this study.  Polymers were synthesized with n values of 2, 4, and 
8. 
Table 5.1.  Polymers used in this study. 
Name DP Hydrophobe Guanidine Expected MW 
G8-r-Ph2 10 2 8 4100 
G16-r-Ph4 20 4 16 8300 
G32-r-Ph8 40 8 32 16500 
G8-b-Ph2 10 2 8 4100 
G16-b-Ph4 20 4 16 8300 
G32-b-Ph8 40 8 32 16500 
G4n-r-Phn
G4n-r-Cyn
G4n-b-Phn
G16-r-Oct4
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G8-r-Cy2 10 2 8 4100 
G16-r-Cy4 20 4 16 8300 
G32-r-Cy8 40 8 32 16600 
G16-r-Oct4 20 4 16 8300 
 
5.3.2 Random Copolymer Series 
 All polymers were shown to be capable of generating the negative Gaussian curvature-
containing Pn3m phase in 20:80 DOPS:DOPE by small angle X-ray scattering (SAXS).  The X-
diffraction plots for the phenyl and cyclohexyl random copolymer series are shown in Figure 5.2.  
All Pn3m lattice parameters and derived curvature values are listed in Table 5.2.  The random 
phenyl series (Figure 5.2a) was shown to have Pn3m lattice parameters of a=17.0, 16.9, and 16.5 
for G8-r-Ph2, G16-r-Ph4, and G32-r-Ph8, respectively.  While these values are commensurate with 
those found for optimal-length homopolymer and more hydrophobic copolymers from Chapter 
4,[7] they show no meaningful variation with length.  Similarly, the cylclohexyl series (Figure 
5.2b) shows lattice parameters of a=16.2, 16.1, and 16.25 for G8-r-Cy2, G16-r-Cy4, and G32-r-Cy8, 
respectively.  This is slightly more curvature than generated for the random phenyl series, but 
the significance of this result is unknown.  The variation between the two series is much smaller 
than between the guanidine homopolymer and polyarginine, for example.[7]   Furthermore, the 
cyclohexyl series also shows no length dependence for Gaussian curvature generation.  Thus, it 
does not appear as if either aromaticity or polymer length measurably alters negative Gaussian 
curvature generation of these random, 20% hydrophobic residue polymers. 
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Figure 5.2.  Small-angle X-ray scattering plots for 20:80 DOPS:DOPE lipid systems combined with 
a) the random phenyl copolymer series and b)the random cyclohexyl copolymer series.  Arrows 
indicate the (110) peak of the Pn3m phase.  The series show similar ability to generate negative 
Gaussian curvature, and no length dependence. 
 This data is perhaps most interesting when compared to the data from Chapter 4.  
There, the guanidine containing polymer had a strong length dependence, with the strongest 
curvature occurring for polymers 14-18 units long.  The curvature values obtained for these 
polymers are never quite as high as the curvature obtained for those polymers, but curvature 
also does not decrease for either shorter or longer polymers.  In chapter 4, this relationship was 
speculated as due to a shift between the polymer inducing a predominantly negative curvature 
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at shorter lengths and a predominantly positive curvature at longer lengths.  At a sweet spot in 
the middle of these two trends, the balance is ideal for maximum negative Gaussian curvature 
generation.  If that were the case for these homopolymers, then the additional positive 
curvature contributed by the addition of hydrophobic groups should mean that the maximum 
curvature occurs at a lower molecular weight.  This is not the case, however.  There are two 
potential factors at play here.  The first is that the introduction of hydrophobic groups, while 
adding positive curvature, also add spacing between guanidinium units.  As was shown in the 
comparison of the homopolymer to polyarginine (Figure 4.3), the increased guanidinium spacing 
both decreases the maximum curvature generation as well as pushes the optimum length 
upwards.  The second component is that the claim that curvature is predominantly negative at 
low molecular weight and predominantly positive at high molecular weight was somewhat 
arbitrary, and it is entirely possible that negative curvature dominates for both short and long 
polymers.  In such a case, then, the added hydrophobicity significantly broadens the ideal length 
range for negative Gaussian curvature generation. 
Table 5.2.  Collected SAXS data.  Cells designated “-“ were tested but displayed no Pn3m phase 
peaks. 
 20:80 DOPS:DOPE 20:70:10 DOPS:DOPE:DOPC 
Name a (nm) |<K>| (nm-2) a (nm) |<K>| (nm-2) 
G
8
-r-Ph
2
 17 0.226 - - 
G
16
-r-Ph
4
 16.9 0.228 - - 
G
32
-r-Ph
8
 16.5 0.240 - - 
G
8
-b-Ph
2
 18 0.201 - - 
G
16
-b-Ph
4
 15.6 0.268 - - 
G
32
-b-Ph
8
 14.8 0.298 18.4 0.193 
G
8
-r-Cy
2
 16.2 0.248 - - 
G
16
-r-Cy
4
 16.1 0.251 - - 
G
32
-r-Cy
8
 16.25 0.247 - - 
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 As a complement to these studies, dye release from EYPC vesicles was also measured 
for each polymer of total length 20 (Figure 5.3).  Rather than looking for a specific mechanistic 
feature regarding pore formation as is the case with the SAXS experiments above, dye release 
simply measures a change in the permeability of the phospholipid membrane to the dye, 
regardless of mechanism.  As has been shown in many studies[5, 13, 14, 16-18] and earlier 
chapters of this work, this approach is often very sensitive to changes in polymer structure, 
membrane composition, and overall hydrophobicity.  In this case, however, there does not 
appear to be any meaningful difference in the dye release profiles of the polymers involved.  All 
four polymers measured had EC50 values ranging from 5.3nM (G16-r-Ph4) to 6.8 nM (G16-r-Cy4) 
and Hill curve maxima ranging from 0.56 (G16-r-Oct4) to 0.65 (G16-r-Ph4).  Similar to the small-
angle X-ray scattering data above, aromaticity of the hydrophobic moieties does not appear to 
be a factor for the random copolymer series. 
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Figure 5.3.  Dye release of all four polymers of length 20 with EYPC large unilamellar vesicles.  
Very little variation is shown between samples. 
5.3.3 Block Copolymer Series 
 The SAXS data for the block copolymer series (Figure 5.4), however, yields far more 
interesting results.  The diffraction shows a steadily increasing curvature with polymer length, 
with lattice parameters a=18.0, 15.6, and 14.8 for G8-b-Ph2, G16-b-Ph4, and G32-b-Ph8, 
respectively.  While the curvature obtained for G16-b-Ph4 is similar to that of G16-r-Ph4 and G16-r-
Cy4, the shorter polymer generates far less curvature and the longer polymer generates far 
more curvature.  This can best be seen in the plot of the mean curvature for all three polymer 
series shown in Figure 5.5.  While the two random copolymer series show relatively little 
variance amongst themselves, the block copolymer series show both a strong length 
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dependence and a strong differentiation from the random series.  Also of importance, G32-b-Ph8 
is the only polymer of any series able to induce negative Gaussian curvature with only 70% PE 
content (Figure 5.4b).  This clearly indicates that, while there may not be a huge difference in 
the curvature values for G16-b-Ph4 and G32-b-Ph8 at 80% PE, the latter polymer is clearly more 
capable of inducing the Pn3m phase. 
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Figure 5.4.  Small-angle X-ray scattering plots for the block phenyl series with a) 20:80 
DOPS:DOPE and b) 20:70:10 DOPS:DOPE:DOPC lipid systems.  Arrows in a) indicate the (110) 
peak of the Pn3m phase.  Arrows and b) indicate the (110), (111), (200), and (211) phases.  The 
polymer series shows a strong length dependence on curvature generation in a) and only G32-b-
Ph8 shows and Pn3m phase generation in b). 
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Figure 5.5.  Compiled curvature generation as a function of polymer length for all three series.  
The two random series show little separation and little length dependence, while the block 
copolymer series shows a strong length dependence. 
 While the random copolymer might be seen as a single chain that is more hydrophobic 
than the guanidinium-containing homopolymer, the block copolymer can perhaps be seen as 
consisting of two different components fused together, one resembling the homopolymer and 
one resembling a purely hydrophobic group.  We then have guanidinium-rich chains of average 
lengths 8, 16, and 32 fused to hydrophobic groups of 2, 4, and 8 units in length.  Chapter 4 
clearly showed a relationship between homopolymer length and curvature generation (Figure 
4.3), and the difference between polymers of length 7-9 and length 14-18 is similar to the 
difference between G8-b-Ph2 and G16-b-Ph4.  However, that relationship also entails a large drop 
in curvature generation between unit lengths 18 and 27, whereas G32-b-Ph8 actually has higher 
curvature than G16-b-Ph4.  This suggests, then, that the longer hydrophobic block is able to 
10 20 30 40
0.20
0.22
0.24
0.26
0.28
0.30
N
e
ga
tiv
e
 
G
au
ss
ia
n
 
Cu
rv
a
tu
re
 
(nm
-
2 )
Degree of Polymerization
 Cyclohexyl
 Phenyl (Random)
 Phenyl (Block)
DOPS:DOPE 20:80
149 
 
maintain high degrees of curvature for longer polymers.  It is uncertain if this is achieved by the 
hydrophobic region inserting into the membrane, or if the polymer forms a micelle before 
interacting with the membrane.  In either case, though, it does not appear as if the series has 
reached a maximum membrane curvature generation, and longer block copolymers may still 
generate more curvature. 
 To see if this effect carries over to membrane activity, dye release experiments were 
performed for the block copolymer series (Figure 5.6).  The curves are shown on a mass 
concentration plot, rather than a molar concentration one, so that each point on the x-axis 
represents a similar ratio between polymer cations and lipid anions.  This is the same standard 
of comparison that is used in the SAXS experiments above, which are all performed at constant 
charge ratio.  These polymers show EC50 values of 89, 46, and 71 ng/mL for polymers G8-b-Ph2, 
G16-b-Ph4, and G32-b-Ph8, respectively.  While these are not large differences (especially when 
compared to the ratios of an order of magnitude or more seen in Chapters 2 and 3), they seem 
more reflective of an optimum length at around DP=20, more like what is seen with the 
homopolymer in Chapter 4.  It is likelier, though, that these differences in EC50 values are not 
particularly meaningful, and that whatever causes the increase in curvature with polymer length 
in the SAXS studies does not carry over to the dye release studies.  This can be due to multiple 
factors.  First and foremost, the lipid systems are very different.  The SAXS studies are 
dominated but negative intrinsic curvature PE lipid, while the dye release studies are performed 
with near-zero curvature EYPC.[23]  PE content is relatively low in mammalian cells, and this 
difference in membrane composition has been demonstrated to be responsible for differences 
in membrane activity in antimicrobial compounds.[24-26]  That relationship between PE lipid 
content and activity of PTD(M)s is far less well established, however. Unlike antimicrobials, 
PTDMs are able to induce dye release in PC vesicles, but at the same time cannot induce 
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negative Gaussian curvature in low PE systems.  Whether trends in negative Gaussian curvature 
generation by PTD(M)s can more generally be applied to overall membrane activity still remains 
to be seen.  While these two tests (SAXS and dye release studies) measured the same effects for 
antimicrobials, it is possible that SAXS and dye release studies measure two different 
mechanisms of action for PTD(M)s. 
 
Figure 5.6.  Dye release for the block copolymer series with large unilamellar vesicles.  x-axis is 
given in units of µg/mL instead of µM to maintain a fixed polymer cation to lipid anion ratio, as 
was done with the SAXS experiments. 
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5.4 Conclusions 
 A diverse series of guanidinium-rich PTDMs was created, with similar hydrophobic 
contents but differing degrees or aromaticity and varying polymer architecture.  It was shown 
that both cyclohexyl- and phenyl-containing random copolymers were able to induce negative 
Gaussian curvature in 80% PE bulk lipid systems, but that there was no variation between the 
series or along polymer length.  The block-phenyl copolymer system G4n-b-Phn, however, 
differed from the random copolymer system and furthermore showed a substantial increase in 
curvature generation with polymer length.  Dye release experiments showed all polymers as 
having similar dye release profiles.  While both experiments have in various experiments been 
shown to correlate with actual cellular activity, it is possible that they are measuring aspects, 
and we should not assume a uniform relationship. What is clearer from this study is that the 
difference in activity between block and random copolymers deserves far more study.  While 
such structures have not been heavily studied in the biophysical realm, polymers with this 
design have been some of the most effective at carrying cargo into cells.[8-10]  It is quite likely 
that there is far more to understand about the nuances of what block copolymer architecture 
does to membrane activity, and this region remains largely unexplored. 
5.5 References 
 
 
1. Killian, J.A. and G. von Heijne, How proteins adapt to a membrane–water interface. 
Trends in Biochemical Sciences, 2000. 25(9): p. 429-434. 
2. White, S.H. and W.C. Wimley, MEMBRANE PROTEIN FOLDING AND STABILITY: Physical 
Principles. Annual Review of Biophysics and Biomolecular Structure, 1999. 28(1): p. 319-
365. 
3. Yau, W.-M., et al., The Preference of Tryptophan for Membrane Interfaces†. 
Biochemistry, 1998. 37(42): p. 14713-14718. 
152 
 
4. Wimley, W.C. and S.H. White, Experimentally determined hydrophobicity scale for 
proteins at membrane interfaces. Nature Structural & Molecular Biology, 1996. 3(10): p. 
842-848. 
5. Som, A., A. Reuter, and G.N. Tew, Protein Transduction Domain Mimics: The Role of 
Aromatic Functionality. Angewandte Chemie International Edition, 2012. 51(4): p. 980-
983. 
6. Mishra, A., et al., Translocation of HIV TAT peptide and analogues induced by 
multiplexed membrane and cytoskeletal interactions. Proceedings of the National 
Academy of Sciences of the United States of America, 2011. 108(41): p. 16883-16888. 
7. Schmidt, N.W., et al., Molecular Basis for Nanoscopic Membrane Curvature Generation 
from Quantum Mechanical Models and Synthetic Transporter Sequences. Journal of the 
American Chemical Society, 2012. 134(46): p. 19207-19216. 
8. Tezgel, A.O., Protein Transduction Domain Mimics by ROMP and Their Bioactive Cargo 
Delivery, in Polymer Science and Engineering2013, University of Massachusetts--
Amherst: Amhest, MA. p. 156. 
9. Tezgel, A.Ö., et al., Novel Protein Transduction Domain Mimics as Nonviral Delivery 
Vectors for siRNA Targeting NOTCH1 in Primary Human T cells. Molecular Therapy, 2013. 
21(1): p. 201-209. 
10. Sgolastra, F., et al., Sequence Segregation Improves Non-covalent Protein Delivery, 2014, 
University of Massachusetts--Amherst: Amherst, MA. 
11. Deshayes, S., et al., Delivery of proteins and nucleic acids using a non-covalent peptide-
based strategy. Advanced Drug Delivery Reviews, 2008. 60(4–5): p. 537-547. 
12. Sgolastra, F., et al., The Importance of Sequence Specific Hydrophobicity in Synthetic 
Protein Transduction Domain Mimics. Biomacromolecules, 2014. 15(3): p. 812-820. 
13. Almeida, P.F. and A. Pokorny, Mechanisms of Antimicrobial, Cytolytic, and Cell-
Penetrating Peptides: From Kinetics to Thermodynamics. Biochemistry, 2009. 48(34): p. 
8083-8093. 
14. Yandek, L.E., et al., Mechanism of the Cell-Penetrating Peptide Transportan 10 
Permeation of Lipid Bilayers. Biophysical Journal, 2007. 92(7): p. 2434-2444. 
15. Som, A., et al., Self-Activation in De Novo Designed Mimics of Cell-Penetrating Peptides. 
Angewandte Chemie International Edition, 2011. 50(27): p. 6147-6150. 
16. Hennig, A., et al., Stimuli-Responsive Polyguanidino-Oxanorbornene Membrane 
Transporters as Multicomponent Sensors in Complex Matrices. Journal of the American 
Chemical Society, 2008. 130(31): p. 10338-10344. 
17. Sakai, N. and S. Matile, Anion-Mediated Transfer of Polyarginine across Liquid and 
Bilayer Membranes. Journal of the American Chemical Society, 2003. 125(47): p. 14348-
14356. 
18. Som, A., et al., Self-Activation in De Novo Designed Mimics of Cell-Penetrating Peptides. 
Angewandte Chemie International Edition, 2011. 50(27): p. 6147-6150. 
19. Gabriel, G.J., et al., Synthetic Mimic of Antimicrobial Peptide with Nonmembrane-
Disrupting Antibacterial Properties. Biomacromolecules, 2008. 9(11): p. 2980-2983. 
20. Schmidt, N.W., et al., Criterion for amino acid composition of defensins and antimicrobial 
peptides based on geometry of membrane destabilization. Journal of the American 
Chemical Society, 2011. 133(17): p. 6720-6727. 
21. Ilavsky, J., <i>Nika</i> : software for two-dimensional data reduction. Journal of Applied 
Crystallography, 2012. 45(2): p. 324-328. 
22. Hammersley, A. THE FIT2D HOME PAGE. 2014/04/20/13:41:53; Available from: 
http://www.esrf.eu/computing/scientific/FIT2D/. 
153 
 
23. Zimmerberg, J. and M.M. Kozlov, How proteins produce cellular membrane curvature. 
Nature Reviews Molecular Cell Biology, 2006. 7(1): p. 9-19. 
24. Som, A., et al., Divalent Metal Ion Triggered Activity of a Synthetic Antimicrobial in 
Cardiolipin Membranes. Journal of the American Chemical Society, 2009. 131(42): p. 
15102-15103. 
25. Yang, L., et al., Synthetic Antimicrobial Oligomers Induce a Composition-Dependent 
Topological Transition in Membranes. Journal of the American Chemical Society, 2007. 
129(40): p. 12141-12147. 
26. Yang, L., et al., Mechanism of a prototypical synthetic membrane-active antimicrobial: 
Efficient hole-punching via interaction with negative intrinsic curvature lipids. 
Proceedings of the National Academy of Sciences, 2008. 105(52): p. 20595-20600. 
 
 
154 
 
CHAPTER 6  
Summary and Future Work 
6.1 Conclusions 
 This thesis presents a step forward in our understanding of PTDM-membrane 
interactions.  It has explored how guanidinium-rich polymers interact with phospholipid 
membrane phase, charge content, and negative Gaussian curvature induction.  It has looked at 
these features across polymer length, charge density, hydrophobicity, aromaticity and 
architecture.  The capability to so carefully compare the effects of different membrane and 
PTDM features is unique to this laboratory, and has resulted in mechanistic insight. 
 Chapter 2 presented the relationship between membrane phase and polymer activity.  
Cooling phospholipid membranes below their phase transition temperature was found to inhibit 
dye release from vesicles as well as uptake in cells.  This is important because cooling cells to 
refrigerator temperatures is a common practice to inhibit endocytosis and to distinguish energy-
dependent from energy-independent uptake.  Additional polymer hydrophobicity, however, was 
found to overcome this barrier. 
 Chapter 3 demonstrated that for this class of polymers, anionic lipid content inhibited 
the ability of these polymers to insert with phospholipid membranes.  This is in direct conflict 
with the generally accepted “adaptive translocation” model of PTDM activity.  It was also shown 
that while anionic lipid content is usually assumed as a necessary feature for surface association 
of the polymer on the lipid membrane, for this class polymer association is driven by 
hydrophobic interactions and the anionic content serves only to “pin” the PTMD to the surface 
of the membrane, and thus acts as a barrier to activity.  Much like the gel phase, however, this 
barrier can be overcome by additional polymer hydrophobicity.  These results call into question 
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the necessity of the cationic nature of the polymer, and suggest that charge-neutral varieties 
may be equally or more effective. 
 Chapters 4 and 5 examine the relationship between PTDM structure and negative 
Gaussian curvature formation in high PE-content lipid systems.  Polymer length, charge density, 
hydrophobicity, and architecture are all found to be important determining factors in the 
effectiveness of these polymers to generate curvature.  While said relationship between 
polymer structure and phase generation in bulk systems is well established, it is still unclear how 
well these results correlate to actual membrane activity. 
 From the sum of these, we find that the energy-independent interactions of PTDMs are 
largely driven by phase and solubility interactions.  Active polymers are soluble enough in 
solution to reach the membrane, but hydrophobic enough to insert into it.  Barriers to activity 
such as anionic lipid content and gel lipid phase can be overcome by additional hydrophobicity, 
or by addressing the barriers more directly.  This research leads us to a better understanding of 
PTDM interaction with membranes as a whole, as well as specific design constraints to consider 
when making polymers for delivery purposes. 
6.2 Future Work 
While meaningful progress was made in this work, there is an enormous wealth of 
topics still remaining to be explored.  Some of the more immediately pressing and achievable 
targets are listed below, areas that each could spawn extensive additional research themselves. 
6.2.1 More complex membrane systems 
The work presented in this thesis has highlighted the important impact of membrane 
phase and anionic lipid content, but cell membranes contain many other variables to consider.  
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Sphingolipids, cholesterols, glycolipids and membrane proteins can all be integrated into vesicle 
structures, but none of which are accounted for in most model systems.  While true parity with 
the organization present in a living cell can never be achieved, systematic understanding of the 
role of each of these components can give us a much better understanding of the relationship 
between membrane components and cellular uptake of PTDMs.   
6.2.2 Membrane activity and osmotic pressure 
Biophysical studies of PTD(M)s have largely focused varying compositional, rather than 
mechanical, aspects of the membrane.  There is, however, a great wealth of literature examining 
the relationship between polymer/peptide adhesion onto and insertion into membranes under 
varying physical constraints.[1-5]  While much of that literature is dedicated to sophisticated 
apparatus such as Langmuir troughs and pipette aspiration, a far simpler approach can be used 
with dye release experiments.  In dye release experiments, the vesicles are removed from their 
normal medium by size-exclusion chromatography and replaced with a buffer of similar 
osmolarity.  Changing the osmolarity of the external buffer through varying concentrations of 
glucose, on the other hand, would provide insight into the relationship between membrane 
tension and PTDM activity.    
6.2.3 Biophysical studies of polymer-cargo complexes 
 The studies presented in this thesis have focused on the interaction of individual 
polymers with lipid membranes.  The intended application of this class of molecules, however, is 
the delivery of macromolecular cargo to cells.  This consists of either direct conjugation of the 
PTDM to the cargo, or the formation of a self-assembled complex of PTDM and cargo.  It is likely 
that the interactions of such aggregates with phospholipid membranes is fundamentally 
157 
 
different than the interaction pure polymer in solution.  While dye release and surface plasmon 
resonance will give some insight into how the complex interacts with the membranes, FRET 
pairing between PTDMs and cargo will make it possible to monitor the interaction between the 
two components after introduction into the membrane.[6] 
6.2.4 Zwitterionic PTDMs 
Chapter 3 demonstrated that surface association of ROMP-based PTDMs was largely 
driven by hydrophobicity, and that electrostatic interactions between the cationic polymer and 
anionic lipid actually reduced membrane activity.  It then follows that even if there is some 
importance to the hydrogen bonding behavior of the guanidinium group, cationic nature in itself 
may not be particularly useful for membrane activity.  A zwitterionic molecule, then, with the 
right balance of water and membrane solubility may make for a superior drug delivery agent.  To 
the author’s knowledge, such a system has only been attempted once, with a micelle-forming 
polymer.[7]  While the results are promising, they are extremely preliminary and far more work 
needs to be done to investigate the effects of changing the charge content of the polymer.  This 
research group is uniquely positioned to advance this field however, due to our experience both 
with PTDMs and in designing zwitterionic polymer systems. 
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